id	sid	tid	token	lemma	pos
dpc-5668	1	1	dermatology	dermatology	NOUN
dpc-5668	1	2	:	:	PUNCT
dpc-5668	1	3	practical	practical	ADJ
dpc-5668	1	4	and	and	CCONJ
dpc-5668	1	5	conceptual	conceptual	ADJ
dpc-5668	1	6	review	review	NOUN
dpc-5668	1	7	|	|	ADV
dpc-5668	1	8	dermatol	dermatol	ADJ
dpc-5668	1	9	pract	pract	NOUN
dpc-5668	1	10	concept	concept	NOUN
dpc-5668	1	11	.	.	PUNCT
dpc-5668	2	1	2025;15(4):5668	2025;15(4):5668	NUM
dpc-5668	2	2	1	1	NUM
dpc-5668	2	3	meta	meta	ADJ
dpc-5668	2	4	-	-	PUNCT
dpc-5668	2	5	research	research	NOUN
dpc-5668	2	6	study	study	NOUN
dpc-5668	2	7	on	on	ADP
dpc-5668	2	8	the	the	DET
dpc-5668	2	9	quality	quality	NOUN
dpc-5668	2	10	of	of	ADP
dpc-5668	2	11	randomized	randomized	ADJ
dpc-5668	2	12	controlled	control	VERB
dpc-5668	2	13	trials	trial	NOUN
dpc-5668	2	14	evaluating	evaluate	VERB
dpc-5668	2	15	drug	drug	NOUN
dpc-5668	2	16	therapy	therapy	NOUN
dpc-5668	2	17	for	for	ADP
dpc-5668	2	18	impetigo	impetigo	PROPN
dpc-5668	2	19	juliana	juliana	PROPN
dpc-5668	2	20	cavaleiro	cavaleiro	PROPN
dpc-5668	2	21	rodrigues1	rodrigues1	PROPN
dpc-5668	2	22	,	,	PUNCT
dpc-5668	2	23	kamilla	kamilla	PROPN
dpc-5668	2	24	mayr	mayr	PROPN
dpc-5668	2	25	martins	martin	VERB
dpc-5668	2	26	sá1	sá1	PROPN
dpc-5668	2	27	,	,	PUNCT
dpc-5668	2	28	giullia	giullia	PROPN
dpc-5668	2	29	carvalho	carvalho	PROPN
dpc-5668	2	30	mangas	mangas	PROPN
dpc-5668	2	31	lopes2	lopes2	PROPN
dpc-5668	2	32	,	,	PUNCT
dpc-5668	2	33	marcella	marcella	PROPN
dpc-5668	2	34	cosmo	cosmo	PROPN
dpc-5668	2	35	piovesan1	piovesan1	PROPN
dpc-5668	2	36	,	,	PUNCT
dpc-5668	2	37	elaine	elaine	PROPN
dpc-5668	2	38	marcílio	marcílio	PROPN
dpc-5668	2	39	santos2	santos2	PROPN
dpc-5668	2	40	,	,	PUNCT
dpc-5668	2	41	ana	ana	PROPN
dpc-5668	2	42	luiza	luiza	PROPN
dpc-5668	2	43	cabrera	cabrera	PROPN
dpc-5668	2	44	martimbianco2	martimbianco2	PROPN
dpc-5668	3	1	1	1	NUM
dpc-5668	3	2	school	school	NOUN
dpc-5668	3	3	of	of	ADP
dpc-5668	3	4	medicine	medicine	NOUN
dpc-5668	3	5	,	,	PUNCT
dpc-5668	3	6	universidade	universidade	PROPN
dpc-5668	3	7	metropolitana	metropolitana	PROPN
dpc-5668	3	8	de	de	PROPN
dpc-5668	3	9	santos	santos	PROPN
dpc-5668	3	10	,	,	PUNCT
dpc-5668	3	11	santos	santos	PROPN
dpc-5668	3	12	,	,	PUNCT
dpc-5668	3	13	sp	sp	NOUN
dpc-5668	3	14	,	,	PUNCT
dpc-5668	3	15	brazil	brazil	PROPN
dpc-5668	3	16	2	2	NUM
dpc-5668	3	17	postgraduate	postgraduate	NOUN
dpc-5668	3	18	program	program	NOUN
dpc-5668	3	19	in	in	ADP
dpc-5668	3	20	health	health	NOUN
dpc-5668	3	21	and	and	CCONJ
dpc-5668	3	22	environment	environment	NOUN
dpc-5668	3	23	,	,	PUNCT
dpc-5668	3	24	universidade	universidade	PROPN
dpc-5668	3	25	metropolitana	metropolitana	PROPN
dpc-5668	3	26	de	de	PROPN
dpc-5668	3	27	santos	santos	PROPN
dpc-5668	3	28	,	,	PUNCT
dpc-5668	3	29	santos	santos	PROPN
dpc-5668	3	30	,	,	PUNCT
dpc-5668	3	31	sp	sp	NOUN
dpc-5668	3	32	,	,	PUNCT
dpc-5668	3	33	brazil	brazil	PROPN
dpc-5668	3	34	key	key	ADJ
dpc-5668	3	35	words	word	NOUN
dpc-5668	3	36	:	:	PUNCT
dpc-5668	3	37	impetigo	impetigo	NOUN
dpc-5668	3	38	,	,	PUNCT
dpc-5668	3	39	drug	drug	NOUN
dpc-5668	3	40	therapy	therapy	NOUN
dpc-5668	3	41	,	,	PUNCT
dpc-5668	3	42	randomized	randomize	VERB
dpc-5668	3	43	controlled	control	VERB
dpc-5668	3	44	trials	trial	NOUN
dpc-5668	3	45	,	,	PUNCT
dpc-5668	3	46	methodological	methodological	ADJ
dpc-5668	3	47	quality	quality	NOUN
dpc-5668	3	48	,	,	PUNCT
dpc-5668	3	49	meta	meta	ADJ
dpc-5668	3	50	-	-	PUNCT
dpc-5668	3	51	research	research	NOUN
dpc-5668	3	52	citation	citation	NOUN
dpc-5668	3	53	:	:	PUNCT
dpc-5668	3	54	rodrigues	rodrigues	PROPN
dpc-5668	3	55	jc	jc	PROPN
dpc-5668	3	56	,	,	PUNCT
dpc-5668	3	57	sá	sá	PROPN
dpc-5668	3	58	kmm	kmm	PROPN
dpc-5668	3	59	,	,	PUNCT
dpc-5668	3	60	lopes	lopes	PROPN
dpc-5668	3	61	gcm	gcm	PROPN
dpc-5668	3	62	,	,	PUNCT
dpc-5668	3	63	piovesan	piovesan	PROPN
dpc-5668	3	64	mc	mc	PROPN
dpc-5668	3	65	,	,	PUNCT
dpc-5668	3	66	santos	santos	PROPN
dpc-5668	3	67	em	em	PRON
dpc-5668	3	68	,	,	PUNCT
dpc-5668	3	69	martimbianco	martimbianco	PROPN
dpc-5668	3	70	alc	alc	PROPN
dpc-5668	3	71	.	.	PUNCT
dpc-5668	4	1	meta	meta	ADJ
dpc-5668	4	2	-	-	PUNCT
dpc-5668	4	3	research	research	NOUN
dpc-5668	4	4	study	study	NOUN
dpc-5668	4	5	on	on	ADP
dpc-5668	4	6	the	the	DET
dpc-5668	4	7	quality	quality	NOUN
dpc-5668	4	8	of	of	ADP
dpc-5668	4	9	randomized	randomized	ADJ
dpc-5668	4	10	controlled	control	VERB
dpc-5668	4	11	trials	trial	NOUN
dpc-5668	4	12	evaluating	evaluate	VERB
dpc-5668	4	13	drug	drug	NOUN
dpc-5668	4	14	therapy	therapy	NOUN
dpc-5668	4	15	for	for	ADP
dpc-5668	4	16	impetigo	impetigo	PROPN
dpc-5668	4	17	.	.	PUNCT
dpc-5668	5	1	dermatol	dermatol	NOUN
dpc-5668	5	2	pract	pract	PROPN
dpc-5668	5	3	concept	concept	NOUN
dpc-5668	5	4	.	.	PUNCT
dpc-5668	6	1	2025;15(4):5668	2025;15(4):5668	NUM
dpc-5668	6	2	.	.	PUNCT
dpc-5668	7	1	doi	doi	NOUN
dpc-5668	7	2	:	:	PUNCT
dpc-5668	7	3	https://doi	https://doi	PROPN
dpc-5668	7	4	.	.	PUNCT
dpc-5668	7	5	org/10.5826	org/10.5826	NUM
dpc-5668	7	6	/	/	SYM
dpc-5668	7	7	dpc.1504a5668	dpc.1504a5668	NOUN
dpc-5668	7	8	accepted	accept	VERB
dpc-5668	7	9	:	:	PUNCT
dpc-5668	7	10	june	june	PROPN
dpc-5668	7	11	11	11	NUM
dpc-5668	7	12	,	,	PUNCT
dpc-5668	7	13	2025	2025	NUM
dpc-5668	7	14	;	;	PUNCT
dpc-5668	7	15	published	publish	VERB
dpc-5668	7	16	:	:	PUNCT
dpc-5668	7	17	october	october	PROPN
dpc-5668	7	18	2025	2025	NUM
dpc-5668	7	19	copyright	copyright	NOUN
dpc-5668	7	20	:	:	PUNCT
dpc-5668	7	21	©	©	PROPN
dpc-5668	7	22	2025	2025	NUM
dpc-5668	7	23	rodrigues	rodrigue	NOUN
dpc-5668	7	24	et	et	PROPN
dpc-5668	7	25	al	al	PROPN
dpc-5668	7	26	.	.	PUNCT
dpc-5668	8	1	this	this	PRON
dpc-5668	8	2	is	be	AUX
dpc-5668	8	3	an	an	DET
dpc-5668	8	4	open	open	ADJ
dpc-5668	8	5	-	-	PUNCT
dpc-5668	8	6	access	access	NOUN
dpc-5668	8	7	article	article	NOUN
dpc-5668	8	8	distributed	distribute	VERB
dpc-5668	8	9	under	under	ADP
dpc-5668	8	10	the	the	DET
dpc-5668	8	11	terms	term	NOUN
dpc-5668	8	12	of	of	ADP
dpc-5668	8	13	the	the	DET
dpc-5668	8	14	creative	creative	ADJ
dpc-5668	8	15	commons	common	NOUN
dpc-5668	8	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-5668	8	17	license	license	NOUN
dpc-5668	8	18	(	(	PUNCT
dpc-5668	8	19	by	by	ADP
dpc-5668	8	20	-	-	PUNCT
dpc-5668	8	21	nc-4.0	nc-4.0	NOUN
dpc-5668	8	22	)	)	PUNCT
dpc-5668	8	23	,	,	PUNCT
dpc-5668	8	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-5668	8	25	,	,	PUNCT
dpc-5668	8	26	which	which	PRON
dpc-5668	8	27	permits	permit	VERB
dpc-5668	8	28	unrestricted	unrestricted	ADJ
dpc-5668	8	29	noncommercial	noncommercial	ADJ
dpc-5668	8	30	use	use	NOUN
dpc-5668	8	31	,	,	PUNCT
dpc-5668	8	32	distribution	distribution	NOUN
dpc-5668	8	33	,	,	PUNCT
dpc-5668	8	34	and	and	CCONJ
dpc-5668	8	35	reproduction	reproduction	NOUN
dpc-5668	8	36	in	in	ADP
dpc-5668	8	37	any	any	DET
dpc-5668	8	38	medium	medium	NOUN
dpc-5668	8	39	,	,	PUNCT
dpc-5668	8	40	provided	provide	VERB
dpc-5668	8	41	the	the	DET
dpc-5668	8	42	original	original	ADJ
dpc-5668	8	43	authors	author	NOUN
dpc-5668	8	44	and	and	CCONJ
dpc-5668	8	45	source	source	NOUN
dpc-5668	8	46	are	be	AUX
dpc-5668	8	47	credited	credit	VERB
dpc-5668	8	48	.	.	PUNCT
dpc-5668	9	1	funding	funding	NOUN
dpc-5668	9	2	:	:	PUNCT
dpc-5668	9	3	none	none	NOUN
dpc-5668	9	4	.	.	PUNCT
dpc-5668	10	1	competing	compete	VERB
dpc-5668	10	2	interests	interest	NOUN
dpc-5668	10	3	:	:	PUNCT
dpc-5668	10	4	none	none	NOUN
dpc-5668	10	5	.	.	PUNCT
dpc-5668	11	1	authorship	authorship	NOUN
dpc-5668	11	2	:	:	PUNCT
dpc-5668	11	3	all	all	DET
dpc-5668	11	4	authors	author	NOUN
dpc-5668	11	5	have	have	AUX
dpc-5668	11	6	contributed	contribute	VERB
dpc-5668	11	7	significantly	significantly	ADV
dpc-5668	11	8	to	to	ADP
dpc-5668	11	9	this	this	DET
dpc-5668	11	10	publication	publication	NOUN
dpc-5668	11	11	.	.	PUNCT
dpc-5668	12	1	corresponding	correspond	VERB
dpc-5668	12	2	author	author	NOUN
dpc-5668	12	3	:	:	PUNCT
dpc-5668	12	4	ana	ana	PROPN
dpc-5668	12	5	luiza	luiza	PROPN
dpc-5668	12	6	cabrera	cabrera	PROPN
dpc-5668	12	7	martimbianco	martimbianco	PROPN
dpc-5668	12	8	,	,	PUNCT
dpc-5668	12	9	postgraduate	postgraduate	NOUN
dpc-5668	12	10	program	program	NOUN
dpc-5668	12	11	of	of	ADP
dpc-5668	12	12	health	health	NOUN
dpc-5668	12	13	and	and	CCONJ
dpc-5668	12	14	environment	environment	NOUN
dpc-5668	12	15	,	,	PUNCT
dpc-5668	12	16	universidade	universidade	PROPN
dpc-5668	12	17	metropolitana	metropolitana	PROPN
dpc-5668	12	18	de	de	PROPN
dpc-5668	12	19	santos	santos	PROPN
dpc-5668	12	20	,	,	PUNCT
dpc-5668	12	21	santos	santos	PROPN
dpc-5668	12	22	,	,	PUNCT
dpc-5668	12	23	sp	sp	NOUN
dpc-5668	12	24	,	,	PUNCT
dpc-5668	12	25	brazil	brazil	PROPN
dpc-5668	12	26	.	.	PUNCT
dpc-5668	13	1	avenida	avenida	PROPN
dpc-5668	13	2	conselheiro	conselheiro	VERB
dpc-5668	13	3	nébias	nébias	PROPN
dpc-5668	13	4	536	536	NUM
dpc-5668	13	5	,	,	PUNCT
dpc-5668	13	6	santos	santos	PROPN
dpc-5668	13	7	sp	sp	PROPN
dpc-5668	13	8	,	,	PUNCT
dpc-5668	13	9	brazil	brazil	PROPN
dpc-5668	13	10	.	.	PUNCT
dpc-5668	14	1	zip	zip	NOUN
dpc-5668	14	2	code	code	NOUN
dpc-5668	14	3	11045	11045	NUM
dpc-5668	14	4	-	-	SYM
dpc-5668	14	5	002	002	NUM
dpc-5668	14	6	.	.	PUNCT
dpc-5668	15	1	orcid	orcid	NOUN
dpc-5668	15	2	:	:	PUNCT
dpc-5668	15	3	0000	0000	NUM
dpc-5668	15	4	-	-	PUNCT
dpc-5668	15	5	0002	0002	NUM
dpc-5668	15	6	-	-	PUNCT
dpc-5668	15	7	4361	4361	NUM
dpc-5668	15	8	-	-	PUNCT
dpc-5668	15	9	4526	4526	NUM
dpc-5668	15	10	.	.	PUNCT
dpc-5668	16	1	email	email	NOUN
dpc-5668	16	2	:	:	PUNCT
dpc-5668	16	3	analuizacabrera@hotmail.com	analuizacabrera@hotmail.com	X
dpc-5668	17	1	introduction	introduction	NOUN
dpc-5668	17	2	:	:	PUNCT
dpc-5668	17	3	impetigo	impetigo	PROPN
dpc-5668	17	4	is	be	AUX
dpc-5668	17	5	a	a	DET
dpc-5668	17	6	common	common	ADJ
dpc-5668	17	7	,	,	PUNCT
dpc-5668	17	8	highly	highly	ADV
dpc-5668	17	9	contagious	contagious	ADJ
dpc-5668	17	10	bacterial	bacterial	ADJ
dpc-5668	17	11	skin	skin	NOUN
dpc-5668	17	12	infection	infection	NOUN
dpc-5668	17	13	primarily	primarily	ADV
dpc-5668	17	14	affecting	affect	VERB
dpc-5668	17	15	children	child	NOUN
dpc-5668	17	16	.	.	PUNCT
dpc-5668	18	1	treatment	treatment	NOUN
dpc-5668	18	2	usually	usually	ADV
dpc-5668	18	3	involves	involve	VERB
dpc-5668	18	4	topical	topical	ADJ
dpc-5668	18	5	or	or	CCONJ
dpc-5668	18	6	oral	oral	ADJ
dpc-5668	18	7	antibiotics	antibiotic	NOUN
dpc-5668	18	8	,	,	PUNCT
dpc-5668	18	9	and	and	CCONJ
dpc-5668	18	10	numerous	numerous	ADJ
dpc-5668	18	11	clinical	clinical	ADJ
dpc-5668	18	12	trials	trial	NOUN
dpc-5668	18	13	have	have	AUX
dpc-5668	18	14	been	be	AUX
dpc-5668	18	15	published	publish	VERB
dpc-5668	18	16	to	to	PART
dpc-5668	18	17	support	support	VERB
dpc-5668	18	18	these	these	DET
dpc-5668	18	19	therapeutic	therapeutic	ADJ
dpc-5668	18	20	approaches	approach	NOUN
dpc-5668	18	21	.	.	PUNCT
dpc-5668	19	1	objectives	objective	NOUN
dpc-5668	19	2	:	:	PUNCT
dpc-5668	19	3	to	to	PART
dpc-5668	19	4	evaluate	evaluate	VERB
dpc-5668	19	5	the	the	DET
dpc-5668	19	6	methodological	methodological	ADJ
dpc-5668	19	7	quality	quality	NOUN
dpc-5668	19	8	of	of	ADP
dpc-5668	19	9	randomized	randomized	ADJ
dpc-5668	19	10	clinical	clinical	ADJ
dpc-5668	19	11	trials	trial	NOUN
dpc-5668	19	12	(	(	PUNCT
dpc-5668	19	13	rcts	rct	NOUN
dpc-5668	19	14	)	)	PUNCT
dpc-5668	19	15	on	on	ADP
dpc-5668	19	16	the	the	DET
dpc-5668	19	17	pharmacological	pharmacological	ADJ
dpc-5668	19	18	treatment	treatment	NOUN
dpc-5668	19	19	of	of	ADP
dpc-5668	19	20	impetigo	impetigo	NOUN
dpc-5668	19	21	in	in	ADP
dpc-5668	19	22	children	child	NOUN
dpc-5668	19	23	and	and	CCONJ
dpc-5668	19	24	adolescents	adolescent	NOUN
dpc-5668	19	25	.	.	PUNCT
dpc-5668	20	1	methods	method	NOUN
dpc-5668	20	2	:	:	PUNCT
dpc-5668	20	3	this	this	DET
dpc-5668	20	4	meta	meta	ADJ
dpc-5668	20	5	-	-	PUNCT
dpc-5668	20	6	research	research	NOUN
dpc-5668	20	7	evaluated	evaluate	VERB
dpc-5668	20	8	rcts	rct	NOUN
dpc-5668	20	9	on	on	ADP
dpc-5668	20	10	systemic	systemic	ADJ
dpc-5668	20	11	or	or	CCONJ
dpc-5668	20	12	topical	topical	ADJ
dpc-5668	20	13	pharmacological	pharmacological	ADJ
dpc-5668	20	14	treatments	treatment	NOUN
dpc-5668	20	15	for	for	ADP
dpc-5668	20	16	impetigo	impetigo	NOUN
dpc-5668	20	17	in	in	ADP
dpc-5668	20	18	children	child	NOUN
dpc-5668	20	19	and	and	CCONJ
dpc-5668	20	20	adolescents	adolescent	NOUN
dpc-5668	20	21	.	.	PUNCT
dpc-5668	21	1	a	a	DET
dpc-5668	21	2	comprehensive	comprehensive	ADJ
dpc-5668	21	3	literature	literature	NOUN
dpc-5668	21	4	search	search	NOUN
dpc-5668	21	5	was	be	AUX
dpc-5668	21	6	conducted	conduct	VERB
dpc-5668	21	7	in	in	ADP
dpc-5668	21	8	september	september	PROPN
dpc-5668	21	9	2024	2024	NUM
dpc-5668	21	10	across	across	ADP
dpc-5668	21	11	medline	medline	NOUN
dpc-5668	21	12	,	,	PUNCT
dpc-5668	21	13	embase	embase	NOUN
dpc-5668	21	14	,	,	PUNCT
dpc-5668	21	15	central	central	ADJ
dpc-5668	21	16	,	,	PUNCT
dpc-5668	21	17	and	and	CCONJ
dpc-5668	21	18	lilacs	lilacs	PROPN
dpc-5668	21	19	databases	database	NOUN
dpc-5668	21	20	.	.	PUNCT
dpc-5668	22	1	the	the	DET
dpc-5668	22	2	methodological	methodological	ADJ
dpc-5668	22	3	quality	quality	NOUN
dpc-5668	22	4	of	of	ADP
dpc-5668	22	5	the	the	DET
dpc-5668	22	6	included	include	VERB
dpc-5668	22	7	rcts	rct	NOUN
dpc-5668	22	8	was	be	AUX
dpc-5668	22	9	assessed	assess	VERB
dpc-5668	22	10	using	use	VERB
dpc-5668	22	11	the	the	DET
dpc-5668	22	12	cochrane	cochrane	NOUN
dpc-5668	22	13	risk	risk	NOUN
dpc-5668	22	14	of	of	ADP
dpc-5668	22	15	bias	bias	NOUN
dpc-5668	22	16	tool	tool	NOUN
dpc-5668	22	17	.	.	PUNCT
dpc-5668	23	1	data	datum	NOUN
dpc-5668	23	2	are	be	AUX
dpc-5668	23	3	presented	present	VERB
dpc-5668	23	4	as	as	ADP
dpc-5668	23	5	percentages	percentage	NOUN
dpc-5668	23	6	.	.	PUNCT
dpc-5668	24	1	results	result	NOUN
dpc-5668	24	2	:	:	PUNCT
dpc-5668	24	3	twenty	twenty	NUM
dpc-5668	24	4	-	-	PUNCT
dpc-5668	24	5	one	one	NUM
dpc-5668	24	6	rcts	rct	NOUN
dpc-5668	24	7	on	on	ADP
dpc-5668	24	8	pharmacological	pharmacological	ADJ
dpc-5668	24	9	treatments	treatment	NOUN
dpc-5668	24	10	for	for	ADP
dpc-5668	24	11	impetigo	impetigo	NOUN
dpc-5668	24	12	were	be	AUX
dpc-5668	24	13	identified	identify	VERB
dpc-5668	24	14	and	and	CCONJ
dpc-5668	24	15	assessed	assess	VERB
dpc-5668	24	16	.	.	PUNCT
dpc-5668	25	1	the	the	DET
dpc-5668	25	2	findings	finding	NOUN
dpc-5668	25	3	identified	identify	VERB
dpc-5668	25	4	some	some	DET
dpc-5668	25	5	methodological	methodological	ADJ
dpc-5668	25	6	concerns	concern	NOUN
dpc-5668	25	7	:	:	PUNCT
dpc-5668	25	8	i	i	NOUN
dpc-5668	25	9	)	)	PUNCT
dpc-5668	25	10	53	53	NUM
dpc-5668	25	11	%	%	NOUN
dpc-5668	25	12	to	to	ADP
dpc-5668	25	13	57	57	NUM
dpc-5668	25	14	%	%	NOUN
dpc-5668	25	15	of	of	ADP
dpc-5668	25	16	rcts	rct	NOUN
dpc-5668	25	17	had	have	VERB
dpc-5668	25	18	an	an	DET
dpc-5668	25	19	unclear	unclear	ADJ
dpc-5668	25	20	risk	risk	NOUN
dpc-5668	25	21	of	of	ADP
dpc-5668	25	22	selection	selection	NOUN
dpc-5668	25	23	bias	bias	NOUN
dpc-5668	25	24	due	due	ADP
dpc-5668	25	25	to	to	ADP
dpc-5668	25	26	insufficient	insufficient	ADJ
dpc-5668	25	27	information	information	NOUN
dpc-5668	25	28	on	on	ADP
dpc-5668	25	29	randomization	randomization	NOUN
dpc-5668	25	30	and	and	CCONJ
dpc-5668	25	31	allocation	allocation	NOUN
dpc-5668	25	32	concealment	concealment	NOUN
dpc-5668	25	33	;	;	PUNCT
dpc-5668	25	34	ii	ii	X
dpc-5668	25	35	)	)	PUNCT
dpc-5668	25	36	71	71	NUM
dpc-5668	25	37	%	%	NOUN
dpc-5668	25	38	were	be	AUX
dpc-5668	25	39	at	at	ADP
dpc-5668	25	40	high	high	ADJ
dpc-5668	25	41	risk	risk	NOUN
dpc-5668	25	42	of	of	ADP
dpc-5668	25	43	bias	bias	NOUN
dpc-5668	25	44	for	for	ADP
dpc-5668	25	45	blinding	blinding	NOUN
dpc-5668	25	46	of	of	ADP
dpc-5668	25	47	participants	participant	NOUN
dpc-5668	25	48	and	and	CCONJ
dpc-5668	25	49	personnel	personnel	NOUN
dpc-5668	25	50	,	,	PUNCT
dpc-5668	25	51	while	while	SCONJ
dpc-5668	25	52	57	57	NUM
dpc-5668	25	53	%	%	NOUN
dpc-5668	25	54	had	have	VERB
dpc-5668	25	55	a	a	DET
dpc-5668	25	56	high	high	ADJ
dpc-5668	25	57	risk	risk	NOUN
dpc-5668	25	58	for	for	ADP
dpc-5668	25	59	abstract	abstract	ADJ
dpc-5668	25	60	2	2	NUM
dpc-5668	25	61	review	review	NOUN
dpc-5668	26	1	|	|	ADV
dpc-5668	26	2	dermatol	dermatol	ADJ
dpc-5668	26	3	pract	pract	NOUN
dpc-5668	26	4	concept	concept	NOUN
dpc-5668	26	5	.	.	PUNCT
dpc-5668	27	1	2025;15(4):5668	2025;15(4):5668	NUM
dpc-5668	27	2	introduction	introduction	NOUN
dpc-5668	27	3	randomized	randomize	VERB
dpc-5668	27	4	controlled	control	VERB
dpc-5668	27	5	trials	trial	NOUN
dpc-5668	27	6	(	(	PUNCT
dpc-5668	27	7	rcts	rct	NOUN
dpc-5668	27	8	)	)	PUNCT
dpc-5668	27	9	are	be	AUX
dpc-5668	27	10	the	the	DET
dpc-5668	27	11	gold	gold	ADJ
dpc-5668	27	12	standard	standard	NOUN
dpc-5668	27	13	for	for	ADP
dpc-5668	27	14	generating	generate	VERB
dpc-5668	27	15	high	high	ADJ
dpc-5668	27	16	-	-	PUNCT
dpc-5668	27	17	quality	quality	NOUN
dpc-5668	27	18	evidence	evidence	NOUN
dpc-5668	27	19	on	on	ADP
dpc-5668	27	20	the	the	DET
dpc-5668	27	21	effects	effect	NOUN
dpc-5668	27	22	of	of	ADP
dpc-5668	27	23	healthcare	healthcare	NOUN
dpc-5668	27	24	interventions	intervention	NOUN
dpc-5668	27	25	.	.	PUNCT
dpc-5668	28	1	their	their	PRON
dpc-5668	28	2	methodological	methodological	ADJ
dpc-5668	28	3	rigor	rigor	NOUN
dpc-5668	28	4	,	,	PUNCT
dpc-5668	28	5	particularly	particularly	ADV
dpc-5668	28	6	in	in	ADP
dpc-5668	28	7	minimizing	minimize	VERB
dpc-5668	28	8	bias	bias	NOUN
dpc-5668	28	9	,	,	PUNCT
dpc-5668	28	10	ensures	ensure	VERB
dpc-5668	28	11	more	more	ADV
dpc-5668	28	12	accurate	accurate	ADJ
dpc-5668	28	13	and	and	CCONJ
dpc-5668	28	14	valid	valid	ADJ
dpc-5668	28	15	estimates	estimate	NOUN
dpc-5668	28	16	of	of	ADP
dpc-5668	28	17	treatment	treatment	NOUN
dpc-5668	28	18	effects	effect	NOUN
dpc-5668	28	19	.	.	PUNCT
dpc-5668	29	1	as	as	ADP
dpc-5668	29	2	a	a	DET
dpc-5668	29	3	result	result	NOUN
dpc-5668	29	4	,	,	PUNCT
dpc-5668	29	5	rcts	rct	NOUN
dpc-5668	29	6	play	play	VERB
dpc-5668	29	7	a	a	DET
dpc-5668	29	8	pivotal	pivotal	ADJ
dpc-5668	29	9	role	role	NOUN
dpc-5668	29	10	in	in	ADP
dpc-5668	29	11	informing	inform	VERB
dpc-5668	29	12	clinical	clinical	ADJ
dpc-5668	29	13	practice	practice	NOUN
dpc-5668	29	14	and	and	CCONJ
dpc-5668	29	15	shaping	shape	VERB
dpc-5668	29	16	healthcare	healthcare	NOUN
dpc-5668	29	17	policies	policy	NOUN
dpc-5668	29	18	,	,	PUNCT
dpc-5668	29	19	either	either	CCONJ
dpc-5668	29	20	directly	directly	ADV
dpc-5668	29	21	or	or	CCONJ
dpc-5668	29	22	through	through	ADP
dpc-5668	29	23	their	their	PRON
dpc-5668	29	24	integration	integration	NOUN
dpc-5668	29	25	into	into	ADP
dpc-5668	29	26	systematic	systematic	ADJ
dpc-5668	29	27	reviews	review	NOUN
dpc-5668	29	28	and	and	CCONJ
dpc-5668	29	29	meta	meta	NOUN
dpc-5668	29	30	-	-	PUNCT
dpc-5668	29	31	analyses	analysis	NOUN
dpc-5668	29	32	[	[	X
dpc-5668	29	33	1–3	1–3	NOUN
dpc-5668	29	34	]	]	X
dpc-5668	29	35	.	.	PUNCT
dpc-5668	30	1	however	however	ADV
dpc-5668	30	2	,	,	PUNCT
dpc-5668	30	3	the	the	DET
dpc-5668	30	4	reliability	reliability	NOUN
dpc-5668	30	5	and	and	CCONJ
dpc-5668	30	6	applicability	applicability	NOUN
dpc-5668	30	7	of	of	ADP
dpc-5668	30	8	rct	rct	PROPN
dpc-5668	30	9	findings	finding	NOUN
dpc-5668	30	10	are	be	AUX
dpc-5668	30	11	highly	highly	ADV
dpc-5668	30	12	dependent	dependent	ADJ
dpc-5668	30	13	on	on	ADP
dpc-5668	30	14	their	their	PRON
dpc-5668	30	15	methodological	methodological	ADJ
dpc-5668	30	16	quality	quality	NOUN
dpc-5668	30	17	.	.	PUNCT
dpc-5668	31	1	across	across	ADP
dpc-5668	31	2	diverse	diverse	ADJ
dpc-5668	31	3	medical	medical	ADJ
dpc-5668	31	4	fields	field	NOUN
dpc-5668	31	5	,	,	PUNCT
dpc-5668	31	6	persistent	persistent	ADJ
dpc-5668	31	7	deficiencies	deficiency	NOUN
dpc-5668	31	8	such	such	ADJ
dpc-5668	31	9	as	as	ADP
dpc-5668	31	10	inadequate	inadequate	ADJ
dpc-5668	31	11	randomization	randomization	NOUN
dpc-5668	31	12	,	,	PUNCT
dpc-5668	31	13	poor	poor	ADJ
dpc-5668	31	14	allocation	allocation	NOUN
dpc-5668	31	15	concealment	concealment	NOUN
dpc-5668	31	16	,	,	PUNCT
dpc-5668	31	17	insufficient	insufficient	ADJ
dpc-5668	31	18	blinding	blinding	NOUN
dpc-5668	31	19	,	,	PUNCT
dpc-5668	31	20	high	high	ADJ
dpc-5668	31	21	attrition	attrition	NOUN
dpc-5668	31	22	without	without	ADP
dpc-5668	31	23	appropriate	appropriate	ADJ
dpc-5668	31	24	handling	handling	NOUN
dpc-5668	31	25	,	,	PUNCT
dpc-5668	31	26	and	and	CCONJ
dpc-5668	31	27	the	the	DET
dpc-5668	31	28	absence	absence	NOUN
dpc-5668	31	29	of	of	ADP
dpc-5668	31	30	prospective	prospective	ADJ
dpc-5668	31	31	protocol	protocol	NOUN
dpc-5668	31	32	registration	registration	NOUN
dpc-5668	31	33	remain	remain	VERB
dpc-5668	31	34	prevalent	prevalent	ADJ
dpc-5668	31	35	.	.	PUNCT
dpc-5668	32	1	these	these	DET
dpc-5668	32	2	shortcomings	shortcoming	NOUN
dpc-5668	32	3	introduce	introduce	VERB
dpc-5668	32	4	various	various	ADJ
dpc-5668	32	5	sources	source	NOUN
dpc-5668	32	6	of	of	ADP
dpc-5668	32	7	bias	bias	NOUN
dpc-5668	32	8	,	,	PUNCT
dpc-5668	32	9	leading	lead	VERB
dpc-5668	32	10	to	to	ADP
dpc-5668	32	11	distorted	distorted	ADJ
dpc-5668	32	12	effect	effect	NOUN
dpc-5668	32	13	estimates	estimate	NOUN
dpc-5668	32	14	and	and	CCONJ
dpc-5668	32	15	ultimately	ultimately	ADV
dpc-5668	32	16	compromising	compromise	VERB
dpc-5668	32	17	the	the	DET
dpc-5668	32	18	credibility	credibility	NOUN
dpc-5668	32	19	of	of	ADP
dpc-5668	32	20	the	the	DET
dpc-5668	32	21	evidence	evidence	NOUN
dpc-5668	32	22	base	base	NOUN
dpc-5668	33	1	[	[	X
dpc-5668	33	2	1,4–6	1,4–6	X
dpc-5668	33	3	]	]	PUNCT
dpc-5668	33	4	.	.	PUNCT
dpc-5668	34	1	the	the	DET
dpc-5668	34	2	evidence	evidence	NOUN
dpc-5668	34	3	on	on	ADP
dpc-5668	34	4	pharmacological	pharmacological	ADJ
dpc-5668	34	5	treatments	treatment	NOUN
dpc-5668	34	6	is	be	AUX
dpc-5668	34	7	well	well	ADV
dpc-5668	34	8	established	establish	VERB
dpc-5668	34	9	in	in	ADP
dpc-5668	34	10	the	the	DET
dpc-5668	34	11	context	context	NOUN
dpc-5668	34	12	of	of	ADP
dpc-5668	34	13	impetigo	impetigo	PROPN
dpc-5668	34	14	,	,	PUNCT
dpc-5668	34	15	a	a	DET
dpc-5668	34	16	common	common	ADJ
dpc-5668	34	17	and	and	CCONJ
dpc-5668	34	18	highly	highly	ADV
dpc-5668	34	19	contagious	contagious	ADJ
dpc-5668	34	20	superficial	superficial	ADJ
dpc-5668	34	21	bacterial	bacterial	ADJ
dpc-5668	34	22	skin	skin	NOUN
dpc-5668	34	23	infection	infection	NOUN
dpc-5668	34	24	that	that	PRON
dpc-5668	34	25	predominantly	predominantly	ADV
dpc-5668	34	26	affects	affect	VERB
dpc-5668	34	27	children	child	NOUN
dpc-5668	34	28	[	[	X
dpc-5668	34	29	7,8	7,8	NUM
dpc-5668	34	30	]	]	PUNCT
dpc-5668	34	31	.	.	PUNCT
dpc-5668	35	1	numerous	numerous	ADJ
dpc-5668	35	2	rcts	rct	NOUN
dpc-5668	35	3	have	have	AUX
dpc-5668	35	4	evaluated	evaluate	VERB
dpc-5668	35	5	the	the	DET
dpc-5668	35	6	efficacy	efficacy	NOUN
dpc-5668	35	7	and	and	CCONJ
dpc-5668	35	8	safety	safety	NOUN
dpc-5668	35	9	of	of	ADP
dpc-5668	35	10	both	both	DET
dpc-5668	35	11	topical	topical	ADJ
dpc-5668	35	12	and	and	CCONJ
dpc-5668	35	13	systemic	systemic	ADJ
dpc-5668	35	14	antibiotics	antibiotic	NOUN
dpc-5668	35	15	for	for	ADP
dpc-5668	35	16	this	this	DET
dpc-5668	35	17	condition	condition	NOUN
dpc-5668	35	18	.	.	PUNCT
dpc-5668	36	1	however	however	ADV
dpc-5668	36	2	,	,	PUNCT
dpc-5668	36	3	despite	despite	SCONJ
dpc-5668	36	4	the	the	DET
dpc-5668	36	5	substantial	substantial	ADJ
dpc-5668	36	6	body	body	NOUN
dpc-5668	36	7	of	of	ADP
dpc-5668	36	8	research	research	NOUN
dpc-5668	36	9	,	,	PUNCT
dpc-5668	36	10	no	no	DET
dpc-5668	36	11	prior	prior	ADJ
dpc-5668	36	12	study	study	NOUN
dpc-5668	36	13	has	have	AUX
dpc-5668	36	14	systematically	systematically	ADV
dpc-5668	36	15	examined	examine	VERB
dpc-5668	36	16	the	the	DET
dpc-5668	36	17	methodological	methodological	ADJ
dpc-5668	36	18	quality	quality	NOUN
dpc-5668	36	19	of	of	ADP
dpc-5668	36	20	these	these	DET
dpc-5668	36	21	trials	trial	NOUN
dpc-5668	36	22	.	.	PUNCT
dpc-5668	37	1	this	this	PRON
dpc-5668	37	2	represents	represent	VERB
dpc-5668	37	3	a	a	DET
dpc-5668	37	4	critical	critical	ADJ
dpc-5668	37	5	gap	gap	NOUN
dpc-5668	37	6	,	,	PUNCT
dpc-5668	37	7	as	as	SCONJ
dpc-5668	37	8	deficiencies	deficiency	NOUN
dpc-5668	37	9	in	in	ADP
dpc-5668	37	10	trial	trial	NOUN
dpc-5668	37	11	design	design	NOUN
dpc-5668	37	12	and	and	CCONJ
dpc-5668	37	13	reporting	reporting	NOUN
dpc-5668	37	14	can	can	AUX
dpc-5668	37	15	undermine	undermine	VERB
dpc-5668	37	16	not	not	PART
dpc-5668	37	17	only	only	ADV
dpc-5668	37	18	the	the	DET
dpc-5668	37	19	validity	validity	NOUN
dpc-5668	37	20	of	of	ADP
dpc-5668	37	21	individual	individual	ADJ
dpc-5668	37	22	studies	study	NOUN
dpc-5668	37	23	but	but	CCONJ
dpc-5668	37	24	also	also	ADV
dpc-5668	37	25	the	the	DET
dpc-5668	37	26	reliability	reliability	NOUN
dpc-5668	37	27	of	of	ADP
dpc-5668	37	28	evidence	evidence	NOUN
dpc-5668	37	29	syntheses	synthesis	NOUN
dpc-5668	37	30	and	and	CCONJ
dpc-5668	37	31	the	the	DET
dpc-5668	37	32	clinical	clinical	ADJ
dpc-5668	37	33	guidelines	guideline	NOUN
dpc-5668	37	34	derived	derive	VERB
dpc-5668	37	35	from	from	ADP
dpc-5668	37	36	them	they	PRON
dpc-5668	37	37	.	.	PUNCT
dpc-5668	38	1	moreover	moreover	ADV
dpc-5668	38	2	,	,	PUNCT
dpc-5668	38	3	systematically	systematically	ADV
dpc-5668	38	4	identifying	identify	VERB
dpc-5668	38	5	recurring	recur	VERB
dpc-5668	38	6	methodological	methodological	ADJ
dpc-5668	38	7	limitations	limitation	NOUN
dpc-5668	38	8	can	can	AUX
dpc-5668	38	9	inform	inform	VERB
dpc-5668	38	10	improvements	improvement	NOUN
dpc-5668	38	11	in	in	ADP
dpc-5668	38	12	the	the	DET
dpc-5668	38	13	design	design	NOUN
dpc-5668	38	14	,	,	PUNCT
dpc-5668	38	15	conduct	conduct	NOUN
dpc-5668	38	16	,	,	PUNCT
dpc-5668	38	17	and	and	CCONJ
dpc-5668	38	18	reporting	reporting	NOUN
dpc-5668	38	19	of	of	ADP
dpc-5668	38	20	future	future	ADJ
dpc-5668	38	21	trials	trial	NOUN
dpc-5668	38	22	,	,	PUNCT
dpc-5668	38	23	ultimately	ultimately	ADV
dpc-5668	38	24	contributing	contribute	VERB
dpc-5668	38	25	to	to	ADP
dpc-5668	38	26	more	more	ADV
dpc-5668	38	27	transparent	transparent	ADJ
dpc-5668	38	28	,	,	PUNCT
dpc-5668	38	29	rigorous	rigorous	ADJ
dpc-5668	38	30	,	,	PUNCT
dpc-5668	38	31	and	and	CCONJ
dpc-5668	38	32	trustworthy	trustworthy	ADJ
dpc-5668	38	33	research	research	NOUN
dpc-5668	38	34	that	that	PRON
dpc-5668	38	35	underpins	underpin	VERB
dpc-5668	38	36	evidence	evidence	NOUN
dpc-5668	38	37	-	-	PUNCT
dpc-5668	38	38	based	base	VERB
dpc-5668	38	39	clinical	clinical	ADJ
dpc-5668	38	40	practice	practice	NOUN
dpc-5668	38	41	[	[	X
dpc-5668	38	42	1,4	1,4	NUM
dpc-5668	38	43	]	]	PUNCT
dpc-5668	38	44	.	.	PUNCT
dpc-5668	39	1	objective	objective	ADJ
dpc-5668	39	2	this	this	DET
dpc-5668	39	3	meta	meta	ADJ
dpc-5668	39	4	-	-	PUNCT
dpc-5668	39	5	research	research	NOUN
dpc-5668	39	6	study	study	NOUN
dpc-5668	39	7	aimed	aim	VERB
dpc-5668	39	8	to	to	PART
dpc-5668	39	9	evaluate	evaluate	VERB
dpc-5668	39	10	the	the	DET
dpc-5668	39	11	methodological	methodological	ADJ
dpc-5668	39	12	quality	quality	NOUN
dpc-5668	39	13	of	of	ADP
dpc-5668	39	14	the	the	DET
dpc-5668	39	15	rcts	rct	NOUN
dpc-5668	39	16	on	on	ADP
dpc-5668	39	17	the	the	DET
dpc-5668	39	18	pharmacological	pharmacological	ADJ
dpc-5668	39	19	treatment	treatment	NOUN
dpc-5668	39	20	of	of	ADP
dpc-5668	39	21	impetigo	impetigo	NOUN
dpc-5668	39	22	in	in	ADP
dpc-5668	39	23	children	child	NOUN
dpc-5668	39	24	and	and	CCONJ
dpc-5668	39	25	adolescents	adolescent	NOUN
dpc-5668	39	26	.	.	PUNCT
dpc-5668	40	1	methods	method	NOUN
dpc-5668	40	2	this	this	DET
dpc-5668	40	3	meta	meta	ADJ
dpc-5668	40	4	-	-	PUNCT
dpc-5668	40	5	research	research	NOUN
dpc-5668	40	6	study	study	NOUN
dpc-5668	40	7	adheres	adhere	VERB
dpc-5668	40	8	to	to	ADP
dpc-5668	40	9	the	the	DET
dpc-5668	40	10	methodological	methodological	ADJ
dpc-5668	40	11	guidance	guidance	NOUN
dpc-5668	40	12	proposed	propose	VERB
dpc-5668	40	13	by	by	ADP
dpc-5668	40	14	murad	murad	PROPN
dpc-5668	40	15	et	et	PROPN
dpc-5668	40	16	al	al	PROPN
dpc-5668	40	17	.	.	PUNCT
dpc-5668	41	1	[	[	X
dpc-5668	41	2	9	9	NUM
dpc-5668	41	3	]	]	PUNCT
dpc-5668	41	4	and	and	CCONJ
dpc-5668	41	5	the	the	DET
dpc-5668	41	6	relevant	relevant	ADJ
dpc-5668	41	7	items	item	NOUN
dpc-5668	41	8	of	of	ADP
dpc-5668	41	9	the	the	DET
dpc-5668	41	10	preferred	preferred	ADJ
dpc-5668	41	11	reporting	reporting	NOUN
dpc-5668	41	12	items	item	NOUN
dpc-5668	41	13	for	for	ADP
dpc-5668	41	14	systematic	systematic	ADJ
dpc-5668	41	15	reviews	review	NOUN
dpc-5668	41	16	and	and	CCONJ
dpc-5668	41	17	meta	meta	NOUN
dpc-5668	41	18	-	-	PUNCT
dpc-5668	41	19	analyses	analysis	NOUN
dpc-5668	41	20	(	(	PUNCT
dpc-5668	41	21	prisma	prisma	NOUN
dpc-5668	41	22	)	)	PUNCT
dpc-5668	42	1	[	[	X
dpc-5668	42	2	10	10	NUM
dpc-5668	42	3	]	]	PUNCT
dpc-5668	42	4	to	to	PART
dpc-5668	42	5	enhance	enhance	VERB
dpc-5668	42	6	the	the	DET
dpc-5668	42	7	quality	quality	NOUN
dpc-5668	42	8	and	and	CCONJ
dpc-5668	42	9	transparency	transparency	NOUN
dpc-5668	42	10	of	of	ADP
dpc-5668	42	11	the	the	DET
dpc-5668	42	12	study	study	NOUN
dpc-5668	42	13	report	report	NOUN
dpc-5668	42	14	.	.	PUNCT
dpc-5668	43	1	criteria	criterion	NOUN
dpc-5668	43	2	for	for	ADP
dpc-5668	43	3	inclusion	inclusion	NOUN
dpc-5668	43	4	of	of	ADP
dpc-5668	43	5	studies	study	NOUN
dpc-5668	43	6	randomized	randomize	VERB
dpc-5668	43	7	clinical	clinical	ADJ
dpc-5668	43	8	trials	trial	NOUN
dpc-5668	43	9	(	(	PUNCT
dpc-5668	43	10	rcts	rct	NOUN
dpc-5668	43	11	)	)	PUNCT
dpc-5668	43	12	that	that	PRON
dpc-5668	43	13	evaluated	evaluate	VERB
dpc-5668	43	14	the	the	DET
dpc-5668	43	15	efficacy	efficacy	NOUN
dpc-5668	43	16	of	of	ADP
dpc-5668	43	17	systemic	systemic	ADJ
dpc-5668	43	18	or	or	CCONJ
dpc-5668	43	19	topical	topical	ADJ
dpc-5668	43	20	pharmacological	pharmacological	ADJ
dpc-5668	43	21	interventions	intervention	NOUN
dpc-5668	43	22	,	,	PUNCT
dpc-5668	43	23	including	include	VERB
dpc-5668	43	24	antimicrobial	antimicrobial	ADJ
dpc-5668	43	25	and	and	CCONJ
dpc-5668	43	26	antiseptic	antiseptic	ADJ
dpc-5668	43	27	agents	agent	NOUN
dpc-5668	43	28	,	,	PUNCT
dpc-5668	43	29	for	for	ADP
dpc-5668	43	30	treating	treat	VERB
dpc-5668	43	31	impetigo	impetigo	NOUN
dpc-5668	43	32	in	in	ADP
dpc-5668	43	33	children	child	NOUN
dpc-5668	43	34	and	and	CCONJ
dpc-5668	43	35	adolescents	adolescent	NOUN
dpc-5668	43	36	,	,	PUNCT
dpc-5668	43	37	regardless	regardless	ADV
dpc-5668	43	38	of	of	ADP
dpc-5668	43	39	dosage	dosage	NOUN
dpc-5668	43	40	,	,	PUNCT
dpc-5668	43	41	treatment	treatment	NOUN
dpc-5668	43	42	duration	duration	NOUN
dpc-5668	43	43	,	,	PUNCT
dpc-5668	43	44	or	or	CCONJ
dpc-5668	43	45	route	route	NOUN
dpc-5668	43	46	of	of	ADP
dpc-5668	43	47	administration	administration	NOUN
dpc-5668	43	48	.	.	PUNCT
dpc-5668	44	1	studies	study	NOUN
dpc-5668	44	2	were	be	AUX
dpc-5668	44	3	eligible	eligible	ADJ
dpc-5668	44	4	if	if	SCONJ
dpc-5668	44	5	the	the	DET
dpc-5668	44	6	authors	author	NOUN
dpc-5668	44	7	identified	identify	VERB
dpc-5668	44	8	them	they	PRON
dpc-5668	44	9	as	as	ADP
dpc-5668	44	10	“	"	PUNCT
dpc-5668	44	11	randomized	randomize	VERB
dpc-5668	44	12	clinical	clinical	ADJ
dpc-5668	44	13	trials	trial	NOUN
dpc-5668	44	14	.	.	PUNCT
dpc-5668	44	15	”	"	PUNCT
dpc-5668	45	1	studies	study	NOUN
dpc-5668	45	2	employing	employ	VERB
dpc-5668	45	3	quasi	quasi	ADJ
dpc-5668	45	4	-	-	ADJ
dpc-5668	45	5	randomized	randomized	ADJ
dpc-5668	45	6	methods	method	NOUN
dpc-5668	45	7	,	,	PUNCT
dpc-5668	45	8	such	such	ADJ
dpc-5668	45	9	as	as	ADP
dpc-5668	45	10	allocation	allocation	NOUN
dpc-5668	45	11	based	base	VERB
dpc-5668	45	12	on	on	ADP
dpc-5668	45	13	date	date	NOUN
dpc-5668	45	14	of	of	ADP
dpc-5668	45	15	birth	birth	NOUN
dpc-5668	45	16	,	,	PUNCT
dpc-5668	45	17	medical	medical	ADJ
dpc-5668	45	18	record	record	NOUN
dpc-5668	45	19	number	number	NOUN
dpc-5668	45	20	,	,	PUNCT
dpc-5668	45	21	or	or	CCONJ
dpc-5668	45	22	alternation	alternation	NOUN
dpc-5668	45	23	,	,	PUNCT
dpc-5668	45	24	were	be	AUX
dpc-5668	45	25	not	not	PART
dpc-5668	45	26	considered	consider	VERB
dpc-5668	45	27	due	due	ADJ
dpc-5668	45	28	to	to	ADP
dpc-5668	45	29	the	the	DET
dpc-5668	45	30	high	high	ADJ
dpc-5668	45	31	risk	risk	NOUN
dpc-5668	45	32	of	of	ADP
dpc-5668	45	33	selection	selection	NOUN
dpc-5668	45	34	bias	bias	NOUN
dpc-5668	45	35	associated	associate	VERB
dpc-5668	45	36	with	with	ADP
dpc-5668	45	37	these	these	DET
dpc-5668	45	38	designs	design	NOUN
dpc-5668	45	39	.	.	PUNCT
dpc-5668	46	1	search	search	NOUN
dpc-5668	46	2	strategy	strategy	NOUN
dpc-5668	46	3	a	a	DET
dpc-5668	46	4	comprehensive	comprehensive	ADJ
dpc-5668	46	5	literature	literature	NOUN
dpc-5668	46	6	search	search	NOUN
dpc-5668	46	7	was	be	AUX
dpc-5668	46	8	conducted	conduct	VERB
dpc-5668	46	9	on	on	ADP
dpc-5668	46	10	19	19	NUM
dpc-5668	46	11	september	september	PROPN
dpc-5668	46	12	2024	2024	NUM
dpc-5668	46	13	to	to	PART
dpc-5668	46	14	identify	identify	VERB
dpc-5668	46	15	the	the	DET
dpc-5668	46	16	rcts	rct	NOUN
dpc-5668	46	17	using	use	VERB
dpc-5668	46	18	the	the	DET
dpc-5668	46	19	following	follow	VERB
dpc-5668	46	20	databases	database	NOUN
dpc-5668	46	21	:	:	PUNCT
dpc-5668	46	22	medical	medical	ADJ
dpc-5668	46	23	literature	literature	NOUN
dpc-5668	46	24	analysis	analysis	NOUN
dpc-5668	46	25	and	and	CCONJ
dpc-5668	46	26	retrieval	retrieval	NOUN
dpc-5668	46	27	system	system	NOUN
dpc-5668	46	28	online	online	ADV
dpc-5668	46	29	(	(	PUNCT
dpc-5668	46	30	medline	medline	NOUN
dpc-5668	46	31	)	)	PUNCT
dpc-5668	46	32	,	,	PUNCT
dpc-5668	46	33	by	by	ADP
dpc-5668	46	34	pubmed	pubmed	PROPN
dpc-5668	46	35	;	;	PUNCT
dpc-5668	46	36	excerpta	excerpta	NOUN
dpc-5668	46	37	medica	medica	PROPN
dpc-5668	46	38	database	database	NOUN
dpc-5668	46	39	(	(	PUNCT
dpc-5668	46	40	embase	embase	NOUN
dpc-5668	46	41	)	)	PUNCT
dpc-5668	46	42	,	,	PUNCT
dpc-5668	46	43	by	by	ADP
dpc-5668	46	44	elsevier	elsevier	NOUN
dpc-5668	46	45	;	;	PUNCT
dpc-5668	46	46	the	the	DET
dpc-5668	46	47	cochrane	cochrane	NOUN
dpc-5668	46	48	central	central	ADJ
dpc-5668	46	49	register	register	NOUN
dpc-5668	46	50	of	of	ADP
dpc-5668	46	51	controlled	control	VERB
dpc-5668	46	52	trials	trial	NOUN
dpc-5668	46	53	(	(	PUNCT
dpc-5668	46	54	central	central	ADJ
dpc-5668	46	55	)	)	PUNCT
dpc-5668	46	56	(	(	PUNCT
dpc-5668	46	57	by	by	ADP
dpc-5668	46	58	wiley	wiley	PROPN
dpc-5668	46	59	)	)	PUNCT
dpc-5668	46	60	;	;	PUNCT
dpc-5668	46	61	latin	latin	ADJ
dpc-5668	46	62	american	american	PROPN
dpc-5668	46	63	literature	literature	PROPN
dpc-5668	46	64	on	on	ADP
dpc-5668	46	65	health	health	NOUN
dpc-5668	46	66	sciences	science	NOUN
dpc-5668	46	67	and	and	CCONJ
dpc-5668	46	68	the	the	DET
dpc-5668	46	69	caribbean	caribbean	ADJ
dpc-5668	46	70	lilacs	lilacs	PROPN
dpc-5668	46	71	(	(	PUNCT
dpc-5668	46	72	biblioteca	biblioteca	PROPN
dpc-5668	46	73	virtual	virtual	ADJ
dpc-5668	46	74	em	em	PRON
dpc-5668	46	75	saúde	saúde	PROPN
dpc-5668	46	76	bvs	bvs	PROPN
dpc-5668	46	77	)	)	PUNCT
dpc-5668	46	78	(	(	PUNCT
dpc-5668	46	79	table	table	NOUN
dpc-5668	46	80	s1	s1	NOUN
dpc-5668	46	81	)	)	PUNCT
dpc-5668	46	82	.	.	PUNCT
dpc-5668	47	1	selection	selection	NOUN
dpc-5668	47	2	of	of	ADP
dpc-5668	47	3	studies	study	NOUN
dpc-5668	47	4	and	and	CCONJ
dpc-5668	47	5	data	datum	NOUN
dpc-5668	47	6	collection	collection	NOUN
dpc-5668	47	7	two	two	NUM
dpc-5668	47	8	independent	independent	ADJ
dpc-5668	47	9	reviewers	reviewer	NOUN
dpc-5668	47	10	screened	screen	VERB
dpc-5668	47	11	the	the	DET
dpc-5668	47	12	titles	title	NOUN
dpc-5668	47	13	and	and	CCONJ
dpc-5668	47	14	abstracts	abstract	NOUN
dpc-5668	47	15	using	use	VERB
dpc-5668	47	16	the	the	DET
dpc-5668	47	17	rayyan	rayyan	ADJ
dpc-5668	47	18	platform	platform	NOUN
dpc-5668	48	1	[	[	X
dpc-5668	48	2	11	11	NUM
dpc-5668	48	3	]	]	PUNCT
dpc-5668	48	4	.	.	PUNCT
dpc-5668	49	1	references	reference	NOUN
dpc-5668	49	2	that	that	PRON
dpc-5668	49	3	met	meet	VERB
dpc-5668	49	4	the	the	DET
dpc-5668	49	5	eligibility	eligibility	NOUN
dpc-5668	49	6	criteria	criterion	NOUN
dpc-5668	49	7	were	be	AUX
dpc-5668	49	8	then	then	ADV
dpc-5668	49	9	selected	select	VERB
dpc-5668	49	10	for	for	ADP
dpc-5668	49	11	a	a	DET
dpc-5668	49	12	more	more	ADV
dpc-5668	49	13	detailed	detailed	ADJ
dpc-5668	49	14	analysis	analysis	NOUN
dpc-5668	49	15	through	through	ADP
dpc-5668	49	16	full	full	ADJ
dpc-5668	49	17	-	-	PUNCT
dpc-5668	49	18	text	text	NOUN
dpc-5668	49	19	reading	reading	NOUN
dpc-5668	49	20	.	.	PUNCT
dpc-5668	50	1	a	a	DET
dpc-5668	50	2	third	third	ADJ
dpc-5668	50	3	author	author	NOUN
dpc-5668	50	4	resolved	resolve	VERB
dpc-5668	50	5	disagreements	disagreement	NOUN
dpc-5668	50	6	between	between	ADP
dpc-5668	50	7	reviewers	reviewer	NOUN
dpc-5668	50	8	about	about	ADP
dpc-5668	50	9	the	the	DET
dpc-5668	50	10	inclusion	inclusion	NOUN
dpc-5668	50	11	or	or	CCONJ
dpc-5668	50	12	exclusion	exclusion	NOUN
dpc-5668	50	13	of	of	ADP
dpc-5668	50	14	studies	study	NOUN
dpc-5668	50	15	.	.	PUNCT
dpc-5668	51	1	data	datum	NOUN
dpc-5668	51	2	extraction	extraction	NOUN
dpc-5668	51	3	was	be	AUX
dpc-5668	51	4	conducted	conduct	VERB
dpc-5668	51	5	by	by	ADP
dpc-5668	51	6	two	two	NUM
dpc-5668	51	7	independent	independent	ADJ
dpc-5668	51	8	reviewers	reviewer	NOUN
dpc-5668	51	9	who	who	PRON
dpc-5668	51	10	collected	collect	VERB
dpc-5668	51	11	the	the	DET
dpc-5668	51	12	following	follow	VERB
dpc-5668	51	13	information	information	NOUN
dpc-5668	51	14	from	from	ADP
dpc-5668	51	15	the	the	DET
dpc-5668	51	16	included	include	VERB
dpc-5668	51	17	rcts	rct	NOUN
dpc-5668	51	18	:	:	PUNCT
dpc-5668	51	19	year	year	NOUN
dpc-5668	51	20	,	,	PUNCT
dpc-5668	51	21	participants	participant	NOUN
dpc-5668	51	22	’	'	PUNCT
dpc-5668	51	23	characteristics	characteristic	NOUN
dpc-5668	51	24	,	,	PUNCT
dpc-5668	51	25	intervention	intervention	NOUN
dpc-5668	51	26	,	,	PUNCT
dpc-5668	51	27	comparator	comparator	NOUN
dpc-5668	51	28	groups	group	NOUN
dpc-5668	51	29	,	,	PUNCT
dpc-5668	51	30	outcomes	outcome	NOUN
dpc-5668	51	31	assessed	assess	VERB
dpc-5668	51	32	,	,	PUNCT
dpc-5668	51	33	and	and	CCONJ
dpc-5668	51	34	funding	funding	NOUN
dpc-5668	51	35	sources	source	NOUN
dpc-5668	51	36	.	.	PUNCT
dpc-5668	52	1	blinding	blind	VERB
dpc-5668	52	2	of	of	ADP
dpc-5668	52	3	outcome	outcome	NOUN
dpc-5668	52	4	assessors	assessor	NOUN
dpc-5668	52	5	;	;	PUNCT
dpc-5668	52	6	iii	iii	X
dpc-5668	52	7	)	)	PUNCT
dpc-5668	52	8	24	24	NUM
dpc-5668	52	9	%	%	NOUN
dpc-5668	52	10	exhibited	exhibit	VERB
dpc-5668	52	11	a	a	DET
dpc-5668	52	12	high	high	ADJ
dpc-5668	52	13	risk	risk	NOUN
dpc-5668	52	14	of	of	ADP
dpc-5668	52	15	attrition	attrition	NOUN
dpc-5668	52	16	bias	bias	NOUN
dpc-5668	52	17	due	due	ADP
dpc-5668	52	18	to	to	ADP
dpc-5668	52	19	significant	significant	ADJ
dpc-5668	52	20	participant	participant	ADJ
dpc-5668	52	21	losses	loss	NOUN
dpc-5668	52	22	without	without	ADP
dpc-5668	52	23	justification	justification	NOUN
dpc-5668	52	24	;	;	PUNCT
dpc-5668	52	25	iv	iv	X
dpc-5668	52	26	)	)	PUNCT
dpc-5668	52	27	81	81	NUM
dpc-5668	52	28	%	%	NOUN
dpc-5668	52	29	had	have	VERB
dpc-5668	52	30	an	an	DET
dpc-5668	52	31	unclear	unclear	ADJ
dpc-5668	52	32	risk	risk	NOUN
dpc-5668	52	33	of	of	ADP
dpc-5668	52	34	bias	bias	NOUN
dpc-5668	52	35	due	due	ADP
dpc-5668	52	36	to	to	ADP
dpc-5668	52	37	the	the	DET
dpc-5668	52	38	lack	lack	NOUN
dpc-5668	52	39	of	of	ADP
dpc-5668	52	40	registered	register	VERB
dpc-5668	52	41	protocols	protocol	NOUN
dpc-5668	52	42	available	available	ADJ
dpc-5668	52	43	.	.	PUNCT
dpc-5668	53	1	conclusions	conclusion	NOUN
dpc-5668	53	2	:	:	PUNCT
dpc-5668	53	3	based	base	VERB
dpc-5668	53	4	on	on	ADP
dpc-5668	53	5	the	the	DET
dpc-5668	53	6	methodological	methodological	ADJ
dpc-5668	53	7	quality	quality	NOUN
dpc-5668	53	8	of	of	ADP
dpc-5668	53	9	the	the	DET
dpc-5668	53	10	assessed	assessed	ADJ
dpc-5668	53	11	rcts	rct	NOUN
dpc-5668	53	12	,	,	PUNCT
dpc-5668	53	13	this	this	DET
dpc-5668	53	14	study	study	NOUN
dpc-5668	53	15	highlights	highlight	VERB
dpc-5668	53	16	the	the	DET
dpc-5668	53	17	need	need	NOUN
dpc-5668	53	18	for	for	ADP
dpc-5668	53	19	more	more	ADV
dpc-5668	53	20	rigorous	rigorous	ADJ
dpc-5668	53	21	design	design	NOUN
dpc-5668	53	22	and	and	CCONJ
dpc-5668	53	23	reporting	reporting	NOUN
dpc-5668	53	24	standards	standard	NOUN
dpc-5668	53	25	in	in	ADP
dpc-5668	53	26	future	future	ADJ
dpc-5668	53	27	research	research	NOUN
dpc-5668	53	28	on	on	ADP
dpc-5668	53	29	pharmacological	pharmacological	ADJ
dpc-5668	53	30	treatments	treatment	NOUN
dpc-5668	53	31	for	for	ADP
dpc-5668	53	32	impetigo	impetigo	NOUN
dpc-5668	53	33	to	to	PART
dpc-5668	53	34	enhance	enhance	VERB
dpc-5668	53	35	the	the	DET
dpc-5668	53	36	reliability	reliability	NOUN
dpc-5668	53	37	and	and	CCONJ
dpc-5668	53	38	validity	validity	NOUN
dpc-5668	53	39	of	of	ADP
dpc-5668	53	40	the	the	DET
dpc-5668	53	41	evidence	evidence	NOUN
dpc-5668	53	42	,	,	PUNCT
dpc-5668	53	43	thereby	thereby	ADV
dpc-5668	53	44	supporting	support	VERB
dpc-5668	53	45	more	more	ADV
dpc-5668	53	46	informed	informed	ADJ
dpc-5668	53	47	clinical	clinical	ADJ
dpc-5668	53	48	decision	decision	NOUN
dpc-5668	53	49	-	-	PUNCT
dpc-5668	53	50	making	making	NOUN
dpc-5668	53	51	.	.	PUNCT
dpc-5668	54	1	review	review	VERB
dpc-5668	54	2	|	|	ADV
dpc-5668	54	3	dermatol	dermatol	ADJ
dpc-5668	54	4	pract	pract	NOUN
dpc-5668	54	5	concept	concept	NOUN
dpc-5668	54	6	.	.	PUNCT
dpc-5668	55	1	2025;15(4):5668	2025;15(4):5668	NUM
dpc-5668	55	2	3	3	NUM
dpc-5668	55	3	assessment	assessment	NOUN
dpc-5668	55	4	of	of	ADP
dpc-5668	55	5	the	the	DET
dpc-5668	55	6	methodological	methodological	ADJ
dpc-5668	55	7	quality	quality	NOUN
dpc-5668	55	8	of	of	ADP
dpc-5668	55	9	the	the	DET
dpc-5668	55	10	included	include	VERB
dpc-5668	55	11	studies	study	NOUN
dpc-5668	55	12	two	two	NUM
dpc-5668	55	13	reviewers	reviewer	NOUN
dpc-5668	55	14	independently	independently	ADV
dpc-5668	55	15	assessed	assess	VERB
dpc-5668	55	16	the	the	DET
dpc-5668	55	17	methodological	methodological	ADJ
dpc-5668	55	18	quality	quality	NOUN
dpc-5668	55	19	(	(	PUNCT
dpc-5668	55	20	risk	risk	NOUN
dpc-5668	55	21	of	of	ADP
dpc-5668	55	22	bias	bias	NOUN
dpc-5668	55	23	)	)	PUNCT
dpc-5668	55	24	of	of	ADP
dpc-5668	55	25	each	each	DET
dpc-5668	55	26	included	include	VERB
dpc-5668	55	27	rct	rct	PROPN
dpc-5668	55	28	,	,	PUNCT
dpc-5668	55	29	using	use	VERB
dpc-5668	55	30	the	the	DET
dpc-5668	55	31	cochrane	cochrane	NOUN
dpc-5668	55	32	risk	risk	NOUN
dpc-5668	55	33	of	of	ADP
dpc-5668	55	34	bias	bias	NOUN
dpc-5668	55	35	(	(	PUNCT
dpc-5668	55	36	rob	rob	PROPN
dpc-5668	55	37	)	)	PUNCT
dpc-5668	55	38	tool	tool	NOUN
dpc-5668	55	39	(	(	PUNCT
dpc-5668	55	40	version	version	NOUN
dpc-5668	55	41	1.0	1.0	NUM
dpc-5668	55	42	)	)	PUNCT
dpc-5668	55	43	following	follow	VERB
dpc-5668	55	44	the	the	DET
dpc-5668	55	45	recommendations	recommendation	NOUN
dpc-5668	55	46	of	of	ADP
dpc-5668	55	47	the	the	DET
dpc-5668	55	48	cochrane	cochrane	PROPN
dpc-5668	55	49	handbook	handbook	NOUN
dpc-5668	55	50	of	of	ADP
dpc-5668	55	51	systematic	systematic	ADJ
dpc-5668	55	52	reviews	review	NOUN
dpc-5668	55	53	of	of	ADP
dpc-5668	55	54	interventions	intervention	NOUN
dpc-5668	55	55	[	[	X
dpc-5668	55	56	12	12	NUM
dpc-5668	55	57	]	]	PUNCT
dpc-5668	55	58	.	.	PUNCT
dpc-5668	56	1	this	this	DET
dpc-5668	56	2	tool	tool	NOUN
dpc-5668	56	3	is	be	AUX
dpc-5668	56	4	composed	compose	VERB
dpc-5668	56	5	of	of	ADP
dpc-5668	56	6	seven	seven	NUM
dpc-5668	56	7	domains	domain	NOUN
dpc-5668	56	8	that	that	PRON
dpc-5668	56	9	assess	assess	VERB
dpc-5668	56	10	potential	potential	ADJ
dpc-5668	56	11	sources	source	NOUN
dpc-5668	56	12	of	of	ADP
dpc-5668	56	13	bias	bias	NOUN
dpc-5668	56	14	that	that	PRON
dpc-5668	56	15	could	could	AUX
dpc-5668	56	16	affect	affect	VERB
dpc-5668	56	17	the	the	DET
dpc-5668	56	18	study	study	NOUN
dpc-5668	56	19	’s	’s	PART
dpc-5668	56	20	validity	validity	NOUN
dpc-5668	56	21	,	,	PUNCT
dpc-5668	56	22	as	as	SCONJ
dpc-5668	56	23	follows	follow	VERB
dpc-5668	56	24	:	:	PUNCT
dpc-5668	56	25	•	•	NUM
dpc-5668	56	26	random	random	ADJ
dpc-5668	56	27	sequence	sequence	NOUN
dpc-5668	56	28	generation	generation	NOUN
dpc-5668	56	29	(	(	PUNCT
dpc-5668	56	30	selection	selection	NOUN
dpc-5668	56	31	bias	bias	NOUN
dpc-5668	56	32	):	):	PUNCT
dpc-5668	56	33	evaluate	evaluate	VERB
dpc-5668	56	34	the	the	DET
dpc-5668	56	35	method	method	NOUN
dpc-5668	56	36	used	use	VERB
dpc-5668	56	37	to	to	PART
dpc-5668	56	38	generate	generate	VERB
dpc-5668	56	39	the	the	DET
dpc-5668	56	40	random	random	ADJ
dpc-5668	56	41	sequence	sequence	NOUN
dpc-5668	56	42	for	for	ADP
dpc-5668	56	43	assigning	assign	VERB
dpc-5668	56	44	participants	participant	NOUN
dpc-5668	56	45	to	to	ADP
dpc-5668	56	46	intervention	intervention	NOUN
dpc-5668	56	47	or	or	CCONJ
dpc-5668	56	48	control	control	NOUN
dpc-5668	56	49	groups	group	NOUN
dpc-5668	56	50	.	.	PUNCT
dpc-5668	57	1	it	it	PRON
dpc-5668	57	2	assesses	assess	VERB
dpc-5668	57	3	whether	whether	SCONJ
dpc-5668	57	4	the	the	DET
dpc-5668	57	5	process	process	NOUN
dpc-5668	57	6	was	be	AUX
dpc-5668	57	7	genuinely	genuinely	ADV
dpc-5668	57	8	random	random	ADJ
dpc-5668	57	9	,	,	PUNCT
dpc-5668	57	10	helping	help	VERB
dpc-5668	57	11	to	to	PART
dpc-5668	57	12	ensure	ensure	VERB
dpc-5668	57	13	that	that	SCONJ
dpc-5668	57	14	any	any	DET
dpc-5668	57	15	systematic	systematic	ADJ
dpc-5668	57	16	factors	factor	NOUN
dpc-5668	57	17	did	do	AUX
dpc-5668	57	18	not	not	PART
dpc-5668	57	19	influence	influence	VERB
dpc-5668	57	20	group	group	NOUN
dpc-5668	57	21	allocation	allocation	NOUN
dpc-5668	57	22	.	.	PUNCT
dpc-5668	58	1	•	•	NUM
dpc-5668	58	2	allocation	allocation	NOUN
dpc-5668	58	3	concealment	concealment	NOUN
dpc-5668	58	4	(	(	PUNCT
dpc-5668	58	5	selection	selection	NOUN
dpc-5668	58	6	bias	bias	NOUN
dpc-5668	58	7	):	):	PUNCT
dpc-5668	58	8	examines	examine	VERB
dpc-5668	58	9	whether	whether	SCONJ
dpc-5668	58	10	the	the	DET
dpc-5668	58	11	allocation	allocation	NOUN
dpc-5668	58	12	of	of	ADP
dpc-5668	58	13	participants	participant	NOUN
dpc-5668	58	14	to	to	ADP
dpc-5668	58	15	intervention	intervention	NOUN
dpc-5668	58	16	or	or	CCONJ
dpc-5668	58	17	control	control	NOUN
dpc-5668	58	18	groups	group	NOUN
dpc-5668	58	19	was	be	AUX
dpc-5668	58	20	concealed	conceal	VERB
dpc-5668	58	21	from	from	ADP
dpc-5668	58	22	those	those	PRON
dpc-5668	58	23	assigning	assign	VERB
dpc-5668	58	24	participants	participant	NOUN
dpc-5668	58	25	.	.	PUNCT
dpc-5668	59	1	proper	proper	ADJ
dpc-5668	59	2	concealment	concealment	NOUN
dpc-5668	59	3	prevents	prevent	VERB
dpc-5668	59	4	selection	selection	NOUN
dpc-5668	59	5	bias	bias	NOUN
dpc-5668	59	6	by	by	ADP
dpc-5668	59	7	ensuring	ensure	VERB
dpc-5668	59	8	the	the	DET
dpc-5668	59	9	researchers	researcher	NOUN
dpc-5668	59	10	can	can	AUX
dpc-5668	59	11	not	not	PART
dpc-5668	59	12	predict	predict	VERB
dpc-5668	59	13	or	or	CCONJ
dpc-5668	59	14	influence	influence	VERB
dpc-5668	59	15	the	the	DET
dpc-5668	59	16	group	group	NOUN
dpc-5668	59	17	assignment	assignment	NOUN
dpc-5668	59	18	.	.	PUNCT
dpc-5668	60	1	•	•	NUM
dpc-5668	61	1	blinding	blind	VERB
dpc-5668	61	2	of	of	ADP
dpc-5668	61	3	participants	participant	NOUN
dpc-5668	61	4	and	and	CCONJ
dpc-5668	61	5	personnel	personnel	NOUN
dpc-5668	61	6	(	(	PUNCT
dpc-5668	61	7	performance	performance	NOUN
dpc-5668	61	8	bias	bias	NOUN
dpc-5668	61	9	):	):	PUNCT
dpc-5668	61	10	assesses	assesse	NOUN
dpc-5668	61	11	whether	whether	SCONJ
dpc-5668	61	12	participants	participant	NOUN
dpc-5668	61	13	and	and	CCONJ
dpc-5668	61	14	personnel	personnel	NOUN
dpc-5668	61	15	were	be	AUX
dpc-5668	61	16	blinded	blind	VERB
dpc-5668	61	17	to	to	ADP
dpc-5668	61	18	the	the	DET
dpc-5668	61	19	administered	administer	VERB
dpc-5668	61	20	intervention	intervention	NOUN
dpc-5668	61	21	.	.	PUNCT
dpc-5668	62	1	blinding	blind	VERB
dpc-5668	62	2	helps	helps	AUX
dpc-5668	62	3	prevent	prevent	VERB
dpc-5668	62	4	performance	performance	NOUN
dpc-5668	62	5	bias	bias	NOUN
dpc-5668	62	6	,	,	PUNCT
dpc-5668	62	7	where	where	SCONJ
dpc-5668	62	8	knowledge	knowledge	NOUN
dpc-5668	62	9	of	of	ADP
dpc-5668	62	10	the	the	DET
dpc-5668	62	11	intervention	intervention	NOUN
dpc-5668	62	12	may	may	AUX
dpc-5668	62	13	influence	influence	VERB
dpc-5668	62	14	how	how	SCONJ
dpc-5668	62	15	participants	participant	NOUN
dpc-5668	62	16	or	or	CCONJ
dpc-5668	62	17	staff	staff	NOUN
dpc-5668	62	18	behave	behave	VERB
dpc-5668	62	19	or	or	CCONJ
dpc-5668	62	20	interact	interact	VERB
dpc-5668	62	21	,	,	PUNCT
dpc-5668	62	22	potentially	potentially	ADV
dpc-5668	62	23	skewing	skew	VERB
dpc-5668	62	24	the	the	DET
dpc-5668	62	25	study	study	NOUN
dpc-5668	62	26	results	result	NOUN
dpc-5668	62	27	.	.	PUNCT
dpc-5668	63	1	•	•	NUM
dpc-5668	63	2	blinding	blind	VERB
dpc-5668	63	3	of	of	ADP
dpc-5668	63	4	outcome	outcome	NOUN
dpc-5668	63	5	assessors	assessor	NOUN
dpc-5668	63	6	(	(	PUNCT
dpc-5668	63	7	detection	detection	NOUN
dpc-5668	63	8	bias	bias	NOUN
dpc-5668	63	9	):	):	PUNCT
dpc-5668	63	10	evaluates	evaluate	VERB
dpc-5668	63	11	whether	whether	SCONJ
dpc-5668	63	12	those	those	DET
dpc-5668	63	13	assessing	assess	VERB
dpc-5668	63	14	outcomes	outcome	NOUN
dpc-5668	63	15	were	be	AUX
dpc-5668	63	16	blinded	blind	VERB
dpc-5668	63	17	to	to	ADP
dpc-5668	63	18	the	the	DET
dpc-5668	63	19	intervention	intervention	NOUN
dpc-5668	63	20	received	receive	VERB
dpc-5668	63	21	by	by	ADP
dpc-5668	63	22	participants	participant	NOUN
dpc-5668	63	23	.	.	PUNCT
dpc-5668	64	1	blinding	blind	VERB
dpc-5668	64	2	of	of	ADP
dpc-5668	64	3	outcome	outcome	NOUN
dpc-5668	64	4	assessors	assessor	NOUN
dpc-5668	64	5	helps	help	VERB
dpc-5668	64	6	prevent	prevent	VERB
dpc-5668	64	7	detection	detection	NOUN
dpc-5668	64	8	bias	bias	NOUN
dpc-5668	64	9	,	,	PUNCT
dpc-5668	64	10	where	where	SCONJ
dpc-5668	64	11	knowledge	knowledge	NOUN
dpc-5668	64	12	of	of	ADP
dpc-5668	64	13	the	the	DET
dpc-5668	64	14	intervention	intervention	NOUN
dpc-5668	64	15	might	might	AUX
dpc-5668	64	16	influence	influence	VERB
dpc-5668	64	17	outcome	outcome	NOUN
dpc-5668	64	18	assessment	assessment	NOUN
dpc-5668	64	19	.	.	PUNCT
dpc-5668	65	1	•	•	ADJ
dpc-5668	65	2	incomplete	incomplete	ADJ
dpc-5668	65	3	outcome	outcome	NOUN
dpc-5668	65	4	data	datum	NOUN
dpc-5668	65	5	(	(	PUNCT
dpc-5668	65	6	attrition	attrition	NOUN
dpc-5668	65	7	bias	bias	NOUN
dpc-5668	65	8	):	):	PUNCT
dpc-5668	65	9	analyses	analyse	VERB
dpc-5668	65	10	how	how	SCONJ
dpc-5668	65	11	incomplete	incomplete	ADJ
dpc-5668	65	12	outcome	outcome	NOUN
dpc-5668	65	13	data	datum	NOUN
dpc-5668	65	14	(	(	PUNCT
dpc-5668	65	15	e.g.	e.g.	ADV
dpc-5668	65	16	,	,	PUNCT
dpc-5668	65	17	losses	loss	NOUN
dpc-5668	65	18	and	and	CCONJ
dpc-5668	65	19	withdrawals	withdrawal	NOUN
dpc-5668	65	20	)	)	PUNCT
dpc-5668	65	21	were	be	AUX
dpc-5668	65	22	handled	handle	VERB
dpc-5668	65	23	.	.	PUNCT
dpc-5668	66	1	it	it	PRON
dpc-5668	66	2	covers	cover	VERB
dpc-5668	66	3	the	the	DET
dpc-5668	66	4	difference	difference	NOUN
dpc-5668	66	5	in	in	ADP
dpc-5668	66	6	the	the	DET
dpc-5668	66	7	number	number	NOUN
dpc-5668	66	8	of	of	ADP
dpc-5668	66	9	participants	participant	NOUN
dpc-5668	66	10	withdrawn	withdraw	VERB
dpc-5668	66	11	from	from	ADP
dpc-5668	66	12	each	each	DET
dpc-5668	66	13	group	group	NOUN
dpc-5668	66	14	(	(	PUNCT
dpc-5668	66	15	intervention	intervention	NOUN
dpc-5668	66	16	and	and	CCONJ
dpc-5668	66	17	control	control	NOUN
dpc-5668	66	18	)	)	PUNCT
dpc-5668	66	19	and	and	CCONJ
dpc-5668	66	20	how	how	SCONJ
dpc-5668	66	21	the	the	DET
dpc-5668	66	22	losses	loss	NOUN
dpc-5668	66	23	were	be	AUX
dpc-5668	66	24	considered	consider	VERB
dpc-5668	66	25	in	in	ADP
dpc-5668	66	26	the	the	DET
dpc-5668	66	27	data	data	NOUN
dpc-5668	66	28	analyses	analysis	NOUN
dpc-5668	66	29	.	.	PUNCT
dpc-5668	67	1	•	•	NUM
dpc-5668	67	2	selective	selective	ADJ
dpc-5668	67	3	reporting	reporting	NOUN
dpc-5668	67	4	:	:	PUNCT
dpc-5668	67	5	assesses	assesse	NOUN
dpc-5668	67	6	whether	whether	SCONJ
dpc-5668	67	7	the	the	DET
dpc-5668	67	8	study	study	NOUN
dpc-5668	67	9	reported	report	VERB
dpc-5668	67	10	all	all	DET
dpc-5668	67	11	intended	intend	VERB
dpc-5668	67	12	outcomes	outcome	NOUN
dpc-5668	67	13	.	.	PUNCT
dpc-5668	68	1	this	this	DET
dpc-5668	68	2	domain	domain	NOUN
dpc-5668	68	3	identifies	identify	VERB
dpc-5668	68	4	any	any	DET
dpc-5668	68	5	selective	selective	ADJ
dpc-5668	68	6	reporting	reporting	NOUN
dpc-5668	68	7	of	of	ADP
dpc-5668	68	8	results	result	NOUN
dpc-5668	68	9	that	that	PRON
dpc-5668	68	10	could	could	AUX
dpc-5668	68	11	skew	skew	VERB
dpc-5668	68	12	findings	finding	NOUN
dpc-5668	68	13	,	,	PUNCT
dpc-5668	68	14	as	as	SCONJ
dpc-5668	68	15	published	publish	VERB
dpc-5668	68	16	studies	study	NOUN
dpc-5668	68	17	are	be	AUX
dpc-5668	68	18	more	more	ADV
dpc-5668	68	19	likely	likely	ADJ
dpc-5668	68	20	to	to	PART
dpc-5668	68	21	report	report	VERB
dpc-5668	68	22	analyses	analysis	NOUN
dpc-5668	68	23	showing	show	VERB
dpc-5668	68	24	significant	significant	ADJ
dpc-5668	68	25	differences	difference	NOUN
dpc-5668	68	26	between	between	ADP
dpc-5668	68	27	groups	group	NOUN
dpc-5668	68	28	rather	rather	ADV
dpc-5668	68	29	than	than	ADP
dpc-5668	68	30	those	those	PRON
dpc-5668	68	31	with	with	ADP
dpc-5668	68	32	non	non	ADJ
dpc-5668	68	33	-	-	ADJ
dpc-5668	68	34	significant	significant	ADJ
dpc-5668	68	35	differences	difference	NOUN
dpc-5668	68	36	.	.	PUNCT
dpc-5668	69	1	•	•	NUM
dpc-5668	69	2	other	other	ADJ
dpc-5668	69	3	sources	source	NOUN
dpc-5668	69	4	of	of	ADP
dpc-5668	69	5	bias	bias	NOUN
dpc-5668	69	6	:	:	PUNCT
dpc-5668	69	7	examines	examine	VERB
dpc-5668	69	8	any	any	DET
dpc-5668	69	9	other	other	ADJ
dpc-5668	69	10	potential	potential	ADJ
dpc-5668	69	11	sources	source	NOUN
dpc-5668	69	12	of	of	ADP
dpc-5668	69	13	bias	bias	NOUN
dpc-5668	69	14	not	not	PART
dpc-5668	69	15	covered	cover	VERB
dpc-5668	69	16	by	by	ADP
dpc-5668	69	17	the	the	DET
dpc-5668	69	18	previous	previous	ADJ
dpc-5668	69	19	domains	domain	NOUN
dpc-5668	69	20	.	.	PUNCT
dpc-5668	70	1	it	it	PRON
dpc-5668	70	2	includes	include	VERB
dpc-5668	70	3	factors	factor	NOUN
dpc-5668	70	4	such	such	ADJ
dpc-5668	70	5	as	as	ADP
dpc-5668	70	6	baseline	baseline	ADJ
dpc-5668	70	7	data	datum	NOUN
dpc-5668	70	8	imbalance	imbalance	NOUN
dpc-5668	70	9	and	and	CCONJ
dpc-5668	70	10	other	other	ADJ
dpc-5668	70	11	factors	factor	NOUN
dpc-5668	70	12	affecting	affect	VERB
dpc-5668	70	13	the	the	DET
dpc-5668	70	14	study	study	NOUN
dpc-5668	70	15	’s	’s	PART
dpc-5668	70	16	validity	validity	NOUN
dpc-5668	70	17	.	.	PUNCT
dpc-5668	71	1	blinding	blinding	ADJ
dpc-5668	71	2	and	and	CCONJ
dpc-5668	71	3	incomplete	incomplete	ADJ
dpc-5668	71	4	outcome	outcome	NOUN
dpc-5668	71	5	data	datum	NOUN
dpc-5668	71	6	were	be	AUX
dpc-5668	71	7	evaluated	evaluate	VERB
dpc-5668	71	8	separately	separately	ADV
dpc-5668	71	9	for	for	ADP
dpc-5668	71	10	each	each	DET
dpc-5668	71	11	outcome	outcome	NOUN
dpc-5668	71	12	,	,	PUNCT
dpc-5668	71	13	as	as	SCONJ
dpc-5668	71	14	recommended	recommend	VERB
dpc-5668	71	15	.	.	PUNCT
dpc-5668	72	1	however	however	ADV
dpc-5668	72	2	,	,	PUNCT
dpc-5668	72	3	since	since	SCONJ
dpc-5668	72	4	all	all	DET
dpc-5668	72	5	outcomes	outcome	NOUN
dpc-5668	72	6	of	of	ADP
dpc-5668	72	7	interest	interest	NOUN
dpc-5668	72	8	in	in	ADP
dpc-5668	72	9	this	this	DET
dpc-5668	72	10	meta	meta	ADJ
dpc-5668	72	11	-	-	PUNCT
dpc-5668	72	12	research	research	NOUN
dpc-5668	72	13	study	study	NOUN
dpc-5668	72	14	were	be	AUX
dpc-5668	72	15	subjective	subjective	ADJ
dpc-5668	72	16	(	(	PUNCT
dpc-5668	72	17	cure	cure	NOUN
dpc-5668	72	18	response	response	NOUN
dpc-5668	72	19	,	,	PUNCT
dpc-5668	72	20	bacteriological	bacteriological	ADJ
dpc-5668	72	21	response	response	NOUN
dpc-5668	72	22	,	,	PUNCT
dpc-5668	72	23	adverse	adverse	ADJ
dpc-5668	72	24	events	event	NOUN
dpc-5668	72	25	,	,	PUNCT
dpc-5668	72	26	and	and	CCONJ
dpc-5668	72	27	quality	quality	NOUN
dpc-5668	72	28	of	of	ADP
dpc-5668	72	29	life	life	NOUN
dpc-5668	72	30	)	)	PUNCT
dpc-5668	72	31	,	,	PUNCT
dpc-5668	72	32	the	the	DET
dpc-5668	72	33	lack	lack	NOUN
dpc-5668	72	34	of	of	ADP
dpc-5668	72	35	blinding	blind	VERB
dpc-5668	72	36	in	in	ADP
dpc-5668	72	37	these	these	DET
dpc-5668	72	38	domains	domain	NOUN
dpc-5668	72	39	could	could	AUX
dpc-5668	72	40	have	have	AUX
dpc-5668	72	41	potentially	potentially	ADV
dpc-5668	72	42	influenced	influence	VERB
dpc-5668	72	43	the	the	DET
dpc-5668	72	44	results	result	NOUN
dpc-5668	72	45	,	,	PUNCT
dpc-5668	72	46	which	which	PRON
dpc-5668	72	47	were	be	AUX
dpc-5668	72	48	assessed	assess	VERB
dpc-5668	72	49	together	together	ADV
dpc-5668	72	50	.	.	PUNCT
dpc-5668	73	1	the	the	DET
dpc-5668	73	2	judgment	judgment	NOUN
dpc-5668	73	3	of	of	ADP
dpc-5668	73	4	risk	risk	NOUN
dpc-5668	73	5	of	of	ADP
dpc-5668	73	6	bias	bias	NOUN
dpc-5668	73	7	for	for	ADP
dpc-5668	73	8	each	each	DET
dpc-5668	73	9	domain	domain	NOUN
dpc-5668	73	10	is	be	AUX
dpc-5668	73	11	categorized	categorize	VERB
dpc-5668	73	12	into	into	ADP
dpc-5668	73	13	three	three	NUM
dpc-5668	73	14	levels	level	NOUN
dpc-5668	73	15	:	:	PUNCT
dpc-5668	73	16	(	(	PUNCT
dpc-5668	73	17	1	1	X
dpc-5668	73	18	)	)	PUNCT
dpc-5668	73	19	low	low	ADJ
dpc-5668	73	20	risk	risk	NOUN
dpc-5668	73	21	of	of	ADP
dpc-5668	73	22	bias	bias	NOUN
dpc-5668	73	23	,	,	PUNCT
dpc-5668	73	24	when	when	SCONJ
dpc-5668	73	25	the	the	DET
dpc-5668	73	26	method	method	NOUN
dpc-5668	73	27	is	be	AUX
dpc-5668	73	28	adequately	adequately	ADV
dpc-5668	73	29	addressed	address	VERB
dpc-5668	73	30	in	in	ADP
dpc-5668	73	31	the	the	DET
dpc-5668	73	32	study	study	NOUN
dpc-5668	73	33	;	;	PUNCT
dpc-5668	73	34	(	(	PUNCT
dpc-5668	73	35	2	2	X
dpc-5668	73	36	)	)	PUNCT
dpc-5668	73	37	high	high	ADJ
dpc-5668	73	38	risk	risk	NOUN
dpc-5668	73	39	of	of	ADP
dpc-5668	73	40	bias	bias	NOUN
dpc-5668	73	41	,	,	PUNCT
dpc-5668	73	42	when	when	SCONJ
dpc-5668	73	43	the	the	DET
dpc-5668	73	44	method	method	NOUN
dpc-5668	73	45	is	be	AUX
dpc-5668	73	46	inadequately	inadequately	ADV
dpc-5668	73	47	addressed	address	VERB
dpc-5668	73	48	;	;	PUNCT
dpc-5668	73	49	(	(	PUNCT
dpc-5668	73	50	3	3	X
dpc-5668	73	51	)	)	PUNCT
dpc-5668	73	52	unclear	unclear	ADJ
dpc-5668	73	53	risk	risk	NOUN
dpc-5668	73	54	of	of	ADP
dpc-5668	73	55	bias	bias	NOUN
dpc-5668	73	56	,	,	PUNCT
dpc-5668	73	57	when	when	SCONJ
dpc-5668	73	58	there	there	PRON
dpc-5668	73	59	is	be	VERB
dpc-5668	73	60	insufficient	insufficient	ADJ
dpc-5668	73	61	information	information	NOUN
dpc-5668	73	62	to	to	PART
dpc-5668	73	63	make	make	VERB
dpc-5668	73	64	a	a	DET
dpc-5668	73	65	definitive	definitive	ADJ
dpc-5668	73	66	assessment	assessment	NOUN
dpc-5668	73	67	.	.	PUNCT
dpc-5668	74	1	data	datum	NOUN
dpc-5668	74	2	synthesis	synthesis	VERB
dpc-5668	74	3	the	the	DET
dpc-5668	74	4	risk	risk	NOUN
dpc-5668	74	5	of	of	ADP
dpc-5668	74	6	bias	bias	NOUN
dpc-5668	74	7	assessments	assessment	NOUN
dpc-5668	74	8	were	be	AUX
dpc-5668	74	9	reported	report	VERB
dpc-5668	74	10	as	as	ADP
dpc-5668	74	11	absolute	absolute	ADJ
dpc-5668	74	12	frequencies	frequency	NOUN
dpc-5668	74	13	and	and	CCONJ
dpc-5668	74	14	proportions	proportion	NOUN
dpc-5668	74	15	for	for	ADP
dpc-5668	74	16	each	each	DET
dpc-5668	74	17	domain	domain	NOUN
dpc-5668	74	18	of	of	ADP
dpc-5668	74	19	the	the	DET
dpc-5668	74	20	rob	rob	PROPN
dpc-5668	74	21	tool	tool	PROPN
dpc-5668	74	22	.	.	PUNCT
dpc-5668	75	1	in	in	ADP
dpc-5668	75	2	addition	addition	NOUN
dpc-5668	75	3	,	,	PUNCT
dpc-5668	75	4	95	95	NUM
dpc-5668	75	5	%	%	NOUN
dpc-5668	75	6	confidence	confidence	NOUN
dpc-5668	75	7	intervals	interval	NOUN
dpc-5668	75	8	(	(	PUNCT
dpc-5668	75	9	95	95	NUM
dpc-5668	75	10	%	%	NOUN
dpc-5668	75	11	ci	ci	NOUN
dpc-5668	75	12	)	)	PUNCT
dpc-5668	75	13	for	for	ADP
dpc-5668	75	14	proportions	proportion	NOUN
dpc-5668	75	15	were	be	AUX
dpc-5668	75	16	calculated	calculate	VERB
dpc-5668	75	17	using	use	VERB
dpc-5668	75	18	the	the	DET
dpc-5668	75	19	wilson	wilson	PROPN
dpc-5668	75	20	score	score	NOUN
dpc-5668	75	21	interval	interval	NOUN
dpc-5668	75	22	,	,	PUNCT
dpc-5668	75	23	in	in	ADP
dpc-5668	75	24	the	the	DET
dpc-5668	75	25	binomial	binomial	ADJ
dpc-5668	75	26	r	r	NOUN
dpc-5668	75	27	®	®	NOUN
dpc-5668	75	28	software	software	NOUN
dpc-5668	75	29	package	package	NOUN
dpc-5668	75	30	(	(	PUNCT
dpc-5668	75	31	version	version	NOUN
dpc-5668	75	32	4.5	4.5	NUM
dpc-5668	75	33	)	)	PUNCT
dpc-5668	75	34	.	.	PUNCT
dpc-5668	76	1	results	result	VERB
dpc-5668	76	2	search	search	NOUN
dpc-5668	76	3	results	result	NOUN
dpc-5668	76	4	the	the	DET
dpc-5668	76	5	database	database	NOUN
dpc-5668	76	6	search	search	NOUN
dpc-5668	76	7	yielded	yield	VERB
dpc-5668	76	8	907	907	NUM
dpc-5668	76	9	references	reference	NOUN
dpc-5668	76	10	.	.	PUNCT
dpc-5668	77	1	after	after	ADP
dpc-5668	77	2	removing	remove	VERB
dpc-5668	77	3	six	six	NUM
dpc-5668	77	4	duplicates	duplicate	NOUN
dpc-5668	77	5	and	and	CCONJ
dpc-5668	77	6	screening	screen	VERB
dpc-5668	77	7	the	the	DET
dpc-5668	77	8	titles	title	NOUN
dpc-5668	77	9	and	and	CCONJ
dpc-5668	77	10	abstracts	abstract	NOUN
dpc-5668	77	11	,	,	PUNCT
dpc-5668	77	12	878	878	NUM
dpc-5668	77	13	studies	study	NOUN
dpc-5668	77	14	were	be	AUX
dpc-5668	77	15	excluded	exclude	VERB
dpc-5668	77	16	for	for	ADP
dpc-5668	77	17	not	not	PART
dpc-5668	77	18	meeting	meet	VERB
dpc-5668	77	19	the	the	DET
dpc-5668	77	20	inclusion	inclusion	NOUN
dpc-5668	77	21	criteria	criterion	NOUN
dpc-5668	77	22	.	.	PUNCT
dpc-5668	78	1	twenty	twenty	NUM
dpc-5668	78	2	-	-	PUNCT
dpc-5668	78	3	nine	nine	NUM
dpc-5668	78	4	studies	study	NOUN
dpc-5668	78	5	were	be	AUX
dpc-5668	78	6	assessed	assess	VERB
dpc-5668	78	7	in	in	ADP
dpc-5668	78	8	full	full	ADJ
dpc-5668	78	9	text	text	NOUN
dpc-5668	78	10	,	,	PUNCT
dpc-5668	78	11	and	and	CCONJ
dpc-5668	78	12	eight	eight	NUM
dpc-5668	78	13	were	be	AUX
dpc-5668	78	14	excluded	exclude	VERB
dpc-5668	78	15	[	[	PUNCT
dpc-5668	78	16	7,13	7,13	NOUN
dpc-5668	78	17	-	-	SYM
dpc-5668	78	18	17	17	NUM
dpc-5668	78	19	]	]	PUNCT
dpc-5668	78	20	because	because	SCONJ
dpc-5668	78	21	they	they	PRON
dpc-5668	78	22	were	be	AUX
dpc-5668	78	23	not	not	PART
dpc-5668	78	24	randomized	randomize	VERB
dpc-5668	78	25	clinical	clinical	ADJ
dpc-5668	78	26	trials	trial	NOUN
dpc-5668	78	27	(	(	PUNCT
dpc-5668	78	28	rcts	rct	NOUN
dpc-5668	78	29	)	)	PUNCT
dpc-5668	78	30	.	.	PUNCT
dpc-5668	79	1	consequently	consequently	ADV
dpc-5668	79	2	,	,	PUNCT
dpc-5668	79	3	21	21	NUM
dpc-5668	79	4	studies	study	NOUN
dpc-5668	79	5	were	be	AUX
dpc-5668	79	6	included	include	VERB
dpc-5668	79	7	in	in	ADP
dpc-5668	79	8	this	this	DET
dpc-5668	79	9	meta	meta	ADJ
dpc-5668	79	10	-	-	PUNCT
dpc-5668	79	11	analysis	analysis	NOUN
dpc-5668	79	12	[	[	X
dpc-5668	79	13	18	18	NUM
dpc-5668	79	14	-	-	SYM
dpc-5668	79	15	38	38	NUM
dpc-5668	79	16	]	]	PUNCT
dpc-5668	79	17	(	(	PUNCT
dpc-5668	79	18	figure	figure	NOUN
dpc-5668	79	19	1	1	NUM
dpc-5668	79	20	)	)	PUNCT
dpc-5668	79	21	.	.	PUNCT
dpc-5668	80	1	characteristics	characteristic	NOUN
dpc-5668	80	2	of	of	ADP
dpc-5668	80	3	the	the	DET
dpc-5668	80	4	included	include	VERB
dpc-5668	80	5	studies	study	NOUN
dpc-5668	80	6	the	the	DET
dpc-5668	80	7	21	21	NUM
dpc-5668	80	8	randomized	randomize	VERB
dpc-5668	80	9	controlled	control	VERB
dpc-5668	80	10	trials	trial	NOUN
dpc-5668	80	11	(	(	PUNCT
dpc-5668	80	12	rcts	rct	NOUN
dpc-5668	80	13	)	)	PUNCT
dpc-5668	80	14	published	publish	VERB
dpc-5668	80	15	between	between	ADP
dpc-5668	80	16	1986	1986	NUM
dpc-5668	80	17	and	and	CCONJ
dpc-5668	80	18	2023	2023	NUM
dpc-5668	80	19	included	include	VERB
dpc-5668	80	20	2,876	2,876	NUM
dpc-5668	80	21	participants	participant	NOUN
dpc-5668	80	22	diagnosed	diagnose	VERB
dpc-5668	80	23	with	with	ADP
dpc-5668	80	24	impetigo	impetigo	PROPN
dpc-5668	80	25	.	.	PUNCT
dpc-5668	81	1	the	the	DET
dpc-5668	81	2	most	most	ADV
dpc-5668	81	3	common	common	ADJ
dpc-5668	81	4	interventions	intervention	NOUN
dpc-5668	81	5	were	be	AUX
dpc-5668	81	6	macrolide	macrolide	ADJ
dpc-5668	81	7	antibiotics	antibiotic	NOUN
dpc-5668	81	8	,	,	PUNCT
dpc-5668	81	9	bacterial	bacterial	ADJ
dpc-5668	81	10	protein	protein	NOUN
dpc-5668	81	11	synthesis	synthesis	NOUN
dpc-5668	81	12	inhibitors	inhibitor	NOUN
dpc-5668	81	13	,	,	PUNCT
dpc-5668	81	14	penicillins	penicillin	NOUN
dpc-5668	81	15	,	,	PUNCT
dpc-5668	81	16	cephalosporins	cephalosporin	NOUN
dpc-5668	81	17	,	,	PUNCT
dpc-5668	81	18	quinolones	quinolone	NOUN
dpc-5668	81	19	,	,	PUNCT
dpc-5668	81	20	sulfonamides	sulfonamide	NOUN
dpc-5668	81	21	,	,	PUNCT
dpc-5668	81	22	and	and	CCONJ
dpc-5668	81	23	antifungals	antifungal	NOUN
dpc-5668	81	24	.	.	PUNCT
dpc-5668	82	1	these	these	DET
dpc-5668	82	2	interventions	intervention	NOUN
dpc-5668	82	3	were	be	AUX
dpc-5668	82	4	compared	compare	VERB
dpc-5668	82	5	regarding	regard	VERB
dpc-5668	82	6	their	their	PRON
dpc-5668	82	7	effects	effect	NOUN
dpc-5668	82	8	via	via	ADP
dpc-5668	82	9	topical	topical	ADJ
dpc-5668	82	10	versus	versus	ADP
dpc-5668	82	11	oral	oral	ADJ
dpc-5668	82	12	administration	administration	NOUN
dpc-5668	82	13	or	or	CCONJ
dpc-5668	82	14	against	against	ADP
dpc-5668	82	15	a	a	DET
dpc-5668	82	16	placebo	placebo	NOUN
dpc-5668	82	17	(	(	PUNCT
dpc-5668	82	18	table	table	NOUN
dpc-5668	82	19	1	1	NUM
dpc-5668	82	20	)	)	PUNCT
dpc-5668	82	21	.	.	PUNCT
dpc-5668	83	1	risk	risk	NOUN
dpc-5668	83	2	of	of	ADP
dpc-5668	83	3	bias	bias	NOUN
dpc-5668	83	4	assessment	assessment	NOUN
dpc-5668	83	5	the	the	DET
dpc-5668	83	6	methodological	methodological	ADJ
dpc-5668	83	7	quality	quality	NOUN
dpc-5668	83	8	of	of	ADP
dpc-5668	83	9	the	the	DET
dpc-5668	83	10	included	include	VERB
dpc-5668	83	11	rcts	rct	NOUN
dpc-5668	83	12	was	be	AUX
dpc-5668	83	13	assessed	assess	VERB
dpc-5668	83	14	using	use	VERB
dpc-5668	83	15	the	the	DET
dpc-5668	83	16	cochrane	cochrane	NOUN
dpc-5668	83	17	risk	risk	NOUN
dpc-5668	83	18	of	of	ADP
dpc-5668	83	19	bias	bias	NOUN
dpc-5668	83	20	(	(	PUNCT
dpc-5668	83	21	rob	rob	PROPN
dpc-5668	83	22	)	)	PUNCT
dpc-5668	83	23	tool	tool	NOUN
dpc-5668	83	24	following	follow	VERB
dpc-5668	83	25	the	the	DET
dpc-5668	83	26	assessment	assessment	NOUN
dpc-5668	83	27	recommendations	recommendation	NOUN
dpc-5668	83	28	outlined	outline	VERB
dpc-5668	83	29	in	in	ADP
dpc-5668	83	30	the	the	DET
dpc-5668	83	31	cochrane	cochrane	PROPN
dpc-5668	83	32	handbook	handbook	NOUN
dpc-5668	83	33	for	for	ADP
dpc-5668	83	34	systematic	systematic	ADJ
dpc-5668	83	35	reviews	review	NOUN
dpc-5668	83	36	of	of	ADP
dpc-5668	83	37	interventions	intervention	NOUN
dpc-5668	83	38	.	.	PUNCT
dpc-5668	84	1	figure	figure	NOUN
dpc-5668	84	2	2	2	NUM
dpc-5668	84	3	presents	present	VERB
dpc-5668	84	4	the	the	DET
dpc-5668	84	5	overall	overall	ADJ
dpc-5668	84	6	assessment	assessment	NOUN
dpc-5668	84	7	,	,	PUNCT
dpc-5668	84	8	while	while	SCONJ
dpc-5668	84	9	table	table	NOUN
dpc-5668	84	10	s2	s2	NOUN
dpc-5668	84	11	provides	provide	VERB
dpc-5668	84	12	detailed	detailed	ADJ
dpc-5668	84	13	judgments	judgment	NOUN
dpc-5668	84	14	for	for	ADP
dpc-5668	84	15	each	each	DET
dpc-5668	84	16	study	study	NOUN
dpc-5668	84	17	.	.	PUNCT
dpc-5668	85	1	only	only	ADV
dpc-5668	85	2	one	one	NUM
dpc-5668	85	3	rct	rct	NOUN
dpc-5668	85	4	(	(	PUNCT
dpc-5668	85	5	5	5	NUM
dpc-5668	85	6	%	%	NOUN
dpc-5668	85	7	,	,	PUNCT
dpc-5668	85	8	95	95	NUM
dpc-5668	85	9	%	%	NOUN
dpc-5668	85	10	ci	ci	NOUN
dpc-5668	85	11	:	:	PUNCT
dpc-5668	85	12	0.85%–23	0.85%–23	NUM
dpc-5668	85	13	%	%	NOUN
dpc-5668	85	14	)	)	PUNCT
dpc-5668	85	15	was	be	AUX
dpc-5668	85	16	classified	classify	VERB
dpc-5668	85	17	as	as	ADP
dpc-5668	85	18	having	have	VERB
dpc-5668	85	19	low	low	ADJ
dpc-5668	85	20	risk	risk	NOUN
dpc-5668	85	21	of	of	ADP
dpc-5668	85	22	bias	bias	NOUN
dpc-5668	85	23	across	across	ADP
dpc-5668	85	24	all	all	DET
dpc-5668	85	25	domains	domain	NOUN
dpc-5668	85	26	assessed	assess	VERB
dpc-5668	85	27	[	[	X
dpc-5668	85	28	35	35	NUM
dpc-5668	85	29	]	]	PUNCT
dpc-5668	85	30	,	,	PUNCT
dpc-5668	85	31	while	while	SCONJ
dpc-5668	85	32	three	three	NUM
dpc-5668	85	33	trials	trial	NOUN
dpc-5668	85	34	(	(	PUNCT
dpc-5668	85	35	14	14	NUM
dpc-5668	85	36	%	%	NOUN
dpc-5668	85	37	,	,	PUNCT
dpc-5668	85	38	95	95	NUM
dpc-5668	85	39	%	%	NOUN
dpc-5668	85	40	ci	ci	NOUN
dpc-5668	85	41	:	:	PUNCT
dpc-5668	85	42	0.5%–35	0.5%–35	NUM
dpc-5668	85	43	%	%	NOUN
dpc-5668	85	44	)	)	PUNCT
dpc-5668	85	45	demonstrated	demonstrate	VERB
dpc-5668	85	46	low	low	ADJ
dpc-5668	85	47	risk	risk	NOUN
dpc-5668	85	48	in	in	ADP
dpc-5668	85	49	six	six	NUM
dpc-5668	85	50	out	out	ADP
dpc-5668	85	51	of	of	ADP
dpc-5668	85	52	the	the	DET
dpc-5668	85	53	seven	seven	NUM
dpc-5668	85	54	domains	domain	NOUN
dpc-5668	85	55	of	of	ADP
dpc-5668	85	56	the	the	DET
dpc-5668	85	57	rob	rob	PROPN
dpc-5668	85	58	tool	tool	PROPN
dpc-5668	86	1	[	[	X
dpc-5668	86	2	26,29,30	26,29,30	NUM
dpc-5668	86	3	]	]	PUNCT
dpc-5668	86	4	.	.	PUNCT
dpc-5668	87	1	4	4	NUM
dpc-5668	87	2	review	review	NOUN
dpc-5668	87	3	|	|	ADV
dpc-5668	87	4	dermatol	dermatol	ADJ
dpc-5668	87	5	pract	pract	NOUN
dpc-5668	87	6	concept	concept	NOUN
dpc-5668	87	7	.	.	PUNCT
dpc-5668	88	1	2025;15(4):5668	2025;15(4):5668	NUM
dpc-5668	89	1	i	i	PRON
dpc-5668	89	2	d	d	PROPN
dpc-5668	89	3	en	en	X
dpc-5668	89	4	tif	tif	PROPN
dpc-5668	89	5	ic	ic	PROPN
dpc-5668	89	6	at	at	ADP
dpc-5668	89	7	io	io	PROPN
dpc-5668	89	8	n	n	PROPN
dpc-5668	89	9	references	reference	NOUN
dpc-5668	89	10	from	from	ADP
dpc-5668	89	11	electronic	electronic	ADJ
dpc-5668	89	12	search	search	NOUN
dpc-5668	89	13	(	(	PUNCT
dpc-5668	89	14	n=907	n=907	PROPN
dpc-5668	89	15	)	)	PUNCT
dpc-5668	89	16	se	se	X
dpc-5668	89	17	le	le	X
dpc-5668	89	18	ct	ct	PROPN
dpc-5668	89	19	io	io	PROPN
dpc-5668	89	20	n	n	PROPN
dpc-5668	89	21	duplicates	duplicate	NOUN
dpc-5668	89	22	removed	remove	VERB
dpc-5668	89	23	(	(	PUNCT
dpc-5668	89	24	n=6	n=6	NOUN
dpc-5668	89	25	)	)	PUNCT
dpc-5668	89	26	references	reference	NOUN
dpc-5668	89	27	eliminated	eliminate	VERB
dpc-5668	89	28	(	(	PUNCT
dpc-5668	89	29	n=872	n=872	PROPN
dpc-5668	89	30	)	)	PUNCT
dpc-5668	89	31	references	reference	NOUN
dpc-5668	89	32	assessed	assess	VERB
dpc-5668	89	33	by	by	ADP
dpc-5668	89	34	title	title	NOUN
dpc-5668	89	35	/	/	SYM
dpc-5668	89	36	abstracts	abstract	NOUN
dpc-5668	89	37	(	(	PUNCT
dpc-5668	89	38	n=901	n=901	PROPN
dpc-5668	89	39	)	)	PUNCT
dpc-5668	89	40	el	el	PROPN
dpc-5668	89	41	ig	ig	PROPN
dpc-5668	89	42	ib	ib	PROPN
dpc-5668	89	43	ili	ili	PROPN
dpc-5668	89	44	ty	ty	INTJ
dpc-5668	89	45	references	reference	NOUN
dpc-5668	89	46	assessed	assess	VERB
dpc-5668	89	47	by	by	ADP
dpc-5668	89	48	full	full	ADJ
dpc-5668	89	49	text	text	NOUN
dpc-5668	89	50	(	(	PUNCT
dpc-5668	89	51	n=29	n=29	NOUN
dpc-5668	89	52	)	)	PUNCT
dpc-5668	89	53	references	reference	NOUN
dpc-5668	89	54	excluded	exclude	VERB
dpc-5668	89	55	(	(	PUNCT
dpc-5668	89	56	n=8	n=8	ADP
dpc-5668	89	57	)	)	PUNCT
dpc-5668	89	58	in	in	ADP
dpc-5668	89	59	cl	cl	NOUN
dpc-5668	89	60	us	us	PROPN
dpc-5668	90	1	io	io	PROPN
dpc-5668	90	2	n	n	PRON
dpc-5668	90	3	included	include	VERB
dpc-5668	90	4	studies	study	NOUN
dpc-5668	90	5	and	and	CCONJ
dpc-5668	90	6	reports	report	NOUN
dpc-5668	90	7	(	(	PUNCT
dpc-5668	90	8	n=21	n=21	NOUN
dpc-5668	90	9	)	)	PUNCT
dpc-5668	90	10	manual	manual	ADJ
dpc-5668	90	11	search	search	NOUN
dpc-5668	90	12	(	(	PUNCT
dpc-5668	90	13	n=0	n=0	NUM
dpc-5668	90	14	)	)	PUNCT
dpc-5668	90	15	figure	figure	NOUN
dpc-5668	90	16	1	1	NUM
dpc-5668	90	17	.	.	PUNCT
dpc-5668	90	18	flowchart	flowchart	NOUN
dpc-5668	90	19	of	of	ADP
dpc-5668	90	20	the	the	DET
dpc-5668	90	21	study	study	NOUN
dpc-5668	90	22	selection	selection	NOUN
dpc-5668	90	23	process	process	NOUN
dpc-5668	90	24	.	.	PUNCT
dpc-5668	91	1	table	table	NOUN
dpc-5668	91	2	1	1	NUM
dpc-5668	91	3	.	.	PUNCT
dpc-5668	92	1	characteristics	characteristic	NOUN
dpc-5668	92	2	of	of	ADP
dpc-5668	92	3	the	the	DET
dpc-5668	92	4	included	include	VERB
dpc-5668	92	5	studies	study	NOUN
dpc-5668	92	6	.	.	PUNCT
dpc-5668	93	1	study	study	NOUN
dpc-5668	93	2	,	,	PUNCT
dpc-5668	93	3	year	year	NOUN
dpc-5668	93	4	intervention	intervention	NOUN
dpc-5668	93	5	/	/	SYM
dpc-5668	93	6	number	number	NOUN
dpc-5668	93	7	of	of	ADP
dpc-5668	93	8	participants	participant	NOUN
dpc-5668	93	9	(	(	PUNCT
dpc-5668	93	10	n	n	CCONJ
dpc-5668	93	11	)	)	PUNCT
dpc-5668	93	12	control	control	NOUN
dpc-5668	93	13	/	/	SYM
dpc-5668	93	14	number	number	NOUN
dpc-5668	93	15	of	of	ADP
dpc-5668	93	16	participants	participant	NOUN
dpc-5668	93	17	(	(	PUNCT
dpc-5668	93	18	n	n	CCONJ
dpc-5668	93	19	)	)	PUNCT
dpc-5668	93	20	outcomes	outcome	NOUN
dpc-5668	93	21	of	of	ADP
dpc-5668	93	22	interest	interest	NOUN
dpc-5668	93	23	funding	funding	NOUN
dpc-5668	93	24	sources	source	NOUN
dpc-5668	93	25	anusharani	anusharani	VERB
dpc-5668	93	26	201918	201918	NUM
dpc-5668	93	27	topical	topical	ADJ
dpc-5668	93	28	2	2	NUM
dpc-5668	93	29	%	%	NOUN
dpc-5668	93	30	fusidic	fusidic	ADJ
dpc-5668	93	31	acid	acid	NOUN
dpc-5668	93	32	cream	cream	NOUN
dpc-5668	93	33	(	(	PUNCT
dpc-5668	93	34	n=50	n=50	ADJ
dpc-5668	93	35	)	)	PUNCT
dpc-5668	93	36	topical	topical	ADJ
dpc-5668	93	37	2	2	NUM
dpc-5668	93	38	%	%	NOUN
dpc-5668	93	39	mupirocin	mupirocin	NOUN
dpc-5668	93	40	ointment	ointment	NOUN
dpc-5668	93	41	(	(	PUNCT
dpc-5668	93	42	n	n	NOUN
dpc-5668	93	43	=	=	SYM
dpc-5668	93	44	50	50	NUM
dpc-5668	93	45	)	)	PUNCT
dpc-5668	93	46	•	•	NOUN
dpc-5668	93	47	clinical	clinical	ADJ
dpc-5668	93	48	response	response	NOUN
dpc-5668	93	49	•	•	ADP
dpc-5668	93	50	adverse	adverse	ADJ
dpc-5668	93	51	events	event	NOUN
dpc-5668	93	52	no	no	DET
dpc-5668	93	53	sources	source	NOUN
dpc-5668	93	54	barton	barton	PROPN
dpc-5668	93	55	198819	198819	NUM
dpc-5668	93	56	oral	oral	ADJ
dpc-5668	93	57	erythromycin	erythromycin	NOUN
dpc-5668	93	58	(	(	PUNCT
dpc-5668	93	59	40	40	NUM
dpc-5668	93	60	mg	mg	NUM
dpc-5668	93	61	/kg	/kg	SYM
dpc-5668	93	62	/	/	SYM
dpc-5668	93	63	day	day	NOUN
dpc-5668	93	64	)	)	PUNCT
dpc-5668	93	65	(	(	PUNCT
dpc-5668	93	66	n	n	NOUN
dpc-5668	93	67	=	=	SYM
dpc-5668	93	68	29	29	NUM
dpc-5668	93	69	)	)	PUNCT
dpc-5668	93	70	oral	oral	ADJ
dpc-5668	93	71	dicloxacillin	dicloxacillin	NOUN
dpc-5668	93	72	(	(	PUNCT
dpc-5668	93	73	25	25	NUM
dpc-5668	93	74	mg	mg	PROPN
dpc-5668	93	75	/	/	SYM
dpc-5668	93	76	kg	kg	PROPN
dpc-5668	93	77	/	/	SYM
dpc-5668	93	78	day	day	NOUN
dpc-5668	93	79	)	)	PUNCT
dpc-5668	93	80	(	(	PUNCT
dpc-5668	93	81	n	n	NOUN
dpc-5668	93	82	=	=	SYM
dpc-5668	93	83	30	30	NUM
dpc-5668	93	84	)	)	PUNCT
dpc-5668	93	85	•	•	NOUN
dpc-5668	93	86	bacteriological	bacteriological	ADJ
dpc-5668	93	87	response	response	NOUN
dpc-5668	93	88	•	•	ADP
dpc-5668	93	89	adverse	adverse	ADJ
dpc-5668	93	90	events	event	NOUN
dpc-5668	93	91	warner	warner	PROPN
dpc-5668	93	92	-	-	PUNCT
dpc-5668	93	93	lambert	lambert	PROPN
dpc-5668	93	94	corporation	corporation	PROPN
dpc-5668	93	95	ciftci	ciftci	PROPN
dpc-5668	93	96	200220	200220	NUM
dpc-5668	93	97	mupirocin	mupirocin	NOUN
dpc-5668	93	98	(	(	PUNCT
dpc-5668	93	99	bactroban	bactroban	NOUN
dpc-5668	93	100	2	2	NUM
dpc-5668	93	101	%	%	NOUN
dpc-5668	93	102	ointment	ointment	NOUN
dpc-5668	93	103	,	,	PUNCT
dpc-5668	93	104	3	3	NUM
dpc-5668	93	105	times/	times/	NUM
dpc-5668	93	106	day	day	NOUN
dpc-5668	93	107	for	for	ADP
dpc-5668	93	108	10	10	NUM
dpc-5668	93	109	days	day	NOUN
dpc-5668	93	110	)	)	PUNCT
dpc-5668	93	111	(	(	PUNCT
dpc-5668	93	112	n=25	n=25	NOUN
dpc-5668	93	113	)	)	PUNCT
dpc-5668	93	114	terbinafine	terbinafine	NOUN
dpc-5668	93	115	(	(	PUNCT
dpc-5668	93	116	lamisil	lamisil	NOUN
dpc-5668	93	117	1	1	NUM
dpc-5668	93	118	%	%	NOUN
dpc-5668	93	119	cream	cream	NOUN
dpc-5668	93	120	topically	topically	ADV
dpc-5668	93	121	,	,	PUNCT
dpc-5668	93	122	3	3	NUM
dpc-5668	93	123	times	time	NOUN
dpc-5668	93	124	/	/	SYM
dpc-5668	93	125	day	day	NOUN
dpc-5668	93	126	,	,	PUNCT
dpc-5668	93	127	for	for	ADP
dpc-5668	93	128	10	10	NUM
dpc-5668	93	129	days	day	NOUN
dpc-5668	93	130	)	)	PUNCT
dpc-5668	93	131	(	(	PUNCT
dpc-5668	93	132	n=23	n=23	PROPN
dpc-5668	93	133	)	)	PUNCT
dpc-5668	93	134	•	•	ADP
dpc-5668	93	135	clinical	clinical	ADJ
dpc-5668	93	136	response	response	NOUN
dpc-5668	93	137	•	•	ADP
dpc-5668	93	138	bacteriological	bacteriological	ADJ
dpc-5668	93	139	response	response	NOUN
dpc-5668	93	140	•	•	ADP
dpc-5668	93	141	adverse	adverse	ADJ
dpc-5668	93	142	events	event	NOUN
dpc-5668	94	1	nr	nr	PROPN
dpc-5668	94	2	dagani	dagani	PROPN
dpc-5668	94	3	199221	199221	NUM
dpc-5668	94	4	oral	oral	ADJ
dpc-5668	94	5	erythromycin	erythromycin	NOUN
dpc-5668	94	6	(	(	PUNCT
dpc-5668	94	7	50	50	NUM
dpc-5668	94	8	mg	mg	PROPN
dpc-5668	94	9	/	/	SYM
dpc-5668	94	10	kg	kg	PROPN
dpc-5668	94	11	daily	daily	ADV
dpc-5668	94	12	)	)	PUNCT
dpc-5668	95	1	+	+	NUM
dpc-5668	95	2	placebo	placebo	NOUN
dpc-5668	95	3	ointment	ointment	NOUN
dpc-5668	95	4	(	(	PUNCT
dpc-5668	95	5	n=51	n=51	NOUN
dpc-5668	95	6	)	)	PUNCT
dpc-5668	95	7	2	2	NUM
dpc-5668	95	8	%	%	NOUN
dpc-5668	95	9	mupirocin	mupirocin	NOUN
dpc-5668	95	10	ointment	ointment	NOUN
dpc-5668	95	11	in	in	ADP
dpc-5668	95	12	polyethylene	polyethylene	NOUN
dpc-5668	95	13	glycol	glycol	NOUN
dpc-5668	95	14	+	+	CCONJ
dpc-5668	95	15	oral	oral	ADJ
dpc-5668	95	16	placebo	placebo	NOUN
dpc-5668	95	17	suspension	suspension	NOUN
dpc-5668	95	18	(	(	PUNCT
dpc-5668	95	19	n=51	n=51	NOUN
dpc-5668	95	20	)	)	PUNCT
dpc-5668	95	21	•	•	ADP
dpc-5668	95	22	clinical	clinical	ADJ
dpc-5668	95	23	response	response	NOUN
dpc-5668	95	24	•	•	ADP
dpc-5668	95	25	adverse	adverse	ADJ
dpc-5668	95	26	events	event	NOUN
dpc-5668	95	27	beecham	beecham	PROPN
dpc-5668	95	28	pharmaceuticals	pharmaceutical	NOUN
dpc-5668	95	29	dash	dash	VERB
dpc-5668	95	30	202322	202322	NUM
dpc-5668	95	31	topical	topical	ADJ
dpc-5668	95	32	1	1	NUM
dpc-5668	95	33	%	%	NOUN
dpc-5668	95	34	ozenoxacin	ozenoxacin	PROPN
dpc-5668	95	35	cream	cream	NOUN
dpc-5668	95	36	(	(	PUNCT
dpc-5668	95	37	n=16	n=16	NOUN
dpc-5668	95	38	)	)	PUNCT
dpc-5668	95	39	topical	topical	ADJ
dpc-5668	95	40	2	2	NUM
dpc-5668	95	41	%	%	NOUN
dpc-5668	95	42	mupirocin	mupirocin	NOUN
dpc-5668	95	43	cream	cream	NOUN
dpc-5668	95	44	(	(	PUNCT
dpc-5668	95	45	n=17	n=17	NOUN
dpc-5668	95	46	)	)	PUNCT
dpc-5668	95	47	•	•	NOUN
dpc-5668	95	48	clinical	clinical	ADJ
dpc-5668	95	49	response	response	NOUN
dpc-5668	95	50	•	•	ADP
dpc-5668	95	51	bacteriological	bacteriological	ADJ
dpc-5668	95	52	response	response	NOUN
dpc-5668	95	53	nr	nr	PROPN
dpc-5668	95	54	review	review	VERB
dpc-5668	95	55	|	|	ADV
dpc-5668	95	56	dermatol	dermatol	ADJ
dpc-5668	95	57	pract	pract	NOUN
dpc-5668	95	58	concept	concept	NOUN
dpc-5668	95	59	.	.	PUNCT
dpc-5668	96	1	2025;15(4):5668	2025;15(4):5668	NUM
dpc-5668	96	2	5	5	NUM
dpc-5668	96	3	study	study	NOUN
dpc-5668	96	4	,	,	PUNCT
dpc-5668	96	5	year	year	NOUN
dpc-5668	96	6	intervention	intervention	NOUN
dpc-5668	96	7	/	/	SYM
dpc-5668	96	8	number	number	NOUN
dpc-5668	96	9	of	of	ADP
dpc-5668	96	10	participants	participant	NOUN
dpc-5668	96	11	(	(	PUNCT
dpc-5668	96	12	n	n	CCONJ
dpc-5668	96	13	)	)	PUNCT
dpc-5668	96	14	control	control	NOUN
dpc-5668	96	15	/	/	SYM
dpc-5668	96	16	number	number	NOUN
dpc-5668	96	17	of	of	ADP
dpc-5668	96	18	participants	participant	NOUN
dpc-5668	96	19	(	(	PUNCT
dpc-5668	96	20	n	n	CCONJ
dpc-5668	96	21	)	)	PUNCT
dpc-5668	96	22	outcomes	outcome	NOUN
dpc-5668	96	23	of	of	ADP
dpc-5668	96	24	interest	interest	NOUN
dpc-5668	96	25	funding	funding	NOUN
dpc-5668	96	26	sources	source	NOUN
dpc-5668	96	27	demidovich	demidovich	PROPN
dpc-5668	96	28	199023	199023	NUM
dpc-5668	96	29	oral	oral	ADJ
dpc-5668	96	30	penicillin	penicillin	NOUN
dpc-5668	96	31	v	v	PROPN
dpc-5668	96	32	potassium	potassium	NOUN
dpc-5668	96	33	(	(	PUNCT
dpc-5668	96	34	40	40	NUM
dpc-5668	96	35	a	a	DET
dpc-5668	96	36	50mg	50mg	PROPN
dpc-5668	96	37	/	/	SYM
dpc-5668	96	38	kg	kg	PROPN
dpc-5668	96	39	,	,	PUNCT
dpc-5668	96	40	daily	daily	ADV
dpc-5668	96	41	for	for	ADP
dpc-5668	96	42	10	10	NUM
dpc-5668	96	43	days	day	NOUN
dpc-5668	96	44	)	)	PUNCT
dpc-5668	96	45	(	(	PUNCT
dpc-5668	96	46	n=25	n=25	X
dpc-5668	96	47	)	)	PUNCT
dpc-5668	96	48	oral	oral	ADJ
dpc-5668	96	49	cephalexin	cephalexin	NOUN
dpc-5668	96	50	monohydrate	monohydrate	NOUN
dpc-5668	96	51	(	(	PUNCT
dpc-5668	96	52	40	40	NUM
dpc-5668	96	53	a	a	DET
dpc-5668	96	54	50	50	NUM
dpc-5668	96	55	mg	mg	NUM
dpc-5668	96	56	/	/	SYM
dpc-5668	96	57	kg	kg	PROPN
dpc-5668	96	58	,	,	PUNCT
dpc-5668	96	59	daily	daily	ADV
dpc-5668	96	60	for	for	ADP
dpc-5668	96	61	10	10	NUM
dpc-5668	96	62	days	day	NOUN
dpc-5668	96	63	)	)	PUNCT
dpc-5668	96	64	(	(	PUNCT
dpc-5668	96	65	n=23	n=23	PROPN
dpc-5668	96	66	)	)	PUNCT
dpc-5668	96	67	•	•	ADP
dpc-5668	96	68	clinical	clinical	ADJ
dpc-5668	96	69	response	response	NOUN
dpc-5668	96	70	•	•	ADP
dpc-5668	96	71	adverse	adverse	ADJ
dpc-5668	96	72	events	event	NOUN
dpc-5668	96	73	nr	nr	PRON
dpc-5668	96	74	oral	oral	ADJ
dpc-5668	96	75	erythromycin	erythromycin	NOUN
dpc-5668	96	76	(	(	PUNCT
dpc-5668	96	77	30	30	NUM
dpc-5668	96	78	a	a	DET
dpc-5668	96	79	40	40	NUM
dpc-5668	96	80	mg	mg	NUM
dpc-5668	96	81	/	/	SYM
dpc-5668	96	82	kg	kg	PROPN
dpc-5668	96	83	,	,	PUNCT
dpc-5668	96	84	daily	daily	ADV
dpc-5668	96	85	for	for	ADP
dpc-5668	96	86	10	10	NUM
dpc-5668	96	87	days	day	NOUN
dpc-5668	96	88	)	)	PUNCT
dpc-5668	96	89	(	(	PUNCT
dpc-5668	96	90	n=25	n=25	X
dpc-5668	96	91	)	)	PUNCT
dpc-5668	96	92	eells	eell	NOUN
dpc-5668	96	93	198624	198624	NUM
dpc-5668	96	94	15	15	NUM
dpc-5668	96	95	g	g	NOUN
dpc-5668	96	96	of	of	ADP
dpc-5668	96	97	2	2	NUM
dpc-5668	96	98	%	%	NOUN
dpc-5668	96	99	mupirocin	mupirocin	NOUN
dpc-5668	96	100	in	in	ADP
dpc-5668	96	101	polyethylene	polyethylene	NOUN
dpc-5668	96	102	glycol	glycol	NOUN
dpc-5668	96	103	(	(	PUNCT
dpc-5668	96	104	3	3	NUM
dpc-5668	96	105	times	time	NOUN
dpc-5668	96	106	/	/	SYM
dpc-5668	96	107	day	day	NOUN
dpc-5668	96	108	for	for	ADP
dpc-5668	96	109	12	12	NUM
dpc-5668	96	110	days	day	NOUN
dpc-5668	96	111	)	)	PUNCT
dpc-5668	96	112	(	(	PUNCT
dpc-5668	96	113	n=18	n=18	NOUN
dpc-5668	96	114	)	)	PUNCT
dpc-5668	96	115	15	15	NUM
dpc-5668	96	116	g	g	NOUN
dpc-5668	96	117	of	of	ADP
dpc-5668	96	118	the	the	DET
dpc-5668	96	119	vehicle	vehicle	NOUN
dpc-5668	96	120	alone	alone	ADV
dpc-5668	96	121	(	(	PUNCT
dpc-5668	96	122	3	3	NUM
dpc-5668	96	123	times	time	NOUN
dpc-5668	96	124	/	/	SYM
dpc-5668	96	125	day	day	NOUN
dpc-5668	96	126	for	for	ADP
dpc-5668	96	127	12	12	NUM
dpc-5668	96	128	days	day	NOUN
dpc-5668	96	129	)	)	PUNCT
dpc-5668	96	130	(	(	PUNCT
dpc-5668	96	131	n=20	n=20	PROPN
dpc-5668	96	132	)	)	PUNCT
dpc-5668	96	133	•	•	ADP
dpc-5668	96	134	clinical	clinical	ADJ
dpc-5668	96	135	response	response	NOUN
dpc-5668	96	136	•	•	ADP
dpc-5668	96	137	bacteriological	bacteriological	ADJ
dpc-5668	96	138	response	response	NOUN
dpc-5668	96	139	•	•	ADP
dpc-5668	96	140	adverse	adverse	ADJ
dpc-5668	96	141	events	event	NOUN
dpc-5668	96	142	nr	nr	X
dpc-5668	96	143	goldfarb	goldfarb	PROPN
dpc-5668	96	144	198825	198825	NUM
dpc-5668	96	145	2	2	NUM
dpc-5668	96	146	%	%	NOUN
dpc-5668	96	147	mupirocin	mupirocin	NOUN
dpc-5668	96	148	ointment	ointment	NOUN
dpc-5668	96	149	(	(	PUNCT
dpc-5668	96	150	3	3	NUM
dpc-5668	96	151	times	time	NOUN
dpc-5668	96	152	/	/	SYM
dpc-5668	96	153	day	day	NOUN
dpc-5668	96	154	,	,	PUNCT
dpc-5668	96	155	for	for	ADP
dpc-5668	96	156	8	8	NUM
dpc-5668	96	157	days	day	NOUN
dpc-5668	96	158	)	)	PUNCT
dpc-5668	96	159	(	(	PUNCT
dpc-5668	96	160	n=30	n=30	NOUN
dpc-5668	96	161	)	)	PUNCT
dpc-5668	96	162	oral	oral	ADJ
dpc-5668	96	163	erythromycin	erythromycin	NOUN
dpc-5668	96	164	(	(	PUNCT
dpc-5668	96	165	40	40	NUM
dpc-5668	96	166	mg	mg	PROPN
dpc-5668	96	167	/	/	SYM
dpc-5668	96	168	kg	kg	PROPN
dpc-5668	96	169	,	,	PUNCT
dpc-5668	96	170	daily	daily	ADV
dpc-5668	96	171	,	,	PUNCT
dpc-5668	96	172	for	for	ADP
dpc-5668	96	173	8	8	NUM
dpc-5668	96	174	days	day	NOUN
dpc-5668	96	175	)	)	PUNCT
dpc-5668	96	176	(	(	PUNCT
dpc-5668	96	177	n=32	n=32	PROPN
dpc-5668	96	178	)	)	PUNCT
dpc-5668	96	179	•	•	NOUN
dpc-5668	96	180	clinical	clinical	ADJ
dpc-5668	96	181	response	response	NOUN
dpc-5668	96	182	•	•	ADP
dpc-5668	96	183	bacteriological	bacteriological	ADJ
dpc-5668	96	184	response	response	NOUN
dpc-5668	96	185	beecham	beecham	PROPN
dpc-5668	96	186	laboratories	laboratory	NOUN
dpc-5668	96	187	and	and	CCONJ
dpc-5668	96	188	children	child	NOUN
dpc-5668	96	189	’s	’s	PART
dpc-5668	96	190	research	research	PROPN
dpc-5668	96	191	foundation	foundation	PROPN
dpc-5668	96	192	of	of	ADP
dpc-5668	96	193	cleveland	cleveland	PROPN
dpc-5668	96	194	gropper	gropper	PROPN
dpc-5668	96	195	201426	201426	NUM
dpc-5668	96	196	topical	topical	NOUN
dpc-5668	96	197	ozenoxacin	ozenoxacin	VERB
dpc-5668	96	198	1	1	NUM
dpc-5668	96	199	%	%	NOUN
dpc-5668	96	200	cream	cream	NOUN
dpc-5668	96	201	(	(	PUNCT
dpc-5668	96	202	twice	twice	ADV
dpc-5668	96	203	daily	daily	ADV
dpc-5668	96	204	,	,	PUNCT
dpc-5668	96	205	for	for	ADP
dpc-5668	96	206	5	5	NUM
dpc-5668	96	207	days	day	NOUN
dpc-5668	96	208	)	)	PUNCT
dpc-5668	96	209	(	(	PUNCT
dpc-5668	96	210	n=155	n=155	NUM
dpc-5668	96	211	)	)	PUNCT
dpc-5668	96	212	topical	topical	ADJ
dpc-5668	96	213	retapamulin	retapamulin	NOUN
dpc-5668	96	214	1	1	NUM
dpc-5668	96	215	%	%	NOUN
dpc-5668	96	216	ointment	ointment	NOUN
dpc-5668	96	217	(	(	PUNCT
dpc-5668	96	218	twice	twice	ADV
dpc-5668	96	219	daily	daily	ADV
dpc-5668	96	220	,	,	PUNCT
dpc-5668	96	221	for	for	ADP
dpc-5668	96	222	5	5	NUM
dpc-5668	96	223	days	day	NOUN
dpc-5668	96	224	)	)	PUNCT
dpc-5668	96	225	(	(	PUNCT
dpc-5668	96	226	n=154	n=154	NOUN
dpc-5668	96	227	)	)	PUNCT
dpc-5668	96	228	•	•	NOUN
dpc-5668	96	229	clinical	clinical	ADJ
dpc-5668	96	230	response	response	NOUN
dpc-5668	96	231	•	•	ADP
dpc-5668	96	232	bacteriological	bacteriological	ADJ
dpc-5668	96	233	response	response	NOUN
dpc-5668	96	234	•	•	ADP
dpc-5668	96	235	adverse	adverse	ADJ
dpc-5668	96	236	events	event	NOUN
dpc-5668	96	237	ferrer	ferrer	PROPN
dpc-5668	96	238	internacional	internacional	PROPN
dpc-5668	96	239	sa	sa	PROPN
dpc-5668	96	240	,	,	PUNCT
dpc-5668	96	241	barcelona	barcelona	PROPN
dpc-5668	96	242	,	,	PUNCT
dpc-5668	96	243	spain	spain	PROPN
dpc-5668	96	244	placebo	placebo	NOUN
dpc-5668	96	245	(	(	PUNCT
dpc-5668	96	246	twice	twice	ADV
dpc-5668	96	247	daily	daily	ADV
dpc-5668	96	248	,	,	PUNCT
dpc-5668	96	249	for	for	ADP
dpc-5668	96	250	5	5	NUM
dpc-5668	96	251	days	day	NOUN
dpc-5668	96	252	)	)	PUNCT
dpc-5668	96	253	(	(	PUNCT
dpc-5668	96	254	n=156	n=156	PROPN
dpc-5668	96	255	)	)	PUNCT
dpc-5668	96	256	iovino	iovino	NOUN
dpc-5668	96	257	201127	201127	NUM
dpc-5668	96	258	nvc-422	nvc-422	ADJ
dpc-5668	96	259	topical	topical	ADJ
dpc-5668	96	260	gel	gel	NOUN
dpc-5668	96	261	0.1	0.1	NUM
dpc-5668	96	262	%	%	NOUN
dpc-5668	96	263	(	(	PUNCT
dpc-5668	96	264	n=43	n=43	X
dpc-5668	96	265	)	)	PUNCT
dpc-5668	96	266	nvc-422	nvc-422	ADJ
dpc-5668	96	267	topical	topical	ADJ
dpc-5668	96	268	gel	gel	NOUN
dpc-5668	96	269	0.5	0.5	NUM
dpc-5668	96	270	%	%	NOUN
dpc-5668	96	271	(	(	PUNCT
dpc-5668	96	272	n=45	n=45	NOUN
dpc-5668	96	273	)	)	PUNCT
dpc-5668	96	274	•	•	ADP
dpc-5668	96	275	clinical	clinical	ADJ
dpc-5668	96	276	response	response	NOUN
dpc-5668	96	277	•	•	ADP
dpc-5668	96	278	bacteriological	bacteriological	ADJ
dpc-5668	96	279	response	response	NOUN
dpc-5668	96	280	•	•	ADP
dpc-5668	96	281	adverse	adverse	ADJ
dpc-5668	96	282	events	event	NOUN
dpc-5668	96	283	nr	nr	PRON
dpc-5668	96	284	nvc-422	nvc-422	VERB
dpc-5668	96	285	topical	topical	ADJ
dpc-5668	96	286	gel	gel	NOUN
dpc-5668	96	287	1,5	1,5	NUM
dpc-5668	96	288	%	%	NOUN
dpc-5668	96	289	(	(	PUNCT
dpc-5668	96	290	n=41	n=41	PROPN
dpc-5668	96	291	)	)	PUNCT
dpc-5668	96	292	jeffrey	jeffrey	PROPN
dpc-5668	96	293	199028	199028	NUM
dpc-5668	96	294	oral	oral	ADJ
dpc-5668	96	295	erythromycin	erythromycin	NOUN
dpc-5668	96	296	(	(	PUNCT
dpc-5668	96	297	40	40	NUM
dpc-5668	96	298	mg	mg	PROPN
dpc-5668	96	299	/	/	SYM
dpc-5668	96	300	kg	kg	PROPN
dpc-5668	96	301	/	/	SYM
dpc-5668	96	302	day	day	NOUN
dpc-5668	96	303	,	,	PUNCT
dpc-5668	96	304	4	4	NUM
dpc-5668	96	305	times	time	NOUN
dpc-5668	96	306	/	/	SYM
dpc-5668	96	307	day	day	NOUN
dpc-5668	96	308	)	)	PUNCT
dpc-5668	97	1	+	+	CCONJ
dpc-5668	97	2	topically	topically	ADV
dpc-5668	97	3	applied	apply	VERB
dpc-5668	97	4	placebo	placebo	NOUN
dpc-5668	97	5	(	(	PUNCT
dpc-5668	97	6	3	3	NUM
dpc-5668	97	7	times/	times/	NUM
dpc-5668	97	8	day	day	NOUN
dpc-5668	97	9	)	)	PUNCT
dpc-5668	97	10	(	(	PUNCT
dpc-5668	97	11	n=	n=	ADJ
dpc-5668	97	12	30	30	NUM
dpc-5668	97	13	)	)	PUNCT
dpc-5668	97	14	topical	topical	ADJ
dpc-5668	97	15	mupirocin	mupirocin	NOUN
dpc-5668	97	16	15	15	NUM
dpc-5668	97	17	g	g	NOUN
dpc-5668	97	18	2	2	NUM
dpc-5668	97	19	%	%	NOUN
dpc-5668	97	20	(	(	PUNCT
dpc-5668	97	21	3	3	NUM
dpc-5668	97	22	times/	times/	NUM
dpc-5668	97	23	day	day	NOUN
dpc-5668	97	24	)	)	PUNCT
dpc-5668	97	25	+	+	CCONJ
dpc-5668	97	26	orally	orally	ADV
dpc-5668	97	27	administered	administer	VERB
dpc-5668	97	28	placebo	placebo	NOUN
dpc-5668	97	29	(	(	PUNCT
dpc-5668	97	30	4	4	NUM
dpc-5668	97	31	times/	times/	NUM
dpc-5668	97	32	day	day	NOUN
dpc-5668	97	33	)	)	PUNCT
dpc-5668	97	34	(	(	PUNCT
dpc-5668	97	35	n=	n=	ADJ
dpc-5668	97	36	24	24	NUM
dpc-5668	97	37	)	)	PUNCT
dpc-5668	97	38	•	•	NOUN
dpc-5668	97	39	clinical	clinical	ADJ
dpc-5668	97	40	response	response	NOUN
dpc-5668	97	41	•	•	ADP
dpc-5668	97	42	bacteriological	bacteriological	ADJ
dpc-5668	97	43	response	response	NOUN
dpc-5668	97	44	united	united	PROPN
dpc-5668	97	45	states	states	PROPN
dpc-5668	97	46	navy	navy	PROPN
dpc-5668	97	47	bureau	bureau	PROPN
dpc-5668	97	48	of	of	ADP
dpc-5668	97	49	medicine	medicine	NOUN
dpc-5668	97	50	and	and	CCONJ
dpc-5668	97	51	surgery	surgery	NOUN
dpc-5668	97	52	clinical	clinical	ADJ
dpc-5668	97	53	investigation	investigation	NOUN
dpc-5668	97	54	program	program	NOUN
dpc-5668	97	55	koning	kone	VERB
dpc-5668	97	56	200229	200229	NUM
dpc-5668	97	57	topical	topical	ADJ
dpc-5668	97	58	fusidic	fusidic	ADJ
dpc-5668	97	59	acid	acid	NOUN
dpc-5668	97	60	cream	cream	NOUN
dpc-5668	97	61	2	2	NUM
dpc-5668	97	62	%	%	NOUN
dpc-5668	97	63	(	(	PUNCT
dpc-5668	97	64	3	3	NUM
dpc-5668	97	65	times	time	NOUN
dpc-5668	97	66	/	/	SYM
dpc-5668	97	67	day	day	NOUN
dpc-5668	97	68	,	,	PUNCT
dpc-5668	97	69	for	for	ADP
dpc-5668	97	70	14	14	NUM
dpc-5668	97	71	days	day	NOUN
dpc-5668	97	72	)	)	PUNCT
dpc-5668	97	73	(	(	PUNCT
dpc-5668	97	74	n=78	n=78	NOUN
dpc-5668	97	75	)	)	PUNCT
dpc-5668	97	76	placebo	placebo	NOUN
dpc-5668	97	77	(	(	PUNCT
dpc-5668	97	78	3	3	NUM
dpc-5668	97	79	times/	times/	NUM
dpc-5668	97	80	day	day	NOUN
dpc-5668	97	81	,	,	PUNCT
dpc-5668	97	82	for	for	ADP
dpc-5668	97	83	14	14	NUM
dpc-5668	97	84	days	day	NOUN
dpc-5668	97	85	)	)	PUNCT
dpc-5668	97	86	(	(	PUNCT
dpc-5668	97	87	n=82	n=82	NOUN
dpc-5668	97	88	)	)	PUNCT
dpc-5668	97	89	•	•	NOUN
dpc-5668	97	90	clinical	clinical	ADJ
dpc-5668	97	91	response	response	NOUN
dpc-5668	97	92	•	•	ADP
dpc-5668	97	93	bacteriological	bacteriological	ADJ
dpc-5668	97	94	response	response	NOUN
dpc-5668	97	95	fonds	fond	NOUN
dpc-5668	97	96	alledaagse	alledaagse	PROPN
dpc-5668	97	97	ziekten	ziekten	NUM
dpc-5668	97	98	of	of	ADP
dpc-5668	97	99	the	the	DET
dpc-5668	97	100	dutch	dutch	PROPN
dpc-5668	97	101	college	college	PROPN
dpc-5668	97	102	of	of	ADP
dpc-5668	97	103	general	general	ADJ
dpc-5668	97	104	practitioners	practitioner	NOUN
dpc-5668	97	105	koning	kone	VERB
dpc-5668	97	106	200830	200830	NUM
dpc-5668	97	107	topical	topical	ADJ
dpc-5668	97	108	retapamulin	retapamulin	NOUN
dpc-5668	97	109	ointment	ointment	NOUN
dpc-5668	97	110	1	1	NUM
dpc-5668	97	111	%	%	NOUN
dpc-5668	97	112	(	(	PUNCT
dpc-5668	97	113	twice	twice	ADV
dpc-5668	97	114	daily	daily	ADV
dpc-5668	97	115	for	for	ADP
dpc-5668	97	116	5	5	NUM
dpc-5668	97	117	days	day	NOUN
dpc-5668	97	118	)	)	PUNCT
dpc-5668	97	119	(	(	PUNCT
dpc-5668	97	120	n=139	n=139	NOUN
dpc-5668	97	121	)	)	PUNCT
dpc-5668	97	122	topical	topical	ADJ
dpc-5668	97	123	placebo	placebo	NOUN
dpc-5668	97	124	(	(	PUNCT
dpc-5668	97	125	twice	twice	ADV
dpc-5668	97	126	daily	daily	ADV
dpc-5668	97	127	for	for	ADP
dpc-5668	97	128	5	5	NUM
dpc-5668	97	129	days	day	NOUN
dpc-5668	97	130	)	)	PUNCT
dpc-5668	97	131	(	(	PUNCT
dpc-5668	97	132	n=71	n=71	NOUN
dpc-5668	97	133	)	)	PUNCT
dpc-5668	97	134	•	•	ADP
dpc-5668	97	135	clinical	clinical	ADJ
dpc-5668	97	136	response	response	NOUN
dpc-5668	97	137	•	•	ADP
dpc-5668	97	138	bacteriological	bacteriological	ADJ
dpc-5668	97	139	response	response	NOUN
dpc-5668	97	140	•	•	ADP
dpc-5668	97	141	adverse	adverse	ADJ
dpc-5668	97	142	events	event	NOUN
dpc-5668	97	143	glaxosmithkline	glaxosmithkline	PROPN
dpc-5668	97	144	kuniyuki	kuniyuki	PROPN
dpc-5668	97	145	200531	200531	NUM
dpc-5668	97	146	topical	topical	ADJ
dpc-5668	97	147	3	3	NUM
dpc-5668	97	148	%	%	NOUN
dpc-5668	97	149	oxytetracyclinehydrochloride	oxytetracyclinehydrochloride	ADJ
dpc-5668	97	150	(	(	PUNCT
dpc-5668	97	151	n=28	n=28	NOUN
dpc-5668	97	152	)	)	PUNCT
dpc-5668	97	153	topical	topical	ADJ
dpc-5668	97	154	tetracycline	tetracycline	NOUN
dpc-5668	97	155	and	and	CCONJ
dpc-5668	97	156	oral	oral	ADJ
dpc-5668	97	157	antibiotics	antibiotic	NOUN
dpc-5668	97	158	(	(	PUNCT
dpc-5668	97	159	cefdinir	cefdinir	NOUN
dpc-5668	97	160	,	,	PUNCT
dpc-5668	97	161	fosfomycin	fosfomycin	PROPN
dpc-5668	97	162	and	and	CCONJ
dpc-5668	97	163	minocycline	minocycline	NOUN
dpc-5668	97	164	)	)	PUNCT
dpc-5668	97	165	(	(	PUNCT
dpc-5668	97	166	n=21	n=21	NOUN
dpc-5668	97	167	)	)	PUNCT
dpc-5668	97	168	•	•	ADP
dpc-5668	97	169	clinical	clinical	ADJ
dpc-5668	97	170	response	response	NOUN
dpc-5668	97	171	•	•	ADP
dpc-5668	97	172	bacteriological	bacteriological	ADJ
dpc-5668	97	173	response	response	NOUN
dpc-5668	97	174	nr	nr	NOUN
dpc-5668	97	175	table	table	NOUN
dpc-5668	97	176	1	1	NUM
dpc-5668	97	177	.	.	PUNCT
dpc-5668	98	1	characteristics	characteristic	NOUN
dpc-5668	98	2	of	of	ADP
dpc-5668	98	3	the	the	DET
dpc-5668	98	4	included	include	VERB
dpc-5668	98	5	studies	study	NOUN
dpc-5668	98	6	.	.	PUNCT
dpc-5668	99	1	(	(	PUNCT
dpc-5668	99	2	continued	continue	VERB
dpc-5668	99	3	)	)	PUNCT
dpc-5668	99	4	6	6	NUM
dpc-5668	99	5	review	review	NOUN
dpc-5668	99	6	|	|	ADV
dpc-5668	99	7	dermatol	dermatol	ADJ
dpc-5668	99	8	pract	pract	NOUN
dpc-5668	99	9	concept	concept	NOUN
dpc-5668	99	10	.	.	PUNCT
dpc-5668	100	1	2025;15(4):5668	2025;15(4):5668	NUM
dpc-5668	100	2	regarding	regard	VERB
dpc-5668	100	3	the	the	DET
dpc-5668	100	4	randomization	randomization	NOUN
dpc-5668	100	5	process	process	NOUN
dpc-5668	100	6	,	,	PUNCT
dpc-5668	100	7	which	which	PRON
dpc-5668	100	8	assesses	assess	VERB
dpc-5668	100	9	the	the	DET
dpc-5668	100	10	method	method	NOUN
dpc-5668	100	11	by	by	ADP
dpc-5668	100	12	which	which	PRON
dpc-5668	100	13	participants	participant	NOUN
dpc-5668	100	14	were	be	AUX
dpc-5668	100	15	assigned	assign	VERB
dpc-5668	100	16	to	to	PART
dpc-5668	100	17	ensure	ensure	VERB
dpc-5668	100	18	comparable	comparable	ADJ
dpc-5668	100	19	groups	group	NOUN
dpc-5668	100	20	,	,	PUNCT
dpc-5668	100	21	53	53	NUM
dpc-5668	100	22	%	%	NOUN
dpc-5668	100	23	(	(	PUNCT
dpc-5668	100	24	11/21	11/21	NUM
dpc-5668	100	25	,	,	PUNCT
dpc-5668	100	26	95	95	NUM
dpc-5668	100	27	%	%	NOUN
dpc-5668	100	28	ci	ci	NOUN
dpc-5668	100	29	:	:	PUNCT
dpc-5668	100	30	32%–72	32%–72	NUM
dpc-5668	100	31	%	%	NOUN
dpc-5668	100	32	)	)	PUNCT
dpc-5668	101	1	[	[	X
dpc-5668	101	2	18	18	NUM
dpc-5668	101	3	-	-	PUNCT
dpc-5668	101	4	23,25,27,31,32,37,38	23,25,27,31,32,37,38	NOUN
dpc-5668	101	5	]	]	PUNCT
dpc-5668	101	6	of	of	ADP
dpc-5668	101	7	the	the	DET
dpc-5668	101	8	rcts	rct	NOUN
dpc-5668	101	9	presented	present	VERB
dpc-5668	101	10	an	an	DET
dpc-5668	101	11	unclear	unclear	ADJ
dpc-5668	101	12	risk	risk	NOUN
dpc-5668	101	13	of	of	ADP
dpc-5668	101	14	bias	bias	NOUN
dpc-5668	101	15	due	due	ADP
dpc-5668	101	16	to	to	ADP
dpc-5668	101	17	insufficient	insufficient	ADJ
dpc-5668	101	18	information	information	NOUN
dpc-5668	101	19	provided	provide	VERB
dpc-5668	101	20	for	for	ADP
dpc-5668	101	21	judgment	judgment	NOUN
dpc-5668	101	22	.	.	PUNCT
dpc-5668	102	1	in	in	ADP
dpc-5668	102	2	contrast	contrast	NOUN
dpc-5668	102	3	,	,	PUNCT
dpc-5668	102	4	47	47	NUM
dpc-5668	102	5	%	%	NOUN
dpc-5668	102	6	(	(	PUNCT
dpc-5668	102	7	10/21	10/21	NUM
dpc-5668	102	8	,	,	PUNCT
dpc-5668	102	9	95	95	NUM
dpc-5668	102	10	%	%	NOUN
dpc-5668	102	11	ci	ci	NOUN
dpc-5668	102	12	:	:	PUNCT
dpc-5668	102	13	28%–68	28%–68	NUM
dpc-5668	102	14	%	%	NOUN
dpc-5668	102	15	)	)	PUNCT
dpc-5668	103	1	[	[	X
dpc-5668	103	2	21,24,26,28	21,24,26,28	NUM
dpc-5668	103	3	-	-	PUNCT
dpc-5668	103	4	30,33	30,33	NUM
dpc-5668	103	5	-	-	SYM
dpc-5668	103	6	36	36	NUM
dpc-5668	103	7	]	]	PUNCT
dpc-5668	103	8	clearly	clearly	ADV
dpc-5668	103	9	described	describe	VERB
dpc-5668	103	10	the	the	DET
dpc-5668	103	11	randomization	randomization	NOUN
dpc-5668	103	12	process	process	NOUN
dpc-5668	103	13	,	,	PUNCT
dpc-5668	103	14	which	which	PRON
dpc-5668	103	15	was	be	AUX
dpc-5668	103	16	typically	typically	ADV
dpc-5668	103	17	carried	carry	VERB
dpc-5668	103	18	out	out	ADP
dpc-5668	103	19	using	use	VERB
dpc-5668	103	20	a	a	DET
dpc-5668	103	21	computer	computer	NOUN
dpc-5668	103	22	-	-	PUNCT
dpc-5668	103	23	generated	generate	VERB
dpc-5668	103	24	randomization	randomization	NOUN
dpc-5668	103	25	code	code	NOUN
dpc-5668	103	26	,	,	PUNCT
dpc-5668	103	27	schedule	schedule	NOUN
dpc-5668	103	28	,	,	PUNCT
dpc-5668	103	29	or	or	CCONJ
dpc-5668	103	30	list	list	NOUN
dpc-5668	103	31	of	of	ADP
dpc-5668	103	32	random	random	ADJ
dpc-5668	103	33	set	set	NOUN
dpc-5668	103	34	numbers	number	NOUN
dpc-5668	103	35	.	.	PUNCT
dpc-5668	104	1	no	no	DET
dpc-5668	104	2	study	study	NOUN
dpc-5668	104	3	was	be	AUX
dpc-5668	104	4	classified	classify	VERB
dpc-5668	104	5	as	as	ADP
dpc-5668	104	6	having	have	VERB
dpc-5668	104	7	a	a	DET
dpc-5668	104	8	high	high	ADJ
dpc-5668	104	9	risk	risk	NOUN
dpc-5668	104	10	of	of	ADP
dpc-5668	104	11	bias	bias	NOUN
dpc-5668	104	12	in	in	ADP
dpc-5668	104	13	this	this	DET
dpc-5668	104	14	domain	domain	NOUN
dpc-5668	104	15	.	.	PUNCT
dpc-5668	105	1	similar	similar	ADJ
dpc-5668	105	2	proportions	proportion	NOUN
dpc-5668	105	3	were	be	AUX
dpc-5668	105	4	observed	observe	VERB
dpc-5668	105	5	regarding	regard	VERB
dpc-5668	105	6	allocation	allocation	NOUN
dpc-5668	105	7	concealment	concealment	NOUN
dpc-5668	105	8	,	,	PUNCT
dpc-5668	105	9	where	where	SCONJ
dpc-5668	105	10	57	57	NUM
dpc-5668	105	11	%	%	NOUN
dpc-5668	105	12	(	(	PUNCT
dpc-5668	105	13	12/21	12/21	NUM
dpc-5668	105	14	,	,	PUNCT
dpc-5668	105	15	95	95	NUM
dpc-5668	105	16	%	%	NOUN
dpc-5668	105	17	ci	ci	NOUN
dpc-5668	105	18	:	:	PUNCT
dpc-5668	105	19	37%–76	37%–76	NUM
dpc-5668	105	20	%	%	NOUN
dpc-5668	105	21	)	)	PUNCT
dpc-5668	106	1	[	[	X
dpc-5668	106	2	18	18	NUM
dpc-5668	106	3	-	-	PUNCT
dpc-5668	106	4	20,22	20,22	NUM
dpc-5668	106	5	-	-	NOUN
dpc-5668	106	6	25,27,38,31,32,37	25,27,38,31,32,37	NUM
dpc-5668	106	7	]	]	PUNCT
dpc-5668	106	8	of	of	ADP
dpc-5668	106	9	the	the	DET
dpc-5668	106	10	rcts	rct	NOUN
dpc-5668	106	11	had	have	VERB
dpc-5668	106	12	an	an	DET
dpc-5668	106	13	unclear	unclear	ADJ
dpc-5668	106	14	risk	risk	NOUN
dpc-5668	106	15	of	of	ADP
dpc-5668	106	16	bias	bias	NOUN
dpc-5668	106	17	.	.	PUNCT
dpc-5668	107	1	in	in	ADP
dpc-5668	107	2	comparison	comparison	NOUN
dpc-5668	107	3	,	,	PUNCT
dpc-5668	107	4	43	43	NUM
dpc-5668	107	5	%	%	NOUN
dpc-5668	107	6	(	(	PUNCT
dpc-5668	107	7	9/21	9/21	NUM
dpc-5668	107	8	,	,	PUNCT
dpc-5668	107	9	95	95	NUM
dpc-5668	107	10	%	%	NOUN
dpc-5668	107	11	ci	ci	NOUN
dpc-5668	107	12	:	:	PUNCT
dpc-5668	107	13	24%–63	24%–63	NUM
dpc-5668	107	14	%	%	NOUN
dpc-5668	107	15	)	)	PUNCT
dpc-5668	108	1	[	[	X
dpc-5668	108	2	21,26,29,30,33	21,26,29,30,33	PROPN
dpc-5668	108	3	-	-	PUNCT
dpc-5668	108	4	35,28	35,28	NUM
dpc-5668	108	5	]	]	PUNCT
dpc-5668	108	6	had	have	VERB
dpc-5668	108	7	a	a	DET
dpc-5668	108	8	low	low	ADJ
dpc-5668	108	9	risk	risk	NOUN
dpc-5668	108	10	of	of	ADP
dpc-5668	108	11	bias	bias	NOUN
dpc-5668	108	12	,	,	PUNCT
dpc-5668	108	13	with	with	ADP
dpc-5668	108	14	most	most	ADJ
dpc-5668	108	15	studies	study	NOUN
dpc-5668	108	16	describing	describe	VERB
dpc-5668	108	17	methods	method	NOUN
dpc-5668	108	18	such	such	ADJ
dpc-5668	108	19	as	as	ADP
dpc-5668	108	20	the	the	DET
dpc-5668	108	21	use	use	NOUN
dpc-5668	108	22	of	of	ADP
dpc-5668	108	23	sequentially	sequentially	ADV
dpc-5668	108	24	sealed	seal	VERB
dpc-5668	108	25	opaque	opaque	ADJ
dpc-5668	108	26	envelopes	envelope	NOUN
dpc-5668	108	27	to	to	PART
dpc-5668	108	28	ensure	ensure	VERB
dpc-5668	108	29	proper	proper	ADJ
dpc-5668	108	30	allocation	allocation	NOUN
dpc-5668	108	31	concealment	concealment	NOUN
dpc-5668	108	32	.	.	PUNCT
dpc-5668	109	1	the	the	DET
dpc-5668	109	2	assessment	assessment	NOUN
dpc-5668	109	3	of	of	ADP
dpc-5668	109	4	the	the	DET
dpc-5668	109	5	blinding	blind	VERB
dpc-5668	109	6	domains	domain	NOUN
dpc-5668	109	7	evaluates	evaluate	VERB
dpc-5668	109	8	whether	whether	SCONJ
dpc-5668	109	9	participants	participant	NOUN
dpc-5668	109	10	and	and	CCONJ
dpc-5668	109	11	outcome	outcome	NOUN
dpc-5668	109	12	assessors	assessor	NOUN
dpc-5668	109	13	were	be	AUX
dpc-5668	109	14	aware	aware	ADJ
dpc-5668	109	15	of	of	ADP
dpc-5668	109	16	the	the	DET
dpc-5668	109	17	intervention	intervention	NOUN
dpc-5668	109	18	assigned	assign	VERB
dpc-5668	109	19	to	to	ADP
dpc-5668	109	20	each	each	DET
dpc-5668	109	21	group	group	NOUN
dpc-5668	109	22	.	.	PUNCT
dpc-5668	110	1	this	this	DET
dpc-5668	110	2	awareness	awareness	NOUN
dpc-5668	110	3	can	can	AUX
dpc-5668	110	4	influence	influence	VERB
dpc-5668	110	5	the	the	DET
dpc-5668	110	6	results	result	NOUN
dpc-5668	110	7	,	,	PUNCT
dpc-5668	110	8	especially	especially	ADV
dpc-5668	110	9	when	when	SCONJ
dpc-5668	110	10	outcomes	outcome	NOUN
dpc-5668	110	11	are	be	AUX
dpc-5668	110	12	measured	measure	VERB
dpc-5668	110	13	subjectively	subjectively	ADV
dpc-5668	110	14	or	or	CCONJ
dpc-5668	110	15	rely	rely	VERB
dpc-5668	110	16	on	on	ADP
dpc-5668	110	17	patients	patient	NOUN
dpc-5668	110	18	’	'	PUNCT
dpc-5668	110	19	perceptions	perception	NOUN
dpc-5668	110	20	.	.	PUNCT
dpc-5668	111	1	among	among	ADP
dpc-5668	111	2	the	the	DET
dpc-5668	111	3	rcts	rct	NOUN
dpc-5668	111	4	,	,	PUNCT
dpc-5668	111	5	71	71	NUM
dpc-5668	111	6	%	%	NOUN
dpc-5668	111	7	(	(	PUNCT
dpc-5668	111	8	15/21	15/21	NUM
dpc-5668	111	9	,	,	PUNCT
dpc-5668	111	10	95	95	NUM
dpc-5668	111	11	%	%	NOUN
dpc-5668	111	12	ci	ci	NOUN
dpc-5668	111	13	:	:	PUNCT
dpc-5668	111	14	50%–86	50%–86	NUM
dpc-5668	111	15	%	%	NOUN
dpc-5668	111	16	)	)	PUNCT
dpc-5668	112	1	[	[	X
dpc-5668	112	2	18,20,22	18,20,22	NUM
dpc-5668	112	3	-	-	PUNCT
dpc-5668	112	4	25,27,31	25,27,31	NUM
dpc-5668	112	5	-	-	SYM
dpc-5668	112	6	28	28	NUM
dpc-5668	112	7	]	]	PUNCT
dpc-5668	112	8	were	be	AUX
dpc-5668	112	9	classified	classify	VERB
dpc-5668	112	10	as	as	ADP
dpc-5668	112	11	high	high	ADJ
dpc-5668	112	12	risk	risk	NOUN
dpc-5668	112	13	of	of	ADP
dpc-5668	112	14	bias	bias	NOUN
dpc-5668	112	15	for	for	ADP
dpc-5668	112	16	blinding	blinding	NOUN
dpc-5668	112	17	of	of	ADP
dpc-5668	112	18	participants	participant	NOUN
dpc-5668	112	19	and	and	CCONJ
dpc-5668	112	20	personnel	personnel	NOUN
dpc-5668	112	21	,	,	PUNCT
dpc-5668	112	22	and	and	CCONJ
dpc-5668	112	23	57	57	NUM
dpc-5668	112	24	%	%	NOUN
dpc-5668	112	25	(	(	PUNCT
dpc-5668	112	26	12/21	12/21	NUM
dpc-5668	112	27	,	,	PUNCT
dpc-5668	112	28	95	95	NUM
dpc-5668	112	29	%	%	NOUN
dpc-5668	112	30	ci	ci	NOUN
dpc-5668	112	31	:	:	PUNCT
dpc-5668	112	32	37%–76	37%–76	NUM
dpc-5668	112	33	%	%	NOUN
dpc-5668	112	34	)	)	PUNCT
dpc-5668	113	1	[	[	X
dpc-5668	113	2	1821,24,25,27,31,32,34,36,37	1821,24,25,27,31,32,34,36,37	X
dpc-5668	113	3	]	]	PUNCT
dpc-5668	113	4	were	be	AUX
dpc-5668	113	5	at	at	ADP
dpc-5668	113	6	high	high	ADJ
dpc-5668	113	7	risk	risk	NOUN
dpc-5668	113	8	of	of	ADP
dpc-5668	113	9	bias	bias	NOUN
dpc-5668	113	10	for	for	ADP
dpc-5668	113	11	blinding	blinding	NOUN
dpc-5668	113	12	of	of	ADP
dpc-5668	113	13	outcome	outcome	NOUN
dpc-5668	113	14	assessors	assessor	NOUN
dpc-5668	113	15	.	.	PUNCT
dpc-5668	114	1	this	this	PRON
dpc-5668	114	2	indicates	indicate	VERB
dpc-5668	114	3	either	either	CCONJ
dpc-5668	114	4	knowledge	knowledge	NOUN
dpc-5668	114	5	of	of	ADP
dpc-5668	114	6	the	the	DET
dpc-5668	114	7	intervention	intervention	NOUN
dpc-5668	114	8	or	or	CCONJ
dpc-5668	114	9	insufficient	insufficient	ADJ
dpc-5668	114	10	information	information	NOUN
dpc-5668	114	11	to	to	PART
dpc-5668	114	12	assess	assess	VERB
dpc-5668	114	13	blinding	blind	VERB
dpc-5668	114	14	.	.	PUNCT
dpc-5668	115	1	the	the	DET
dpc-5668	115	2	lack	lack	NOUN
dpc-5668	115	3	of	of	ADP
dpc-5668	115	4	blinding	blinding	NOUN
dpc-5668	115	5	of	of	ADP
dpc-5668	115	6	participants	participant	NOUN
dpc-5668	115	7	and	and	CCONJ
dpc-5668	115	8	assessors	assessor	NOUN
dpc-5668	115	9	study	study	VERB
dpc-5668	115	10	,	,	PUNCT
dpc-5668	115	11	year	year	NOUN
dpc-5668	115	12	intervention	intervention	NOUN
dpc-5668	115	13	/	/	SYM
dpc-5668	115	14	number	number	NOUN
dpc-5668	115	15	of	of	ADP
dpc-5668	115	16	participants	participant	NOUN
dpc-5668	115	17	(	(	PUNCT
dpc-5668	115	18	n	n	CCONJ
dpc-5668	115	19	)	)	PUNCT
dpc-5668	115	20	control	control	NOUN
dpc-5668	115	21	/	/	SYM
dpc-5668	115	22	number	number	NOUN
dpc-5668	115	23	of	of	ADP
dpc-5668	115	24	participants	participant	NOUN
dpc-5668	115	25	(	(	PUNCT
dpc-5668	115	26	n	n	CCONJ
dpc-5668	115	27	)	)	PUNCT
dpc-5668	115	28	outcomes	outcome	NOUN
dpc-5668	115	29	of	of	ADP
dpc-5668	115	30	interest	interest	NOUN
dpc-5668	115	31	funding	funding	NOUN
dpc-5668	115	32	sources	source	NOUN
dpc-5668	115	33	mclinn	mclinn	VERB
dpc-5668	115	34	199032	199032	NUM
dpc-5668	115	35	topical	topical	ADJ
dpc-5668	115	36	mupirocin	mupirocin	NOUN
dpc-5668	115	37	ointment	ointment	NOUN
dpc-5668	115	38	2	2	NUM
dpc-5668	115	39	%	%	NOUN
dpc-5668	115	40	(	(	PUNCT
dpc-5668	115	41	3	3	NUM
dpc-5668	115	42	times	time	NOUN
dpc-5668	115	43	/	/	SYM
dpc-5668	115	44	day	day	NOUN
dpc-5668	115	45	)	)	PUNCT
dpc-5668	115	46	(	(	PUNCT
dpc-5668	115	47	n=29	n=29	ADJ
dpc-5668	115	48	)	)	PUNCT
dpc-5668	115	49	oral	oral	ADJ
dpc-5668	115	50	erythromycin	erythromycin	NOUN
dpc-5668	115	51	(	(	PUNCT
dpc-5668	115	52	30	30	NUM
dpc-5668	115	53	to	to	PART
dpc-5668	115	54	40	40	NUM
dpc-5668	115	55	mg	mg	NUM
dpc-5668	115	56	/	/	SYM
dpc-5668	115	57	kg/	kg/	NOUN
dpc-5668	115	58	day	day	PROPN
dpc-5668	115	59	)	)	PUNCT
dpc-5668	115	60	(	(	PUNCT
dpc-5668	115	61	n=30	n=30	NOUN
dpc-5668	115	62	)	)	PUNCT
dpc-5668	116	1	•	•	ADP
dpc-5668	116	2	clinical	clinical	ADJ
dpc-5668	116	3	response	response	NOUN
dpc-5668	116	4	•	•	ADP
dpc-5668	116	5	bacteriological	bacteriological	ADJ
dpc-5668	116	6	response	response	NOUN
dpc-5668	116	7	•	•	ADP
dpc-5668	116	8	adverse	adverse	ADJ
dpc-5668	116	9	events	event	NOUN
dpc-5668	116	10	nr	nr	PROPN
dpc-5668	116	11	mertz	mertz	PROPN
dpc-5668	116	12	198933	198933	NUM
dpc-5668	116	13	topical	topical	ADJ
dpc-5668	116	14	15	15	NUM
dpc-5668	116	15	g	g	NOUN
dpc-5668	116	16	mupirocin	mupirocin	NOUN
dpc-5668	116	17	ointment	ointment	NOUN
dpc-5668	116	18	2	2	NUM
dpc-5668	116	19	%	%	NOUN
dpc-5668	116	20	(	(	PUNCT
dpc-5668	116	21	3	3	NUM
dpc-5668	116	22	times	time	NOUN
dpc-5668	116	23	/	/	SYM
dpc-5668	116	24	day	day	NOUN
dpc-5668	116	25	,	,	PUNCT
dpc-5668	116	26	for	for	ADP
dpc-5668	116	27	8	8	NUM
dpc-5668	116	28	days	day	NOUN
dpc-5668	116	29	)	)	PUNCT
dpc-5668	116	30	(	(	PUNCT
dpc-5668	116	31	n=28	n=28	NOUN
dpc-5668	116	32	)	)	PUNCT
dpc-5668	116	33	oral	oral	ADJ
dpc-5668	116	34	erythromycin	erythromycin	NOUN
dpc-5668	116	35	(	(	PUNCT
dpc-5668	116	36	30	30	NUM
dpc-5668	116	37	to	to	PART
dpc-5668	116	38	50	50	NUM
dpc-5668	116	39	mg	mg	NUM
dpc-5668	116	40	/	/	SYM
dpc-5668	116	41	kg/	kg/	NOUN
dpc-5668	116	42	day	day	PROPN
dpc-5668	116	43	)	)	PUNCT
dpc-5668	116	44	(	(	PUNCT
dpc-5668	116	45	n=25	n=25	NOUN
dpc-5668	116	46	)	)	PUNCT
dpc-5668	116	47	•	•	NOUN
dpc-5668	116	48	clinical	clinical	ADJ
dpc-5668	116	49	response	response	NOUN
dpc-5668	116	50	•	•	ADP
dpc-5668	116	51	bacteriological	bacteriological	ADJ
dpc-5668	116	52	response	response	NOUN
dpc-5668	116	53	beecham	beecham	PROPN
dpc-5668	116	54	laboratories	laboratory	NOUN
dpc-5668	116	55	,	,	PUNCT
dpc-5668	116	56	bristol	bristol	PROPN
dpc-5668	116	57	,	,	PUNCT
dpc-5668	116	58	tenn	tenn	PROPN
dpc-5668	116	59	nolting	nolte	VERB
dpc-5668	116	60	199834	199834	NUM
dpc-5668	116	61	topical	topical	ADJ
dpc-5668	116	62	sulconazole	sulconazole	NOUN
dpc-5668	116	63	nitrate	nitrate	NOUN
dpc-5668	116	64	1	1	NUM
dpc-5668	116	65	%	%	NOUN
dpc-5668	116	66	cream	cream	NOUN
dpc-5668	116	67	(	(	PUNCT
dpc-5668	116	68	twice	twice	ADV
dpc-5668	116	69	daily	daily	ADV
dpc-5668	116	70	,	,	PUNCT
dpc-5668	116	71	for	for	ADP
dpc-5668	116	72	14	14	NUM
dpc-5668	116	73	days	day	NOUN
dpc-5668	116	74	)	)	PUNCT
dpc-5668	116	75	(	(	PUNCT
dpc-5668	116	76	n=32	n=32	PROPN
dpc-5668	116	77	)	)	PUNCT
dpc-5668	116	78	topical	topical	ADJ
dpc-5668	116	79	miconazole	miconazole	NOUN
dpc-5668	116	80	nitrate	nitrate	NOUN
dpc-5668	116	81	2	2	NUM
dpc-5668	116	82	%	%	NOUN
dpc-5668	116	83	cream	cream	NOUN
dpc-5668	116	84	(	(	PUNCT
dpc-5668	116	85	twice	twice	ADV
dpc-5668	116	86	daily	daily	ADV
dpc-5668	116	87	,	,	PUNCT
dpc-5668	116	88	for	for	ADP
dpc-5668	116	89	14	14	NUM
dpc-5668	116	90	days	day	NOUN
dpc-5668	116	91	)	)	PUNCT
dpc-5668	116	92	(	(	PUNCT
dpc-5668	116	93	n=34	n=34	NOUN
dpc-5668	116	94	)	)	PUNCT
dpc-5668	116	95	•	•	ADP
dpc-5668	116	96	clinical	clinical	ADJ
dpc-5668	116	97	response	response	NOUN
dpc-5668	116	98	•	•	ADP
dpc-5668	116	99	bacteriological	bacteriological	ADJ
dpc-5668	116	100	response	response	NOUN
dpc-5668	116	101	nr	nr	PROPN
dpc-5668	116	102	oranje	oranje	PROPN
dpc-5668	116	103	200735	200735	NUM
dpc-5668	116	104	topical	topical	ADJ
dpc-5668	116	105	retapamulin	retapamulin	NOUN
dpc-5668	116	106	ointment	ointment	NOUN
dpc-5668	116	107	1	1	NUM
dpc-5668	116	108	%	%	NOUN
dpc-5668	116	109	(	(	PUNCT
dpc-5668	116	110	twice	twice	ADV
dpc-5668	116	111	daily	daily	ADV
dpc-5668	116	112	for	for	ADP
dpc-5668	116	113	5	5	NUM
dpc-5668	116	114	days	day	NOUN
dpc-5668	116	115	)	)	PUNCT
dpc-5668	116	116	(	(	PUNCT
dpc-5668	116	117	n=345	n=345	X
dpc-5668	116	118	)	)	PUNCT
dpc-5668	116	119	topical	topical	ADJ
dpc-5668	116	120	sodium	sodium	NOUN
dpc-5668	116	121	fusidate	fusidate	ADJ
dpc-5668	116	122	ointment	ointment	NOUN
dpc-5668	116	123	2	2	NUM
dpc-5668	116	124	%	%	NOUN
dpc-5668	116	125	(	(	PUNCT
dpc-5668	116	126	3	3	NUM
dpc-5668	116	127	times	time	NOUN
dpc-5668	116	128	daily	daily	ADV
dpc-5668	116	129	for	for	ADP
dpc-5668	116	130	7	7	NUM
dpc-5668	116	131	days	day	NOUN
dpc-5668	116	132	)	)	PUNCT
dpc-5668	116	133	(	(	PUNCT
dpc-5668	116	134	n=172	n=172	NOUN
dpc-5668	116	135	)	)	PUNCT
dpc-5668	116	136	•	•	NOUN
dpc-5668	116	137	clinical	clinical	ADJ
dpc-5668	116	138	response	response	NOUN
dpc-5668	116	139	•	•	ADP
dpc-5668	116	140	bacteriological	bacteriological	ADJ
dpc-5668	116	141	response	response	NOUN
dpc-5668	116	142	glaxosmithkline	glaxosmithkline	PROPN
dpc-5668	116	143	rosen	rosen	PROPN
dpc-5668	116	144	201836	201836	NUM
dpc-5668	116	145	topical	topical	ADJ
dpc-5668	116	146	ozenoxacin	ozenoxacin	NUM
dpc-5668	116	147	cream	cream	NOUN
dpc-5668	116	148	1	1	NUM
dpc-5668	116	149	%	%	NOUN
dpc-5668	116	150	(	(	PUNCT
dpc-5668	116	151	twice	twice	ADV
dpc-5668	116	152	daily	daily	ADV
dpc-5668	116	153	for	for	ADP
dpc-5668	116	154	5	5	NUM
dpc-5668	116	155	days	day	NOUN
dpc-5668	116	156	)	)	PUNCT
dpc-5668	116	157	(	(	PUNCT
dpc-5668	116	158	n=206	n=206	NOUN
dpc-5668	116	159	)	)	PUNCT
dpc-5668	116	160	placebo	placebo	NOUN
dpc-5668	116	161	(	(	PUNCT
dpc-5668	116	162	twice	twice	ADV
dpc-5668	116	163	daily	daily	ADV
dpc-5668	116	164	for	for	ADP
dpc-5668	116	165	5	5	NUM
dpc-5668	116	166	days	day	NOUN
dpc-5668	116	167	)	)	PUNCT
dpc-5668	116	168	(	(	PUNCT
dpc-5668	116	169	n=206	n=206	ADV
dpc-5668	116	170	)	)	PUNCT
dpc-5668	116	171	•	•	NOUN
dpc-5668	116	172	clinical	clinical	ADJ
dpc-5668	116	173	response	response	NOUN
dpc-5668	116	174	•	•	ADP
dpc-5668	116	175	bacteriological	bacteriological	ADJ
dpc-5668	116	176	response	response	NOUN
dpc-5668	116	177	ferrer	ferrer	PROPN
dpc-5668	116	178	internacional	internacional	PROPN
dpc-5668	116	179	,	,	PUNCT
dpc-5668	117	1	sa	sa	PROPN
dpc-5668	117	2	.	.	PROPN
dpc-5668	117	3	sudha	sudha	PROPN
dpc-5668	117	4	201737	201737	NUM
dpc-5668	117	5	oral	oral	ADJ
dpc-5668	117	6	azithromycin	azithromycin	NOUN
dpc-5668	117	7	(	(	PUNCT
dpc-5668	117	8	10	10	NUM
dpc-5668	117	9	mg	mg	PROPN
dpc-5668	117	10	/	/	SYM
dpc-5668	117	11	kg	kg	PROPN
dpc-5668	117	12	/	/	SYM
dpc-5668	117	13	day	day	NOUN
dpc-5668	117	14	)	)	PUNCT
dpc-5668	117	15	(	(	PUNCT
dpc-5668	117	16	n=50	n=50	ADJ
dpc-5668	117	17	)	)	PUNCT
dpc-5668	117	18	oral	oral	ADJ
dpc-5668	117	19	azithromycin	azithromycin	NOUN
dpc-5668	117	20	(	(	PUNCT
dpc-5668	117	21	10	10	NUM
dpc-5668	117	22	mg	mg	PROPN
dpc-5668	117	23	/	/	SYM
dpc-5668	117	24	kg	kg	PROPN
dpc-5668	117	25	/	/	SYM
dpc-5668	117	26	day	day	NOUN
dpc-5668	117	27	)	)	PUNCT
dpc-5668	118	1	+	+	CCONJ
dpc-5668	118	2	probiotic	probiotic	ADJ
dpc-5668	118	3	(	(	PUNCT
dpc-5668	118	4	n=50	n=50	ADJ
dpc-5668	118	5	)	)	PUNCT
dpc-5668	118	6	•	•	ADP
dpc-5668	118	7	clinical	clinical	ADJ
dpc-5668	118	8	response	response	NOUN
dpc-5668	118	9	no	no	DET
dpc-5668	118	10	sources	source	NOUN
dpc-5668	118	11	tong	tong	PROPN
dpc-5668	118	12	201038	201038	NUM
dpc-5668	118	13	oral	oral	ADJ
dpc-5668	118	14	trimethoprim	trimethoprim	ADJ
dpc-5668	118	15	-	-	PUNCT
dpc-5668	118	16	sulfamethoxazole	sulfamethoxazole	NOUN
dpc-5668	118	17	(	(	PUNCT
dpc-5668	118	18	4	4	NUM
dpc-5668	118	19	+	+	NOUN
dpc-5668	118	20	20	20	NUM
dpc-5668	118	21	mg	mg	NUM
dpc-5668	118	22	/	/	SYM
dpc-5668	118	23	kg	kg	NOUN
dpc-5668	118	24	up	up	ADP
dpc-5668	118	25	to	to	ADP
dpc-5668	118	26	160	160	NUM
dpc-5668	118	27	+	+	NOUN
dpc-5668	118	28	800	800	NUM
dpc-5668	118	29	mg	mg	NUM
dpc-5668	118	30	)	)	PUNCT
dpc-5668	118	31	(	(	PUNCT
dpc-5668	118	32	n=7	n=7	X
dpc-5668	118	33	)	)	PUNCT
dpc-5668	118	34	intramuscular	intramuscular	ADJ
dpc-5668	118	35	benzathine	benzathine	ADJ
dpc-5668	118	36	penicillin	penicillin	NOUN
dpc-5668	118	37	(	(	PUNCT
dpc-5668	118	38	45	45	NUM
dpc-5668	118	39	mg/	mg/	NOUN
dpc-5668	118	40	kg	kg	X
dpc-5668	118	41	up	up	ADP
dpc-5668	118	42	to	to	PART
dpc-5668	118	43	900	900	NUM
dpc-5668	118	44	mg	mg	NUM
dpc-5668	118	45	)	)	PUNCT
dpc-5668	118	46	(	(	PUNCT
dpc-5668	118	47	n=6	n=6	NOUN
dpc-5668	118	48	)	)	PUNCT
dpc-5668	118	49	•	•	NOUN
dpc-5668	118	50	clinical	clinical	ADJ
dpc-5668	118	51	response	response	NOUN
dpc-5668	118	52	•	•	ADP
dpc-5668	118	53	bacteriological	bacteriological	ADJ
dpc-5668	118	54	response	response	NOUN
dpc-5668	118	55	australian	australian	ADJ
dpc-5668	118	56	national	national	ADJ
dpc-5668	118	57	health	health	PROPN
dpc-5668	118	58	and	and	CCONJ
dpc-5668	118	59	medical	medical	ADJ
dpc-5668	118	60	research	research	PROPN
dpc-5668	118	61	council	council	PROPN
dpc-5668	118	62	,	,	PUNCT
dpc-5668	118	63	australian	australian	ADJ
dpc-5668	118	64	national	national	ADJ
dpc-5668	118	65	heart	heart	PROPN
dpc-5668	118	66	foundation	foundation	PROPN
dpc-5668	118	67	,	,	PUNCT
dpc-5668	118	68	cooperative	cooperative	ADJ
dpc-5668	118	69	research	research	NOUN
dpc-5668	118	70	centre	centre	NOUN
dpc-5668	118	71	for	for	ADP
dpc-5668	118	72	aboriginal	aboriginal	ADJ
dpc-5668	118	73	health	health	NOUN
dpc-5668	118	74	,	,	PUNCT
dpc-5668	118	75	ian	ian	PROPN
dpc-5668	118	76	potter	potter	PROPN
dpc-5668	118	77	foundation	foundation	PROPN
dpc-5668	118	78	,	,	PUNCT
dpc-5668	118	79	and	and	CCONJ
dpc-5668	118	80	the	the	DET
dpc-5668	118	81	rio	rio	NOUN
dpc-5668	118	82	tinto	tinto	PROPN
dpc-5668	118	83	aboriginal	aboriginal	PROPN
dpc-5668	118	84	foundation	foundation	PROPN
dpc-5668	118	85	.	.	PUNCT
dpc-5668	119	1	abbreviations	abbreviation	NOUN
dpc-5668	119	2	:	:	PUNCT
dpc-5668	119	3	n	n	NUM
dpc-5668	119	4	:	:	PUNCT
dpc-5668	119	5	number	number	NOUN
dpc-5668	119	6	of	of	ADP
dpc-5668	119	7	participants	participant	NOUN
dpc-5668	119	8	,	,	PUNCT
dpc-5668	119	9	nr	nr	PRON
dpc-5668	119	10	:	:	PUNCT
dpc-5668	119	11	not	not	PART
dpc-5668	119	12	reported	report	VERB
dpc-5668	119	13	,	,	PUNCT
dpc-5668	119	14	nvc-422	nvc-422	NOUN
dpc-5668	119	15	:	:	PUNCT
dpc-5668	119	16	n	n	CCONJ
dpc-5668	119	17	,	,	PUNCT
dpc-5668	119	18	n	n	CCONJ
dpc-5668	119	19	-	-	PUNCT
dpc-5668	119	20	dichloro-2	dichloro-2	VERB
dpc-5668	119	21	,	,	PUNCT
dpc-5668	119	22	2	2	NUM
dpc-5668	119	23	-	-	PUNCT
dpc-5668	119	24	dimethyltaurine	dimethyltaurine	NOUN
dpc-5668	119	25	.	.	PUNCT
dpc-5668	120	1	table	table	NOUN
dpc-5668	120	2	1	1	NUM
dpc-5668	120	3	.	.	PUNCT
dpc-5668	121	1	characteristics	characteristic	NOUN
dpc-5668	121	2	of	of	ADP
dpc-5668	121	3	the	the	DET
dpc-5668	121	4	included	include	VERB
dpc-5668	121	5	studies	study	NOUN
dpc-5668	121	6	.	.	PUNCT
dpc-5668	122	1	(	(	PUNCT
dpc-5668	122	2	continued	continue	VERB
dpc-5668	122	3	)	)	PUNCT
dpc-5668	122	4	review	review	NOUN
dpc-5668	122	5	|	|	ADV
dpc-5668	122	6	dermatol	dermatol	ADJ
dpc-5668	122	7	pract	pract	NOUN
dpc-5668	122	8	concept	concept	NOUN
dpc-5668	122	9	.	.	PUNCT
dpc-5668	123	1	2025;15(4):5668	2025;15(4):5668	NUM
dpc-5668	123	2	7	7	NUM
dpc-5668	123	3	figure	figure	NOUN
dpc-5668	123	4	2	2	NUM
dpc-5668	123	5	.	.	PUNCT
dpc-5668	123	6	risk	risk	NOUN
dpc-5668	123	7	of	of	ADP
dpc-5668	123	8	bias	bias	NOUN
dpc-5668	123	9	assessment	assessment	NOUN
dpc-5668	123	10	.	.	PUNCT
dpc-5668	124	1	can	can	AUX
dpc-5668	124	2	significantly	significantly	ADV
dpc-5668	124	3	impact	impact	VERB
dpc-5668	124	4	the	the	DET
dpc-5668	124	5	results	result	NOUN
dpc-5668	124	6	since	since	SCONJ
dpc-5668	124	7	clinically	clinically	ADV
dpc-5668	124	8	relevant	relevant	ADJ
dpc-5668	124	9	efficacy	efficacy	NOUN
dpc-5668	124	10	and	and	CCONJ
dpc-5668	124	11	safety	safety	NOUN
dpc-5668	124	12	outcomes	outcome	NOUN
dpc-5668	124	13	were	be	AUX
dpc-5668	124	14	measured	measure	VERB
dpc-5668	124	15	subjectively	subjectively	ADV
dpc-5668	124	16	.	.	PUNCT
dpc-5668	125	1	with	with	ADP
dpc-5668	125	2	a	a	DET
dpc-5668	125	3	low	low	ADJ
dpc-5668	125	4	risk	risk	NOUN
dpc-5668	125	5	of	of	ADP
dpc-5668	125	6	bias	bias	NOUN
dpc-5668	125	7	,	,	PUNCT
dpc-5668	125	8	29	29	NUM
dpc-5668	125	9	%	%	NOUN
dpc-5668	125	10	(	(	PUNCT
dpc-5668	125	11	6/21	6/21	NUM
dpc-5668	125	12	,	,	PUNCT
dpc-5668	125	13	95	95	NUM
dpc-5668	125	14	%	%	NOUN
dpc-5668	125	15	ci	ci	NOUN
dpc-5668	125	16	:	:	PUNCT
dpc-5668	125	17	14%–50	14%–50	NUM
dpc-5668	125	18	%	%	NOUN
dpc-5668	125	19	)	)	PUNCT
dpc-5668	126	1	[	[	X
dpc-5668	126	2	19,21,26,28	19,21,26,28	NUM
dpc-5668	126	3	-	-	SYM
dpc-5668	126	4	30	30	NUM
dpc-5668	126	5	]	]	PUNCT
dpc-5668	126	6	had	have	VERB
dpc-5668	126	7	adequate	adequate	ADJ
dpc-5668	126	8	blinding	blinding	NOUN
dpc-5668	126	9	of	of	ADP
dpc-5668	126	10	participants	participant	NOUN
dpc-5668	126	11	,	,	PUNCT
dpc-5668	126	12	and	and	CCONJ
dpc-5668	126	13	43	43	NUM
dpc-5668	126	14	%	%	NOUN
dpc-5668	126	15	(	(	PUNCT
dpc-5668	126	16	9/21	9/21	NUM
dpc-5668	126	17	,	,	PUNCT
dpc-5668	126	18	95	95	NUM
dpc-5668	126	19	%	%	NOUN
dpc-5668	126	20	ci	ci	NOUN
dpc-5668	126	21	:	:	PUNCT
dpc-5668	126	22	24%–63	24%–63	NUM
dpc-5668	126	23	%	%	NOUN
dpc-5668	126	24	)	)	PUNCT
dpc-5668	127	1	[	[	X
dpc-5668	127	2	22,23,26,28	22,23,26,28	NUM
dpc-5668	127	3	-	-	SYM
dpc-5668	127	4	30,33,35,38	30,33,35,38	NUM
dpc-5668	127	5	]	]	PUNCT
dpc-5668	127	6	had	have	VERB
dpc-5668	127	7	adequate	adequate	ADJ
dpc-5668	127	8	blinding	blinding	NOUN
dpc-5668	127	9	of	of	ADP
dpc-5668	127	10	assessors	assessor	NOUN
dpc-5668	127	11	.	.	PUNCT
dpc-5668	128	1	in	in	ADP
dpc-5668	128	2	these	these	DET
dpc-5668	128	3	studies	study	NOUN
dpc-5668	128	4	,	,	PUNCT
dpc-5668	128	5	the	the	DET
dpc-5668	128	6	compared	compare	VERB
dpc-5668	128	7	medications	medication	NOUN
dpc-5668	128	8	were	be	AUX
dpc-5668	128	9	identical	identical	ADJ
dpc-5668	128	10	in	in	ADP
dpc-5668	128	11	appearance	appearance	NOUN
dpc-5668	128	12	and	and	CCONJ
dpc-5668	128	13	characteristics	characteristic	NOUN
dpc-5668	128	14	,	,	PUNCT
dpc-5668	128	15	or	or	CCONJ
dpc-5668	128	16	participants	participant	NOUN
dpc-5668	128	17	received	receive	VERB
dpc-5668	128	18	a	a	DET
dpc-5668	128	19	placebo	placebo	NOUN
dpc-5668	128	20	that	that	PRON
dpc-5668	128	21	closely	closely	ADV
dpc-5668	128	22	resembled	resemble	VERB
dpc-5668	128	23	the	the	DET
dpc-5668	128	24	intervention	intervention	NOUN
dpc-5668	128	25	,	,	PUNCT
dpc-5668	128	26	such	such	ADJ
dpc-5668	128	27	as	as	ADP
dpc-5668	128	28	a	a	DET
dpc-5668	128	29	placebo	placebo	NOUN
dpc-5668	128	30	ointment	ointment	NOUN
dpc-5668	128	31	for	for	ADP
dpc-5668	128	32	the	the	DET
dpc-5668	128	33	oral	oral	ADJ
dpc-5668	128	34	administration	administration	NOUN
dpc-5668	128	35	group	group	NOUN
dpc-5668	128	36	versus	versus	ADP
dpc-5668	128	37	the	the	DET
dpc-5668	128	38	topical	topical	ADJ
dpc-5668	128	39	treatment	treatment	NOUN
dpc-5668	128	40	.	.	PUNCT
dpc-5668	129	1	the	the	DET
dpc-5668	129	2	incomplete	incomplete	ADJ
dpc-5668	129	3	outcome	outcome	NOUN
dpc-5668	129	4	data	datum	NOUN
dpc-5668	129	5	domain	domain	NOUN
dpc-5668	129	6	assesses	assesse	NOUN
dpc-5668	129	7	how	how	SCONJ
dpc-5668	129	8	results	result	NOUN
dpc-5668	129	9	are	be	AUX
dpc-5668	129	10	reported	report	VERB
dpc-5668	129	11	,	,	PUNCT
dpc-5668	129	12	including	include	VERB
dpc-5668	129	13	participant	participant	ADJ
dpc-5668	129	14	losses	loss	NOUN
dpc-5668	129	15	or	or	CCONJ
dpc-5668	129	16	withdrawals	withdrawal	NOUN
dpc-5668	129	17	during	during	ADP
dpc-5668	129	18	the	the	DET
dpc-5668	129	19	study	study	NOUN
dpc-5668	129	20	,	,	PUNCT
dpc-5668	129	21	and	and	CCONJ
dpc-5668	129	22	examines	examine	VERB
dpc-5668	129	23	the	the	DET
dpc-5668	129	24	impact	impact	NOUN
dpc-5668	129	25	of	of	ADP
dpc-5668	129	26	these	these	DET
dpc-5668	129	27	losses	loss	NOUN
dpc-5668	129	28	on	on	ADP
dpc-5668	129	29	the	the	DET
dpc-5668	129	30	final	final	ADJ
dpc-5668	129	31	analysis	analysis	NOUN
dpc-5668	129	32	.	.	PUNCT
dpc-5668	130	1	among	among	ADP
dpc-5668	130	2	the	the	DET
dpc-5668	130	3	included	include	VERB
dpc-5668	130	4	rcts	rct	NOUN
dpc-5668	130	5	,	,	PUNCT
dpc-5668	130	6	76	76	NUM
dpc-5668	130	7	%	%	NOUN
dpc-5668	130	8	(	(	PUNCT
dpc-5668	130	9	16/21	16/21	NUM
dpc-5668	130	10	,	,	PUNCT
dpc-5668	130	11	95	95	NUM
dpc-5668	130	12	%	%	NOUN
dpc-5668	130	13	ci	ci	NOUN
dpc-5668	130	14	:	:	PUNCT
dpc-5668	130	15	55%–89	55%–89	NUM
dpc-5668	130	16	%	%	NOUN
dpc-5668	130	17	)	)	PUNCT
dpc-5668	131	1	[	[	X
dpc-5668	131	2	18,19,21	18,19,21	NUM
dpc-5668	131	3	-	-	PUNCT
dpc-5668	131	4	23,25	23,25	NUM
dpc-5668	131	5	-	-	PUNCT
dpc-5668	131	6	27,29,31,32,34	27,29,31,32,34	NOUN
dpc-5668	131	7	-	-	PUNCT
dpc-5668	131	8	38	38	NUM
dpc-5668	131	9	]	]	PUNCT
dpc-5668	131	10	were	be	AUX
dpc-5668	131	11	considered	consider	VERB
dpc-5668	131	12	to	to	PART
dpc-5668	131	13	have	have	VERB
dpc-5668	131	14	a	a	DET
dpc-5668	131	15	low	low	ADJ
dpc-5668	131	16	risk	risk	NOUN
dpc-5668	131	17	of	of	ADP
dpc-5668	131	18	bias	bias	NOUN
dpc-5668	131	19	,	,	PUNCT
dpc-5668	131	20	as	as	SCONJ
dpc-5668	131	21	they	they	PRON
dpc-5668	131	22	reported	report	VERB
dpc-5668	131	23	losses	loss	NOUN
dpc-5668	131	24	of	of	ADP
dpc-5668	131	25	less	less	ADJ
dpc-5668	131	26	than	than	ADP
dpc-5668	131	27	20	20	NUM
dpc-5668	131	28	%	%	NOUN
dpc-5668	131	29	of	of	ADP
dpc-5668	131	30	participants	participant	NOUN
dpc-5668	131	31	and	and	CCONJ
dpc-5668	131	32	provided	provide	VERB
dpc-5668	131	33	appropriate	appropriate	ADJ
dpc-5668	131	34	justifications	justification	NOUN
dpc-5668	131	35	.	.	PUNCT
dpc-5668	132	1	in	in	ADP
dpc-5668	132	2	contrast	contrast	NOUN
dpc-5668	132	3	,	,	PUNCT
dpc-5668	132	4	24	24	NUM
dpc-5668	132	5	%	%	NOUN
dpc-5668	132	6	(	(	PUNCT
dpc-5668	132	7	5/21	5/21	NUM
dpc-5668	132	8	,	,	PUNCT
dpc-5668	132	9	95	95	NUM
dpc-5668	132	10	%	%	NOUN
dpc-5668	132	11	ci	ci	NOUN
dpc-5668	132	12	:	:	PUNCT
dpc-5668	132	13	11	11	NUM
dpc-5668	132	14	%	%	NOUN
dpc-5668	132	15	–	–	PUNCT
dpc-5668	132	16	45	45	NUM
dpc-5668	132	17	%	%	NOUN
dpc-5668	132	18	)	)	PUNCT
dpc-5668	133	1	[	[	X
dpc-5668	133	2	20,24,28,30,33	20,24,28,30,33	X
dpc-5668	133	3	]	]	X
dpc-5668	133	4	had	have	VERB
dpc-5668	133	5	a	a	DET
dpc-5668	133	6	high	high	ADJ
dpc-5668	133	7	risk	risk	NOUN
dpc-5668	133	8	of	of	ADP
dpc-5668	133	9	bias	bias	NOUN
dpc-5668	133	10	due	due	ADP
dpc-5668	133	11	to	to	ADP
dpc-5668	133	12	losses	loss	NOUN
dpc-5668	133	13	exceeding	exceed	VERB
dpc-5668	133	14	20	20	NUM
dpc-5668	133	15	%	%	NOUN
dpc-5668	133	16	and	and	CCONJ
dpc-5668	133	17	lacking	lack	VERB
dpc-5668	133	18	justification	justification	NOUN
dpc-5668	133	19	.	.	PUNCT
dpc-5668	134	1	the	the	DET
dpc-5668	134	2	selective	selective	ADJ
dpc-5668	134	3	reporting	reporting	NOUN
dpc-5668	134	4	domain	domain	NOUN
dpc-5668	134	5	revealed	reveal	VERB
dpc-5668	134	6	that	that	SCONJ
dpc-5668	134	7	81	81	NUM
dpc-5668	134	8	%	%	NOUN
dpc-5668	134	9	(	(	PUNCT
dpc-5668	134	10	17/21	17/21	NUM
dpc-5668	134	11	,	,	PUNCT
dpc-5668	134	12	95	95	NUM
dpc-5668	134	13	%	%	NOUN
dpc-5668	134	14	ci	ci	NOUN
dpc-5668	134	15	:	:	PUNCT
dpc-5668	134	16	60%–92	60%–92	NUM
dpc-5668	134	17	%	%	NOUN
dpc-5668	134	18	)	)	PUNCT
dpc-5668	135	1	[	[	X
dpc-5668	135	2	18	18	NUM
dpc-5668	135	3	-	-	PUNCT
dpc-5668	135	4	29,31	29,31	NUM
dpc-5668	135	5	-	-	PUNCT
dpc-5668	135	6	34,37	34,37	NUM
dpc-5668	135	7	]	]	PUNCT
dpc-5668	135	8	of	of	ADP
dpc-5668	135	9	the	the	DET
dpc-5668	135	10	studies	study	NOUN
dpc-5668	135	11	had	have	VERB
dpc-5668	135	12	an	an	DET
dpc-5668	135	13	unclear	unclear	ADJ
dpc-5668	135	14	risk	risk	NOUN
dpc-5668	135	15	of	of	ADP
dpc-5668	135	16	bias	bias	NOUN
dpc-5668	135	17	,	,	PUNCT
dpc-5668	135	18	as	as	SCONJ
dpc-5668	135	19	most	most	ADJ
dpc-5668	135	20	did	do	AUX
dpc-5668	135	21	not	not	PART
dpc-5668	135	22	provide	provide	VERB
dpc-5668	135	23	a	a	DET
dpc-5668	135	24	registered	register	VERB
dpc-5668	135	25	protocol	protocol	NOUN
dpc-5668	135	26	,	,	PUNCT
dpc-5668	135	27	making	make	VERB
dpc-5668	135	28	it	it	PRON
dpc-5668	135	29	impossible	impossible	ADJ
dpc-5668	135	30	to	to	PART
dpc-5668	135	31	assess	assess	VERB
dpc-5668	135	32	the	the	DET
dpc-5668	135	33	differences	difference	NOUN
dpc-5668	135	34	between	between	ADP
dpc-5668	135	35	reported	report	VERB
dpc-5668	135	36	and	and	CCONJ
dpc-5668	135	37	unreported	unreported	ADJ
dpc-5668	135	38	outcomes	outcome	NOUN
dpc-5668	135	39	and	and	CCONJ
dpc-5668	135	40	results	result	NOUN
dpc-5668	135	41	.	.	PUNCT
dpc-5668	136	1	no	no	DET
dpc-5668	136	2	other	other	ADJ
dpc-5668	136	3	source	source	NOUN
dpc-5668	136	4	of	of	ADP
dpc-5668	136	5	bias	bias	NOUN
dpc-5668	136	6	was	be	AUX
dpc-5668	136	7	identified	identify	VERB
dpc-5668	136	8	in	in	ADP
dpc-5668	136	9	the	the	DET
dpc-5668	136	10	evaluated	evaluated	ADJ
dpc-5668	136	11	rcts	rct	NOUN
dpc-5668	136	12	.	.	PUNCT
dpc-5668	137	1	discussion	discussion	NOUN
dpc-5668	137	2	this	this	DET
dpc-5668	137	3	meta	meta	ADJ
dpc-5668	137	4	-	-	PUNCT
dpc-5668	137	5	research	research	NOUN
dpc-5668	137	6	evaluated	evaluate	VERB
dpc-5668	137	7	the	the	DET
dpc-5668	137	8	methodological	methodological	ADJ
dpc-5668	137	9	quality	quality	NOUN
dpc-5668	137	10	and	and	CCONJ
dpc-5668	137	11	risk	risk	NOUN
dpc-5668	137	12	of	of	ADP
dpc-5668	137	13	bias	bias	NOUN
dpc-5668	137	14	in	in	ADP
dpc-5668	137	15	randomized	randomized	ADJ
dpc-5668	137	16	clinical	clinical	ADJ
dpc-5668	137	17	trials	trial	NOUN
dpc-5668	137	18	(	(	PUNCT
dpc-5668	137	19	rcts	rct	NOUN
dpc-5668	137	20	)	)	PUNCT
dpc-5668	137	21	concerning	concern	VERB
dpc-5668	137	22	pharmacological	pharmacological	ADJ
dpc-5668	137	23	treatments	treatment	NOUN
dpc-5668	137	24	for	for	ADP
dpc-5668	137	25	impetigo	impetigo	NOUN
dpc-5668	137	26	in	in	ADP
dpc-5668	137	27	children	child	NOUN
dpc-5668	137	28	and	and	CCONJ
dpc-5668	137	29	adolescents	adolescent	NOUN
dpc-5668	137	30	.	.	PUNCT
dpc-5668	138	1	impetigo	impetigo	PROPN
dpc-5668	138	2	,	,	PUNCT
dpc-5668	138	3	a	a	DET
dpc-5668	138	4	highly	highly	ADV
dpc-5668	138	5	contagious	contagious	ADJ
dpc-5668	138	6	skin	skin	NOUN
dpc-5668	138	7	infection	infection	NOUN
dpc-5668	138	8	,	,	PUNCT
dpc-5668	138	9	is	be	AUX
dpc-5668	138	10	a	a	DET
dpc-5668	138	11	common	common	ADJ
dpc-5668	138	12	condition	condition	NOUN
dpc-5668	138	13	requiring	require	VERB
dpc-5668	138	14	effective	effective	ADJ
dpc-5668	138	15	treatment	treatment	NOUN
dpc-5668	138	16	options	option	NOUN
dpc-5668	138	17	,	,	PUNCT
dpc-5668	138	18	yet	yet	CCONJ
dpc-5668	138	19	evidence	evidence	NOUN
dpc-5668	138	20	supporting	support	VERB
dpc-5668	138	21	various	various	ADJ
dpc-5668	138	22	interventions	intervention	NOUN
dpc-5668	138	23	remains	remain	VERB
dpc-5668	138	24	uncertain	uncertain	ADJ
dpc-5668	138	25	.	.	PUNCT
dpc-5668	139	1	this	this	DET
dpc-5668	139	2	study	study	NOUN
dpc-5668	139	3	aimed	aim	VERB
dpc-5668	139	4	to	to	PART
dpc-5668	139	5	assess	assess	VERB
dpc-5668	139	6	the	the	DET
dpc-5668	139	7	reliability	reliability	NOUN
dpc-5668	139	8	and	and	CCONJ
dpc-5668	139	9	applicability	applicability	NOUN
dpc-5668	139	10	of	of	ADP
dpc-5668	139	11	current	current	ADJ
dpc-5668	139	12	rcts	rct	NOUN
dpc-5668	139	13	,	,	PUNCT
dpc-5668	139	14	mapping	map	VERB
dpc-5668	139	15	the	the	DET
dpc-5668	139	16	methodological	methodological	ADJ
dpc-5668	139	17	flaws	flaw	NOUN
dpc-5668	139	18	to	to	ADP
dpc-5668	139	19	clinical	clinical	ADJ
dpc-5668	139	20	practice	practice	NOUN
dpc-5668	139	21	and	and	CCONJ
dpc-5668	139	22	providing	provide	VERB
dpc-5668	139	23	recommendations	recommendation	NOUN
dpc-5668	139	24	for	for	ADP
dpc-5668	139	25	future	future	ADJ
dpc-5668	139	26	research	research	NOUN
dpc-5668	139	27	.	.	PUNCT
dpc-5668	140	1	the	the	DET
dpc-5668	140	2	results	result	NOUN
dpc-5668	140	3	revealed	reveal	VERB
dpc-5668	140	4	that	that	SCONJ
dpc-5668	140	5	a	a	DET
dpc-5668	140	6	significant	significant	ADJ
dpc-5668	140	7	proportion	proportion	NOUN
dpc-5668	140	8	of	of	ADP
dpc-5668	140	9	the	the	DET
dpc-5668	140	10	included	include	VERB
dpc-5668	140	11	rcts	rct	NOUN
dpc-5668	140	12	exhibited	exhibit	VERB
dpc-5668	140	13	unclear	unclear	ADJ
dpc-5668	140	14	or	or	CCONJ
dpc-5668	140	15	high	high	ADJ
dpc-5668	140	16	risks	risk	NOUN
dpc-5668	140	17	of	of	ADP
dpc-5668	140	18	bias	bias	NOUN
dpc-5668	140	19	,	,	PUNCT
dpc-5668	140	20	particularly	particularly	ADV
dpc-5668	140	21	in	in	ADP
dpc-5668	140	22	domains	domain	NOUN
dpc-5668	140	23	related	relate	VERB
dpc-5668	140	24	to	to	ADP
dpc-5668	140	25	randomization	randomization	NOUN
dpc-5668	140	26	,	,	PUNCT
dpc-5668	140	27	blinding	blinding	NOUN
dpc-5668	140	28	,	,	PUNCT
dpc-5668	140	29	and	and	CCONJ
dpc-5668	140	30	handling	handling	NOUN
dpc-5668	140	31	of	of	ADP
dpc-5668	140	32	incomplete	incomplete	ADJ
dpc-5668	140	33	outcome	outcome	NOUN
dpc-5668	140	34	data	datum	NOUN
dpc-5668	140	35	.	.	PUNCT
dpc-5668	141	1	a	a	DET
dpc-5668	141	2	significant	significant	ADJ
dpc-5668	141	3	proportion	proportion	NOUN
dpc-5668	141	4	of	of	ADP
dpc-5668	141	5	the	the	DET
dpc-5668	141	6	included	include	VERB
dpc-5668	141	7	studies	study	NOUN
dpc-5668	141	8	presented	present	VERB
dpc-5668	141	9	an	an	DET
dpc-5668	141	10	unclear	unclear	ADJ
dpc-5668	141	11	or	or	CCONJ
dpc-5668	141	12	high	high	ADJ
dpc-5668	141	13	risk	risk	NOUN
dpc-5668	141	14	of	of	ADP
dpc-5668	141	15	bias	bias	NOUN
dpc-5668	141	16	regarding	regard	VERB
dpc-5668	141	17	the	the	DET
dpc-5668	141	18	randomization	randomization	NOUN
dpc-5668	141	19	process	process	NOUN
dpc-5668	141	20	,	,	PUNCT
dpc-5668	141	21	with	with	ADP
dpc-5668	141	22	53%–57	53%–57	NUM
dpc-5668	141	23	%	%	NOUN
dpc-5668	141	24	of	of	ADP
dpc-5668	141	25	studies	study	NOUN
dpc-5668	141	26	lacking	lack	VERB
dpc-5668	141	27	sufficient	sufficient	ADJ
dpc-5668	141	28	details	detail	NOUN
dpc-5668	141	29	.	.	PUNCT
dpc-5668	142	1	randomization	randomization	NOUN
dpc-5668	142	2	is	be	AUX
dpc-5668	142	3	critical	critical	ADJ
dpc-5668	142	4	to	to	ADP
dpc-5668	142	5	ensuring	ensure	VERB
dpc-5668	142	6	that	that	SCONJ
dpc-5668	142	7	participants	participant	NOUN
dpc-5668	142	8	are	be	AUX
dpc-5668	142	9	allocated	allocate	VERB
dpc-5668	142	10	to	to	ADP
dpc-5668	142	11	treatment	treatment	NOUN
dpc-5668	142	12	groups	group	NOUN
dpc-5668	142	13	without	without	ADP
dpc-5668	142	14	bias	bias	NOUN
dpc-5668	142	15	,	,	PUNCT
dpc-5668	142	16	guaranteeing	guarantee	VERB
dpc-5668	142	17	comparability	comparability	NOUN
dpc-5668	142	18	.	.	PUNCT
dpc-5668	143	1	inadequate	inadequate	ADJ
dpc-5668	143	2	or	or	CCONJ
dpc-5668	143	3	poorly	poorly	ADV
dpc-5668	143	4	described	describe	VERB
dpc-5668	143	5	randomization	randomization	NOUN
dpc-5668	143	6	methods	method	NOUN
dpc-5668	143	7	can	can	AUX
dpc-5668	143	8	lead	lead	VERB
dpc-5668	143	9	to	to	ADP
dpc-5668	143	10	selection	selection	NOUN
dpc-5668	143	11	bias	bias	NOUN
dpc-5668	143	12	,	,	PUNCT
dpc-5668	143	13	potentially	potentially	ADV
dpc-5668	143	14	affecting	affect	VERB
dpc-5668	143	15	the	the	DET
dpc-5668	143	16	generalizability	generalizability	NOUN
dpc-5668	143	17	of	of	ADP
dpc-5668	143	18	the	the	DET
dpc-5668	143	19	results	result	NOUN
dpc-5668	143	20	and	and	CCONJ
dpc-5668	143	21	distorting	distort	VERB
dpc-5668	143	22	the	the	DET
dpc-5668	143	23	perceived	perceive	VERB
dpc-5668	143	24	treatment	treatment	NOUN
dpc-5668	143	25	effect	effect	NOUN
dpc-5668	143	26	.	.	PUNCT
dpc-5668	144	1	rigorous	rigorous	ADJ
dpc-5668	144	2	randomization	randomization	NOUN
dpc-5668	144	3	procedures	procedure	NOUN
dpc-5668	144	4	are	be	AUX
dpc-5668	144	5	essential	essential	ADJ
dpc-5668	144	6	to	to	ADP
dpc-5668	144	7	ensuring	ensure	VERB
dpc-5668	144	8	baseline	baseline	ADJ
dpc-5668	144	9	comparability	comparability	NOUN
dpc-5668	144	10	and	and	CCONJ
dpc-5668	144	11	to	to	ADP
dpc-5668	144	12	reducing	reduce	VERB
dpc-5668	144	13	the	the	DET
dpc-5668	144	14	risk	risk	NOUN
dpc-5668	144	15	of	of	ADP
dpc-5668	144	16	bias	bias	NOUN
dpc-5668	144	17	[	[	X
dpc-5668	144	18	1,5,39	1,5,39	NUM
dpc-5668	144	19	]	]	X
dpc-5668	144	20	.	.	PUNCT
dpc-5668	145	1	most	most	ADJ
dpc-5668	145	2	studies	study	NOUN
dpc-5668	145	3	had	have	VERB
dpc-5668	145	4	a	a	DET
dpc-5668	145	5	high	high	ADJ
dpc-5668	145	6	risk	risk	NOUN
dpc-5668	145	7	of	of	ADP
dpc-5668	145	8	bias	bias	NOUN
dpc-5668	145	9	concerning	concern	VERB
dpc-5668	145	10	the	the	DET
dpc-5668	145	11	blinding	blinding	NOUN
dpc-5668	145	12	of	of	ADP
dpc-5668	145	13	participants	participant	NOUN
dpc-5668	145	14	and	and	CCONJ
dpc-5668	145	15	outcome	outcome	NOUN
dpc-5668	145	16	assessors	assessor	NOUN
dpc-5668	145	17	.	.	PUNCT
dpc-5668	146	1	this	this	DET
dpc-5668	146	2	lack	lack	NOUN
dpc-5668	146	3	of	of	ADP
dpc-5668	146	4	blinding	blinding	NOUN
dpc-5668	146	5	can	can	AUX
dpc-5668	146	6	introduce	introduce	VERB
dpc-5668	146	7	performance	performance	NOUN
dpc-5668	146	8	and	and	CCONJ
dpc-5668	146	9	detection	detection	NOUN
dpc-5668	146	10	biases	bias	NOUN
dpc-5668	146	11	.	.	PUNCT
dpc-5668	147	1	when	when	SCONJ
dpc-5668	147	2	participants	participant	NOUN
dpc-5668	147	3	or	or	CCONJ
dpc-5668	147	4	researchers	researcher	NOUN
dpc-5668	147	5	know	know	VERB
dpc-5668	147	6	the	the	DET
dpc-5668	147	7	treatment	treatment	NOUN
dpc-5668	147	8	allocation	allocation	NOUN
dpc-5668	147	9	,	,	PUNCT
dpc-5668	147	10	it	it	PRON
dpc-5668	147	11	may	may	AUX
dpc-5668	147	12	influence	influence	VERB
dpc-5668	147	13	participant	participant	ADJ
dpc-5668	147	14	behavior	behavior	NOUN
dpc-5668	147	15	and	and	CCONJ
dpc-5668	147	16	the	the	DET
dpc-5668	147	17	interpretation	interpretation	NOUN
dpc-5668	147	18	of	of	ADP
dpc-5668	147	19	outcomes	outcome	NOUN
dpc-5668	147	20	.	.	PUNCT
dpc-5668	148	1	for	for	ADP
dpc-5668	148	2	example	example	NOUN
dpc-5668	148	3	,	,	PUNCT
dpc-5668	148	4	participants	participant	NOUN
dpc-5668	148	5	aware	aware	ADJ
dpc-5668	148	6	of	of	ADP
dpc-5668	148	7	receiving	receive	VERB
dpc-5668	148	8	a	a	DET
dpc-5668	148	9	placebo	placebo	NOUN
dpc-5668	148	10	might	might	AUX
dpc-5668	148	11	report	report	VERB
dpc-5668	148	12	subjective	subjective	ADJ
dpc-5668	148	13	outcomes	outcome	NOUN
dpc-5668	148	14	differently	differently	ADV
dpc-5668	148	15	from	from	ADP
dpc-5668	148	16	those	those	PRON
dpc-5668	148	17	receiving	receive	VERB
dpc-5668	148	18	the	the	DET
dpc-5668	148	19	active	active	ADJ
dpc-5668	148	20	treatment	treatment	NOUN
dpc-5668	148	21	.	.	PUNCT
dpc-5668	149	1	similarly	similarly	ADV
dpc-5668	149	2	,	,	PUNCT
dpc-5668	149	3	unblinded	unblinded	ADJ
dpc-5668	149	4	assessors	assessor	NOUN
dpc-5668	149	5	may	may	AUX
dpc-5668	149	6	unintentionally	unintentionally	ADV
dpc-5668	149	7	assess	assess	VERB
dpc-5668	149	8	outcomes	outcome	NOUN
dpc-5668	149	9	in	in	ADP
dpc-5668	149	10	a	a	DET
dpc-5668	149	11	biased	biased	ADJ
dpc-5668	149	12	manner	manner	NOUN
dpc-5668	149	13	.	.	PUNCT
dpc-5668	150	1	such	such	ADJ
dpc-5668	150	2	biases	bias	NOUN
dpc-5668	150	3	can	can	AUX
dpc-5668	150	4	lead	lead	VERB
dpc-5668	150	5	to	to	ADP
dpc-5668	150	6	overestimations	overestimation	NOUN
dpc-5668	150	7	or	or	CCONJ
dpc-5668	150	8	underestimations	underestimation	NOUN
dpc-5668	150	9	of	of	ADP
dpc-5668	150	10	treatment	treatment	NOUN
dpc-5668	150	11	effects	effect	NOUN
dpc-5668	150	12	,	,	PUNCT
dpc-5668	150	13	affecting	affect	VERB
dpc-5668	150	14	the	the	DET
dpc-5668	150	15	reliability	reliability	NOUN
dpc-5668	150	16	of	of	ADP
dpc-5668	150	17	study	study	NOUN
dpc-5668	150	18	results	result	NOUN
dpc-5668	150	19	[	[	X
dpc-5668	150	20	6	6	NUM
dpc-5668	150	21	]	]	PUNCT
dpc-5668	150	22	.	.	PUNCT
dpc-5668	150	23	8	8	NUM
dpc-5668	150	24	review	review	NOUN
dpc-5668	150	25	|	|	ADV
dpc-5668	150	26	dermatol	dermatol	ADJ
dpc-5668	150	27	pract	pract	NOUN
dpc-5668	150	28	concept	concept	NOUN
dpc-5668	150	29	.	.	PUNCT
dpc-5668	151	1	2025;15(4):5668	2025;15(4):5668	NUM
dpc-5668	151	2	1.0	1.0	NUM
dpc-5668	151	3	was	be	AUX
dpc-5668	151	4	made	make	VERB
dpc-5668	151	5	because	because	SCONJ
dpc-5668	151	6	it	it	PRON
dpc-5668	151	7	includes	include	VERB
dpc-5668	151	8	a	a	DET
dpc-5668	151	9	dedicated	dedicated	ADJ
dpc-5668	151	10	domain	domain	NOUN
dpc-5668	151	11	for	for	ADP
dpc-5668	151	12	selective	selective	ADJ
dpc-5668	151	13	reporting	reporting	NOUN
dpc-5668	151	14	,	,	PUNCT
dpc-5668	151	15	a	a	DET
dpc-5668	151	16	critical	critical	ADJ
dpc-5668	151	17	issue	issue	NOUN
dpc-5668	151	18	not	not	PART
dpc-5668	151	19	explicitly	explicitly	ADV
dpc-5668	151	20	assessed	assess	VERB
dpc-5668	151	21	in	in	ADP
dpc-5668	151	22	rob	rob	PROPN
dpc-5668	151	23	2.0	2.0	NUM
dpc-5668	151	24	.	.	PUNCT
dpc-5668	152	1	selective	selective	ADJ
dpc-5668	152	2	reporting	reporting	NOUN
dpc-5668	152	3	bias	bias	NOUN
dpc-5668	152	4	is	be	AUX
dpc-5668	152	5	a	a	DET
dpc-5668	152	6	significant	significant	ADJ
dpc-5668	152	7	concern	concern	NOUN
dpc-5668	152	8	in	in	ADP
dpc-5668	152	9	clinical	clinical	ADJ
dpc-5668	152	10	research	research	NOUN
dpc-5668	152	11	,	,	PUNCT
dpc-5668	152	12	occurring	occur	VERB
dpc-5668	152	13	when	when	SCONJ
dpc-5668	152	14	pre	pre	ADJ
dpc-5668	152	15	-	-	ADJ
dpc-5668	152	16	specified	specified	ADJ
dpc-5668	152	17	outcomes	outcome	NOUN
dpc-5668	152	18	are	be	AUX
dpc-5668	152	19	omitted	omit	VERB
dpc-5668	152	20	,	,	PUNCT
dpc-5668	152	21	reported	report	VERB
dpc-5668	152	22	incompletely	incompletely	ADV
dpc-5668	152	23	,	,	PUNCT
dpc-5668	152	24	or	or	CCONJ
dpc-5668	152	25	presented	present	VERB
dpc-5668	152	26	selectively	selectively	ADV
dpc-5668	152	27	,	,	PUNCT
dpc-5668	152	28	leading	lead	VERB
dpc-5668	152	29	to	to	ADP
dpc-5668	152	30	biased	biased	ADJ
dpc-5668	152	31	effect	effect	NOUN
dpc-5668	152	32	estimates	estimate	NOUN
dpc-5668	152	33	with	with	ADP
dpc-5668	152	34	overestimation	overestimation	NOUN
dpc-5668	152	35	of	of	ADP
dpc-5668	152	36	benefits	benefit	NOUN
dpc-5668	152	37	and	and	CCONJ
dpc-5668	152	38	underestimation	underestimation	NOUN
dpc-5668	152	39	of	of	ADP
dpc-5668	152	40	harms	harm	NOUN
dpc-5668	152	41	.	.	PUNCT
dpc-5668	153	1	the	the	DET
dpc-5668	153	2	decision	decision	NOUN
dpc-5668	153	3	also	also	ADV
dpc-5668	153	4	reflects	reflect	VERB
dpc-5668	153	5	growing	grow	VERB
dpc-5668	153	6	concerns	concern	NOUN
dpc-5668	153	7	in	in	ADP
dpc-5668	153	8	the	the	DET
dpc-5668	153	9	literature	literature	NOUN
dpc-5668	153	10	regarding	regard	VERB
dpc-5668	153	11	the	the	DET
dpc-5668	153	12	complexity	complexity	NOUN
dpc-5668	153	13	and	and	CCONJ
dpc-5668	153	14	operational	operational	ADJ
dpc-5668	153	15	challenges	challenge	NOUN
dpc-5668	153	16	associated	associate	VERB
dpc-5668	153	17	with	with	ADP
dpc-5668	153	18	rob	rob	PROPN
dpc-5668	153	19	2.0	2.0	NUM
dpc-5668	153	20	,	,	PUNCT
dpc-5668	153	21	which	which	PRON
dpc-5668	153	22	has	have	AUX
dpc-5668	153	23	demonstrated	demonstrate	VERB
dpc-5668	153	24	lower	low	ADJ
dpc-5668	153	25	inter	inter	ADJ
dpc-5668	153	26	-	-	ADJ
dpc-5668	153	27	rater	rater	ADJ
dpc-5668	153	28	reliability	reliability	NOUN
dpc-5668	153	29	and	and	CCONJ
dpc-5668	153	30	considerable	considerable	ADJ
dpc-5668	153	31	implementation	implementation	NOUN
dpc-5668	153	32	challenges	challenge	NOUN
dpc-5668	153	33	,	,	PUNCT
dpc-5668	153	34	even	even	ADV
dpc-5668	153	35	when	when	SCONJ
dpc-5668	153	36	applied	apply	VERB
dpc-5668	153	37	by	by	ADP
dpc-5668	153	38	experienced	experienced	ADJ
dpc-5668	153	39	systematic	systematic	ADJ
dpc-5668	153	40	reviewers	reviewer	NOUN
dpc-5668	153	41	[	[	X
dpc-5668	153	42	44–46	44–46	NUM
dpc-5668	153	43	]	]	PUNCT
dpc-5668	153	44	.	.	PUNCT
dpc-5668	154	1	the	the	DET
dpc-5668	154	2	methodological	methodological	ADJ
dpc-5668	154	3	shortcomings	shortcoming	NOUN
dpc-5668	154	4	identified	identify	VERB
dpc-5668	154	5	in	in	ADP
dpc-5668	154	6	this	this	DET
dpc-5668	154	7	meta	meta	ADJ
dpc-5668	154	8	-	-	PUNCT
dpc-5668	154	9	research	research	NOUN
dpc-5668	154	10	have	have	VERB
dpc-5668	154	11	important	important	ADJ
dpc-5668	154	12	implications	implication	NOUN
dpc-5668	154	13	for	for	ADP
dpc-5668	154	14	both	both	CCONJ
dpc-5668	154	15	clinical	clinical	ADJ
dpc-5668	154	16	practice	practice	NOUN
dpc-5668	154	17	and	and	CCONJ
dpc-5668	154	18	future	future	ADJ
dpc-5668	154	19	research	research	NOUN
dpc-5668	154	20	.	.	PUNCT
dpc-5668	155	1	for	for	ADP
dpc-5668	155	2	clinicians	clinician	NOUN
dpc-5668	155	3	,	,	PUNCT
dpc-5668	155	4	the	the	DET
dpc-5668	155	5	variability	variability	NOUN
dpc-5668	155	6	and	and	CCONJ
dpc-5668	155	7	potential	potential	ADJ
dpc-5668	155	8	biases	bias	NOUN
dpc-5668	155	9	in	in	ADP
dpc-5668	155	10	the	the	DET
dpc-5668	155	11	current	current	ADJ
dpc-5668	155	12	evidence	evidence	NOUN
dpc-5668	155	13	base	base	NOUN
dpc-5668	155	14	emphasize	emphasize	VERB
dpc-5668	155	15	the	the	DET
dpc-5668	155	16	need	need	NOUN
dpc-5668	155	17	for	for	ADP
dpc-5668	155	18	cautious	cautious	ADJ
dpc-5668	155	19	interpretation	interpretation	NOUN
dpc-5668	155	20	of	of	ADP
dpc-5668	155	21	studies	study	NOUN
dpc-5668	155	22	on	on	ADP
dpc-5668	155	23	impetigo	impetigo	NOUN
dpc-5668	155	24	treatments	treatment	NOUN
dpc-5668	155	25	.	.	PUNCT
dpc-5668	156	1	evidence	evidence	NOUN
dpc-5668	156	2	derived	derive	VERB
dpc-5668	156	3	from	from	ADP
dpc-5668	156	4	trials	trial	NOUN
dpc-5668	156	5	with	with	ADP
dpc-5668	156	6	a	a	DET
dpc-5668	156	7	high	high	ADJ
dpc-5668	156	8	risk	risk	NOUN
dpc-5668	156	9	of	of	ADP
dpc-5668	156	10	bias	bias	NOUN
dpc-5668	156	11	may	may	AUX
dpc-5668	156	12	not	not	PART
dpc-5668	156	13	accurately	accurately	ADV
dpc-5668	156	14	represent	represent	VERB
dpc-5668	156	15	the	the	DET
dpc-5668	156	16	true	true	ADJ
dpc-5668	156	17	efficacy	efficacy	NOUN
dpc-5668	156	18	and	and	CCONJ
dpc-5668	156	19	safety	safety	NOUN
dpc-5668	156	20	of	of	ADP
dpc-5668	156	21	pharmacological	pharmacological	ADJ
dpc-5668	156	22	interventions	intervention	NOUN
dpc-5668	156	23	,	,	PUNCT
dpc-5668	156	24	potentially	potentially	ADV
dpc-5668	156	25	leading	lead	VERB
dpc-5668	156	26	to	to	ADP
dpc-5668	156	27	suboptimal	suboptimal	ADJ
dpc-5668	156	28	treatment	treatment	NOUN
dpc-5668	156	29	decisions	decision	NOUN
dpc-5668	156	30	.	.	PUNCT
dpc-5668	157	1	for	for	ADP
dpc-5668	157	2	researchers	researcher	NOUN
dpc-5668	157	3	,	,	PUNCT
dpc-5668	157	4	these	these	DET
dpc-5668	157	5	findings	finding	NOUN
dpc-5668	157	6	highlight	highlight	VERB
dpc-5668	157	7	the	the	DET
dpc-5668	157	8	urgent	urgent	ADJ
dpc-5668	157	9	need	need	NOUN
dpc-5668	157	10	to	to	PART
dpc-5668	157	11	strengthen	strengthen	VERB
dpc-5668	157	12	methodological	methodological	ADJ
dpc-5668	157	13	rigor	rigor	NOUN
dpc-5668	157	14	in	in	ADP
dpc-5668	157	15	future	future	ADJ
dpc-5668	157	16	rcts	rct	NOUN
dpc-5668	157	17	.	.	PUNCT
dpc-5668	158	1	key	key	ADJ
dpc-5668	158	2	areas	area	NOUN
dpc-5668	158	3	for	for	ADP
dpc-5668	158	4	improvement	improvement	NOUN
dpc-5668	158	5	include	include	VERB
dpc-5668	158	6	robust	robust	ADJ
dpc-5668	158	7	randomization	randomization	NOUN
dpc-5668	158	8	procedures	procedure	NOUN
dpc-5668	158	9	,	,	PUNCT
dpc-5668	158	10	proper	proper	ADJ
dpc-5668	158	11	allocation	allocation	NOUN
dpc-5668	158	12	concealment	concealment	NOUN
dpc-5668	158	13	,	,	PUNCT
dpc-5668	158	14	adequate	adequate	ADJ
dpc-5668	158	15	blinding	blinding	NOUN
dpc-5668	158	16	,	,	PUNCT
dpc-5668	158	17	and	and	CCONJ
dpc-5668	158	18	appropriate	appropriate	ADJ
dpc-5668	158	19	handling	handling	NOUN
dpc-5668	158	20	of	of	ADP
dpc-5668	158	21	incomplete	incomplete	ADJ
dpc-5668	158	22	outcome	outcome	NOUN
dpc-5668	158	23	data	datum	NOUN
dpc-5668	158	24	.	.	PUNCT
dpc-5668	159	1	equally	equally	ADV
dpc-5668	159	2	important	important	ADJ
dpc-5668	159	3	is	be	AUX
dpc-5668	159	4	the	the	DET
dpc-5668	159	5	commitment	commitment	NOUN
dpc-5668	159	6	to	to	ADP
dpc-5668	159	7	transparency	transparency	NOUN
dpc-5668	159	8	through	through	ADP
dpc-5668	159	9	prospective	prospective	ADJ
dpc-5668	159	10	protocol	protocol	NOUN
dpc-5668	159	11	registration	registration	NOUN
dpc-5668	159	12	and	and	CCONJ
dpc-5668	159	13	adherence	adherence	NOUN
dpc-5668	159	14	to	to	ADP
dpc-5668	159	15	standardized	standardized	ADJ
dpc-5668	159	16	reporting	reporting	NOUN
dpc-5668	159	17	guidelines	guideline	NOUN
dpc-5668	159	18	.	.	PUNCT
dpc-5668	160	1	in	in	ADP
dpc-5668	160	2	this	this	DET
dpc-5668	160	3	context	context	NOUN
dpc-5668	160	4	,	,	PUNCT
dpc-5668	160	5	future	future	ADJ
dpc-5668	160	6	rcts	rct	NOUN
dpc-5668	160	7	should	should	AUX
dpc-5668	160	8	comply	comply	VERB
dpc-5668	160	9	with	with	ADP
dpc-5668	160	10	the	the	DET
dpc-5668	160	11	spirit	spirit	PROPN
dpc-5668	160	12	checklist	checklist	NOUN
dpc-5668	160	13	for	for	ADP
dpc-5668	160	14	comprehensive	comprehensive	ADJ
dpc-5668	160	15	and	and	CCONJ
dpc-5668	160	16	transparent	transparent	ADJ
dpc-5668	160	17	protocol	protocol	NOUN
dpc-5668	160	18	development	development	NOUN
dpc-5668	160	19	[	[	X
dpc-5668	160	20	47,48	47,48	NOUN
dpc-5668	160	21	]	]	X
dpc-5668	160	22	and	and	CCONJ
dpc-5668	160	23	the	the	DET
dpc-5668	160	24	consort	consort	NOUN
dpc-5668	160	25	statement	statement	NOUN
dpc-5668	160	26	to	to	PART
dpc-5668	160	27	ensure	ensure	VERB
dpc-5668	160	28	complete	complete	ADJ
dpc-5668	160	29	and	and	CCONJ
dpc-5668	160	30	accurate	accurate	ADJ
dpc-5668	160	31	reporting	reporting	NOUN
dpc-5668	160	32	of	of	ADP
dpc-5668	160	33	trial	trial	NOUN
dpc-5668	160	34	findings	finding	NOUN
dpc-5668	160	35	[	[	X
dpc-5668	160	36	49	49	NUM
dpc-5668	160	37	]	]	PUNCT
dpc-5668	160	38	,	,	PUNCT
dpc-5668	160	39	and	and	CCONJ
dpc-5668	160	40	they	they	PRON
dpc-5668	160	41	should	should	AUX
dpc-5668	160	42	incorporate	incorporate	VERB
dpc-5668	160	43	the	the	DET
dpc-5668	160	44	cochrane	cochrane	NOUN
dpc-5668	160	45	risk	risk	NOUN
dpc-5668	160	46	of	of	ADP
dpc-5668	160	47	bias	bias	NOUN
dpc-5668	160	48	tool	tool	NOUN
dpc-5668	160	49	to	to	PART
dpc-5668	160	50	guide	guide	VERB
dpc-5668	160	51	risk	risk	NOUN
dpc-5668	160	52	of	of	ADP
dpc-5668	160	53	bias	bias	NOUN
dpc-5668	160	54	assessment	assessment	NOUN
dpc-5668	160	55	and	and	CCONJ
dpc-5668	160	56	improve	improve	VERB
dpc-5668	160	57	internal	internal	ADJ
dpc-5668	160	58	validity	validity	NOUN
dpc-5668	160	59	[	[	X
dpc-5668	160	60	12	12	NUM
dpc-5668	160	61	]	]	PUNCT
dpc-5668	160	62	.	.	PUNCT
dpc-5668	161	1	these	these	DET
dpc-5668	161	2	practices	practice	NOUN
dpc-5668	161	3	are	be	AUX
dpc-5668	161	4	essential	essential	ADJ
dpc-5668	161	5	to	to	ADP
dpc-5668	161	6	enhancing	enhance	VERB
dpc-5668	161	7	the	the	DET
dpc-5668	161	8	credibility	credibility	NOUN
dpc-5668	161	9	,	,	PUNCT
dpc-5668	161	10	reproducibility	reproducibility	NOUN
dpc-5668	161	11	,	,	PUNCT
dpc-5668	161	12	and	and	CCONJ
dpc-5668	161	13	utility	utility	NOUN
dpc-5668	161	14	of	of	ADP
dpc-5668	161	15	clinical	clinical	ADJ
dpc-5668	161	16	research	research	NOUN
dpc-5668	161	17	on	on	ADP
dpc-5668	161	18	impetigo	impetigo	PROPN
dpc-5668	161	19	.	.	PUNCT
dpc-5668	162	1	ultimately	ultimately	ADV
dpc-5668	162	2	,	,	PUNCT
dpc-5668	162	3	improving	improve	VERB
dpc-5668	162	4	the	the	DET
dpc-5668	162	5	methodological	methodological	ADJ
dpc-5668	162	6	quality	quality	NOUN
dpc-5668	162	7	of	of	ADP
dpc-5668	162	8	trials	trial	NOUN
dpc-5668	162	9	will	will	AUX
dpc-5668	162	10	support	support	VERB
dpc-5668	162	11	more	more	ADV
dpc-5668	162	12	reliable	reliable	ADJ
dpc-5668	162	13	evidence	evidence	NOUN
dpc-5668	162	14	synthesis	synthesis	NOUN
dpc-5668	162	15	,	,	PUNCT
dpc-5668	162	16	inform	inform	VERB
dpc-5668	162	17	guideline	guideline	NOUN
dpc-5668	162	18	development	development	NOUN
dpc-5668	162	19	,	,	PUNCT
dpc-5668	162	20	and	and	CCONJ
dpc-5668	162	21	guide	guide	VERB
dpc-5668	162	22	decision	decision	NOUN
dpc-5668	162	23	-	-	PUNCT
dpc-5668	162	24	making	making	NOUN
dpc-5668	162	25	about	about	ADP
dpc-5668	162	26	which	which	PRON
dpc-5668	162	27	treatments	treatment	NOUN
dpc-5668	162	28	should	should	AUX
dpc-5668	162	29	be	be	AUX
dpc-5668	162	30	prioritized	prioritize	VERB
dpc-5668	162	31	,	,	PUNCT
dpc-5668	162	32	recommended	recommend	VERB
dpc-5668	162	33	,	,	PUNCT
dpc-5668	162	34	or	or	CCONJ
dpc-5668	162	35	funded	fund	VERB
dpc-5668	162	36	in	in	ADP
dpc-5668	162	37	clinical	clinical	ADJ
dpc-5668	162	38	practice	practice	NOUN
dpc-5668	162	39	.	.	PUNCT
dpc-5668	163	1	conclusion	conclusion	NOUN
dpc-5668	163	2	this	this	DET
dpc-5668	163	3	meta	meta	ADJ
dpc-5668	163	4	-	-	PUNCT
dpc-5668	163	5	research	research	NOUN
dpc-5668	163	6	study	study	NOUN
dpc-5668	163	7	evaluated	evaluate	VERB
dpc-5668	163	8	the	the	DET
dpc-5668	163	9	methodological	methodological	ADJ
dpc-5668	163	10	quality	quality	NOUN
dpc-5668	163	11	of	of	ADP
dpc-5668	163	12	21	21	NUM
dpc-5668	163	13	rcts	rct	NOUN
dpc-5668	163	14	on	on	ADP
dpc-5668	163	15	pharmacological	pharmacological	ADJ
dpc-5668	163	16	treatments	treatment	NOUN
dpc-5668	163	17	for	for	ADP
dpc-5668	163	18	impetigo	impetigo	PROPN
dpc-5668	163	19	.	.	PUNCT
dpc-5668	164	1	the	the	DET
dpc-5668	164	2	findings	finding	NOUN
dpc-5668	164	3	identified	identify	VERB
dpc-5668	164	4	critical	critical	ADJ
dpc-5668	164	5	areas	area	NOUN
dpc-5668	164	6	of	of	ADP
dpc-5668	164	7	concern	concern	NOUN
dpc-5668	164	8	:	:	PUNCT
dpc-5668	164	9	i	i	NOUN
dpc-5668	164	10	)	)	PUNCT
dpc-5668	164	11	53	53	NUM
dpc-5668	164	12	%	%	NOUN
dpc-5668	164	13	to	to	ADP
dpc-5668	164	14	57	57	NUM
dpc-5668	164	15	%	%	NOUN
dpc-5668	164	16	of	of	ADP
dpc-5668	164	17	rcts	rct	NOUN
dpc-5668	164	18	had	have	VERB
dpc-5668	164	19	an	an	DET
dpc-5668	164	20	unclear	unclear	ADJ
dpc-5668	164	21	risk	risk	NOUN
dpc-5668	164	22	of	of	ADP
dpc-5668	164	23	selection	selection	NOUN
dpc-5668	164	24	bias	bias	NOUN
dpc-5668	164	25	due	due	ADP
dpc-5668	164	26	to	to	ADP
dpc-5668	164	27	insufficient	insufficient	ADJ
dpc-5668	164	28	information	information	NOUN
dpc-5668	164	29	on	on	ADP
dpc-5668	164	30	randomization	randomization	NOUN
dpc-5668	164	31	and	and	CCONJ
dpc-5668	164	32	allocation	allocation	NOUN
dpc-5668	164	33	concealment	concealment	NOUN
dpc-5668	164	34	;	;	PUNCT
dpc-5668	164	35	ii	ii	X
dpc-5668	164	36	)	)	PUNCT
dpc-5668	164	37	71	71	NUM
dpc-5668	164	38	%	%	NOUN
dpc-5668	164	39	were	be	AUX
dpc-5668	164	40	at	at	ADP
dpc-5668	164	41	high	high	ADJ
dpc-5668	164	42	risk	risk	NOUN
dpc-5668	164	43	of	of	ADP
dpc-5668	164	44	bias	bias	NOUN
dpc-5668	164	45	for	for	ADP
dpc-5668	164	46	blinding	blinding	NOUN
dpc-5668	164	47	of	of	ADP
dpc-5668	164	48	participants	participant	NOUN
dpc-5668	164	49	and	and	CCONJ
dpc-5668	164	50	personnel	personnel	NOUN
dpc-5668	164	51	,	,	PUNCT
dpc-5668	164	52	while	while	SCONJ
dpc-5668	164	53	57	57	NUM
dpc-5668	164	54	%	%	NOUN
dpc-5668	164	55	had	have	VERB
dpc-5668	164	56	a	a	DET
dpc-5668	164	57	high	high	ADJ
dpc-5668	164	58	risk	risk	NOUN
dpc-5668	164	59	of	of	ADP
dpc-5668	164	60	blinding	blinding	NOUN
dpc-5668	164	61	of	of	ADP
dpc-5668	164	62	outcome	outcome	NOUN
dpc-5668	164	63	assessors	assessor	NOUN
dpc-5668	164	64	;	;	PUNCT
dpc-5668	164	65	iii	iii	X
dpc-5668	164	66	)	)	PUNCT
dpc-5668	164	67	24	24	NUM
dpc-5668	164	68	%	%	NOUN
dpc-5668	164	69	exhibited	exhibit	VERB
dpc-5668	164	70	a	a	DET
dpc-5668	164	71	high	high	ADJ
dpc-5668	164	72	risk	risk	NOUN
dpc-5668	164	73	over	over	ADP
dpc-5668	164	74	70	70	NUM
dpc-5668	164	75	%	%	NOUN
dpc-5668	164	76	of	of	ADP
dpc-5668	164	77	the	the	DET
dpc-5668	164	78	rcts	rct	NOUN
dpc-5668	164	79	were	be	AUX
dpc-5668	164	80	classified	classify	VERB
dpc-5668	164	81	as	as	ADP
dpc-5668	164	82	having	have	VERB
dpc-5668	164	83	a	a	DET
dpc-5668	164	84	low	low	ADJ
dpc-5668	164	85	risk	risk	NOUN
dpc-5668	164	86	of	of	ADP
dpc-5668	164	87	bias	bias	NOUN
dpc-5668	164	88	regarding	regard	VERB
dpc-5668	164	89	participant	participant	ADJ
dpc-5668	164	90	losses	loss	NOUN
dpc-5668	164	91	or	or	CCONJ
dpc-5668	164	92	withdrawals	withdrawal	NOUN
dpc-5668	164	93	during	during	ADP
dpc-5668	164	94	study	study	NOUN
dpc-5668	164	95	follow	follow	NOUN
dpc-5668	164	96	-	-	PUNCT
dpc-5668	164	97	up	up	NOUN
dpc-5668	164	98	.	.	PUNCT
dpc-5668	165	1	incomplete	incomplete	ADJ
dpc-5668	165	2	outcome	outcome	NOUN
dpc-5668	165	3	data	datum	NOUN
dpc-5668	165	4	can	can	AUX
dpc-5668	165	5	compromise	compromise	VERB
dpc-5668	165	6	the	the	DET
dpc-5668	165	7	validity	validity	NOUN
dpc-5668	165	8	of	of	ADP
dpc-5668	165	9	the	the	DET
dpc-5668	165	10	results	result	NOUN
dpc-5668	165	11	and	and	CCONJ
dpc-5668	165	12	introduce	introduce	VERB
dpc-5668	165	13	bias	bias	NOUN
dpc-5668	165	14	if	if	SCONJ
dpc-5668	165	15	not	not	PART
dpc-5668	165	16	adequately	adequately	ADV
dpc-5668	165	17	managed	manage	VERB
dpc-5668	165	18	.	.	PUNCT
dpc-5668	166	1	it	it	PRON
dpc-5668	166	2	is	be	AUX
dpc-5668	166	3	crucial	crucial	ADJ
dpc-5668	166	4	that	that	SCONJ
dpc-5668	166	5	future	future	ADJ
dpc-5668	166	6	studies	study	NOUN
dpc-5668	166	7	employ	employ	VERB
dpc-5668	166	8	rigorous	rigorous	ADJ
dpc-5668	166	9	methods	method	NOUN
dpc-5668	166	10	for	for	ADP
dpc-5668	166	11	dealing	deal	VERB
dpc-5668	166	12	with	with	ADP
dpc-5668	166	13	missing	miss	VERB
dpc-5668	166	14	data	datum	NOUN
dpc-5668	166	15	and	and	CCONJ
dpc-5668	166	16	that	that	SCONJ
dpc-5668	166	17	they	they	PRON
dpc-5668	166	18	provide	provide	VERB
dpc-5668	166	19	transparent	transparent	ADJ
dpc-5668	166	20	reporting	reporting	NOUN
dpc-5668	166	21	to	to	PART
dpc-5668	166	22	allow	allow	VERB
dpc-5668	166	23	for	for	ADP
dpc-5668	166	24	accurate	accurate	ADJ
dpc-5668	166	25	assessments	assessment	NOUN
dpc-5668	166	26	of	of	ADP
dpc-5668	166	27	treatment	treatment	NOUN
dpc-5668	166	28	efficacy	efficacy	NOUN
dpc-5668	166	29	[	[	X
dpc-5668	166	30	39	39	NUM
dpc-5668	166	31	]	]	PUNCT
dpc-5668	166	32	.	.	PUNCT
dpc-5668	167	1	finally	finally	ADV
dpc-5668	167	2	,	,	PUNCT
dpc-5668	167	3	regarding	regard	VERB
dpc-5668	167	4	selective	selective	ADJ
dpc-5668	167	5	reporting	reporting	NOUN
dpc-5668	167	6	bias	bias	NOUN
dpc-5668	167	7	,	,	PUNCT
dpc-5668	167	8	81	81	NUM
dpc-5668	167	9	%	%	NOUN
dpc-5668	167	10	of	of	ADP
dpc-5668	167	11	the	the	DET
dpc-5668	167	12	evaluated	evaluated	ADJ
dpc-5668	167	13	rcts	rct	NOUN
dpc-5668	167	14	were	be	AUX
dpc-5668	167	15	classified	classify	VERB
dpc-5668	167	16	as	as	ADP
dpc-5668	167	17	having	have	VERB
dpc-5668	167	18	unclear	unclear	ADJ
dpc-5668	167	19	risk	risk	NOUN
dpc-5668	167	20	of	of	ADP
dpc-5668	167	21	bias	bias	NOUN
dpc-5668	167	22	,	,	PUNCT
dpc-5668	167	23	mainly	mainly	ADV
dpc-5668	167	24	due	due	ADP
dpc-5668	167	25	to	to	ADP
dpc-5668	167	26	the	the	DET
dpc-5668	167	27	lack	lack	NOUN
dpc-5668	167	28	of	of	ADP
dpc-5668	167	29	prospective	prospective	ADJ
dpc-5668	167	30	protocol	protocol	NOUN
dpc-5668	167	31	registration	registration	NOUN
dpc-5668	167	32	.	.	PUNCT
dpc-5668	168	1	the	the	DET
dpc-5668	168	2	absence	absence	NOUN
dpc-5668	168	3	of	of	ADP
dpc-5668	168	4	a	a	DET
dpc-5668	168	5	publicly	publicly	ADV
dpc-5668	168	6	available	available	ADJ
dpc-5668	168	7	protocol	protocol	NOUN
dpc-5668	168	8	compromises	compromise	VERB
dpc-5668	168	9	the	the	DET
dpc-5668	168	10	ability	ability	NOUN
dpc-5668	168	11	to	to	PART
dpc-5668	168	12	verify	verify	VERB
dpc-5668	168	13	whether	whether	SCONJ
dpc-5668	168	14	predefined	predefine	VERB
dpc-5668	168	15	outcomes	outcome	NOUN
dpc-5668	168	16	were	be	AUX
dpc-5668	168	17	altered	alter	VERB
dpc-5668	168	18	,	,	PUNCT
dpc-5668	168	19	selectively	selectively	ADV
dpc-5668	168	20	reported	report	VERB
dpc-5668	168	21	,	,	PUNCT
dpc-5668	168	22	or	or	CCONJ
dpc-5668	168	23	omitted	omit	VERB
dpc-5668	168	24	,	,	PUNCT
dpc-5668	168	25	which	which	PRON
dpc-5668	168	26	may	may	AUX
dpc-5668	168	27	distort	distort	VERB
dpc-5668	168	28	study	study	NOUN
dpc-5668	168	29	conclusions	conclusion	NOUN
dpc-5668	168	30	by	by	ADP
dpc-5668	168	31	overestimating	overestimate	VERB
dpc-5668	168	32	benefits	benefit	NOUN
dpc-5668	168	33	or	or	CCONJ
dpc-5668	168	34	underestimating	underestimate	VERB
dpc-5668	168	35	harms	harm	NOUN
dpc-5668	168	36	.	.	PUNCT
dpc-5668	169	1	this	this	DET
dpc-5668	169	2	issue	issue	NOUN
dpc-5668	169	3	is	be	AUX
dpc-5668	169	4	particularly	particularly	ADV
dpc-5668	169	5	critical	critical	ADJ
dpc-5668	169	6	in	in	ADP
dpc-5668	169	7	impetigo	impetigo	ADJ
dpc-5668	169	8	clinical	clinical	ADJ
dpc-5668	169	9	trials	trial	NOUN
dpc-5668	169	10	,	,	PUNCT
dpc-5668	169	11	in	in	ADP
dpc-5668	169	12	which	which	PRON
dpc-5668	169	13	outcomes	outcome	NOUN
dpc-5668	169	14	are	be	AUX
dpc-5668	169	15	largely	largely	ADV
dpc-5668	169	16	subjective	subjective	ADJ
dpc-5668	169	17	and	and	CCONJ
dpc-5668	169	18	prone	prone	ADJ
dpc-5668	169	19	to	to	PART
dpc-5668	169	20	bias	bias	VERB
dpc-5668	169	21	.	.	PUNCT
dpc-5668	170	1	mandatory	mandatory	ADJ
dpc-5668	170	2	prospective	prospective	ADJ
dpc-5668	170	3	registration	registration	NOUN
dpc-5668	170	4	of	of	ADP
dpc-5668	170	5	clinical	clinical	ADJ
dpc-5668	170	6	trials	trial	NOUN
dpc-5668	170	7	in	in	ADP
dpc-5668	170	8	international	international	ADJ
dpc-5668	170	9	registries	registry	NOUN
dpc-5668	170	10	such	such	ADJ
dpc-5668	170	11	as	as	ADP
dpc-5668	170	12	clinicaltrials.gov	clinicaltrials.gov	NOUN
dpc-5668	170	13	and	and	CCONJ
dpc-5668	170	14	the	the	PRON
dpc-5668	170	15	who	who	PRON
dpc-5668	170	16	ictrp	ictrp	VERB
dpc-5668	170	17	should	should	AUX
dpc-5668	170	18	be	be	AUX
dpc-5668	170	19	strictly	strictly	ADV
dpc-5668	170	20	enforced	enforce	VERB
dpc-5668	170	21	to	to	PART
dpc-5668	170	22	mitigate	mitigate	VERB
dpc-5668	170	23	this	this	DET
dpc-5668	170	24	bias	bias	NOUN
dpc-5668	170	25	.	.	PUNCT
dpc-5668	171	1	this	this	DET
dpc-5668	171	2	practice	practice	NOUN
dpc-5668	171	3	is	be	AUX
dpc-5668	171	4	widely	widely	ADV
dpc-5668	171	5	recognized	recognize	VERB
dpc-5668	171	6	as	as	ADP
dpc-5668	171	7	an	an	DET
dpc-5668	171	8	essential	essential	ADJ
dpc-5668	171	9	safeguard	safeguard	NOUN
dpc-5668	171	10	for	for	ADP
dpc-5668	171	11	research	research	NOUN
dpc-5668	171	12	integrity	integrity	NOUN
dpc-5668	171	13	,	,	PUNCT
dpc-5668	171	14	as	as	SCONJ
dpc-5668	171	15	it	it	PRON
dpc-5668	171	16	increases	increase	VERB
dpc-5668	171	17	transparency	transparency	NOUN
dpc-5668	171	18	,	,	PUNCT
dpc-5668	171	19	reduces	reduce	VERB
dpc-5668	171	20	reporting	reporting	NOUN
dpc-5668	171	21	bias	bias	NOUN
dpc-5668	171	22	,	,	PUNCT
dpc-5668	171	23	and	and	CCONJ
dpc-5668	171	24	ensures	ensure	VERB
dpc-5668	171	25	that	that	SCONJ
dpc-5668	171	26	all	all	DET
dpc-5668	171	27	prespecified	prespecified	ADJ
dpc-5668	171	28	results	result	NOUN
dpc-5668	171	29	are	be	AUX
dpc-5668	171	30	publicly	publicly	ADV
dpc-5668	171	31	accessible	accessible	ADJ
dpc-5668	171	32	for	for	ADP
dpc-5668	171	33	verification	verification	NOUN
dpc-5668	171	34	[	[	X
dpc-5668	171	35	40	40	NUM
dpc-5668	171	36	-	-	SYM
dpc-5668	171	37	42	42	NUM
dpc-5668	171	38	]	]	PUNCT
dpc-5668	171	39	.	.	PUNCT
dpc-5668	172	1	the	the	DET
dpc-5668	172	2	methodological	methodological	ADJ
dpc-5668	172	3	weaknesses	weakness	NOUN
dpc-5668	172	4	identified	identify	VERB
dpc-5668	172	5	in	in	ADP
dpc-5668	172	6	the	the	DET
dpc-5668	172	7	included	include	VERB
dpc-5668	172	8	rcts	rct	NOUN
dpc-5668	172	9	are	be	AUX
dpc-5668	172	10	consistent	consistent	ADJ
dpc-5668	172	11	with	with	ADP
dpc-5668	172	12	patterns	pattern	NOUN
dpc-5668	172	13	observed	observe	VERB
dpc-5668	172	14	in	in	ADP
dpc-5668	172	15	dermatology	dermatology	NOUN
dpc-5668	172	16	research	research	NOUN
dpc-5668	172	17	.	.	PUNCT
dpc-5668	173	1	a	a	DET
dpc-5668	173	2	meta	meta	ADJ
dpc-5668	173	3	-	-	PUNCT
dpc-5668	173	4	research	research	NOUN
dpc-5668	173	5	study	study	NOUN
dpc-5668	173	6	[	[	X
dpc-5668	173	7	42	42	NUM
dpc-5668	173	8	]	]	PUNCT
dpc-5668	173	9	assessed	assess	VERB
dpc-5668	173	10	dermatological	dermatological	ADJ
dpc-5668	173	11	rcts	rct	NOUN
dpc-5668	173	12	included	include	VERB
dpc-5668	173	13	in	in	ADP
dpc-5668	173	14	cochrane	cochrane	NOUN
dpc-5668	173	15	reviews	review	NOUN
dpc-5668	173	16	and	and	CCONJ
dpc-5668	173	17	reported	report	VERB
dpc-5668	173	18	a	a	DET
dpc-5668	173	19	high	high	ADJ
dpc-5668	173	20	prevalence	prevalence	NOUN
dpc-5668	173	21	of	of	ADP
dpc-5668	173	22	unclear	unclear	ADJ
dpc-5668	173	23	risk	risk	NOUN
dpc-5668	173	24	of	of	ADP
dpc-5668	173	25	bias	bias	NOUN
dpc-5668	173	26	,	,	PUNCT
dpc-5668	173	27	particularly	particularly	ADV
dpc-5668	173	28	for	for	ADP
dpc-5668	173	29	allocation	allocation	NOUN
dpc-5668	173	30	concealment	concealment	NOUN
dpc-5668	173	31	(	(	PUNCT
dpc-5668	173	32	79	79	NUM
dpc-5668	173	33	%	%	NOUN
dpc-5668	173	34	)	)	PUNCT
dpc-5668	173	35	and	and	CCONJ
dpc-5668	173	36	random	random	ADJ
dpc-5668	173	37	sequence	sequence	NOUN
dpc-5668	173	38	generation	generation	NOUN
dpc-5668	173	39	(	(	PUNCT
dpc-5668	173	40	64	64	NUM
dpc-5668	173	41	%	%	NOUN
dpc-5668	173	42	)	)	PUNCT
dpc-5668	173	43	,	,	PUNCT
dpc-5668	173	44	which	which	PRON
dpc-5668	173	45	closely	closely	ADV
dpc-5668	173	46	reflects	reflect	VERB
dpc-5668	173	47	the	the	DET
dpc-5668	173	48	findings	finding	NOUN
dpc-5668	173	49	of	of	ADP
dpc-5668	173	50	our	our	PRON
dpc-5668	173	51	study	study	NOUN
dpc-5668	173	52	.	.	PUNCT
dpc-5668	174	1	similarly	similarly	ADV
dpc-5668	174	2	,	,	PUNCT
dpc-5668	174	3	another	another	DET
dpc-5668	174	4	recent	recent	ADJ
dpc-5668	174	5	meta	meta	ADJ
dpc-5668	174	6	-	-	PUNCT
dpc-5668	174	7	research	research	NOUN
dpc-5668	174	8	study	study	NOUN
dpc-5668	174	9	[	[	X
dpc-5668	174	10	43	43	NUM
dpc-5668	174	11	]	]	PUNCT
dpc-5668	174	12	evaluating	evaluate	VERB
dpc-5668	174	13	systematic	systematic	ADJ
dpc-5668	174	14	reviews	review	NOUN
dpc-5668	174	15	of	of	ADP
dpc-5668	174	16	rcts	rct	NOUN
dpc-5668	174	17	on	on	ADP
dpc-5668	174	18	vesiculobullous	vesiculobullous	ADJ
dpc-5668	174	19	skin	skin	NOUN
dpc-5668	174	20	diseases	disease	NOUN
dpc-5668	174	21	found	find	VERB
dpc-5668	174	22	that	that	SCONJ
dpc-5668	174	23	over	over	ADP
dpc-5668	174	24	half	half	NOUN
dpc-5668	174	25	(	(	PUNCT
dpc-5668	174	26	55.5	55.5	NUM
dpc-5668	174	27	%	%	NOUN
dpc-5668	174	28	)	)	PUNCT
dpc-5668	174	29	of	of	ADP
dpc-5668	174	30	the	the	DET
dpc-5668	174	31	reviews	review	NOUN
dpc-5668	174	32	were	be	AUX
dpc-5668	174	33	rated	rate	VERB
dpc-5668	174	34	as	as	ADP
dpc-5668	174	35	critically	critically	ADV
dpc-5668	174	36	low	low	ADJ
dpc-5668	174	37	quality	quality	NOUN
dpc-5668	174	38	according	accord	VERB
dpc-5668	174	39	to	to	ADP
dpc-5668	174	40	the	the	DET
dpc-5668	174	41	amstar-2	amstar-2	NUM
dpc-5668	174	42	tool	tool	NOUN
dpc-5668	174	43	assessment	assessment	NOUN
dpc-5668	174	44	.	.	PUNCT
dpc-5668	175	1	this	this	PRON
dpc-5668	175	2	reinforces	reinforce	VERB
dpc-5668	175	3	that	that	SCONJ
dpc-5668	175	4	the	the	DET
dpc-5668	175	5	methodological	methodological	ADJ
dpc-5668	175	6	limitations	limitation	NOUN
dpc-5668	175	7	observed	observe	VERB
dpc-5668	175	8	in	in	ADP
dpc-5668	175	9	impetigo	impetigo	NOUN
dpc-5668	175	10	trials	trial	NOUN
dpc-5668	175	11	are	be	AUX
dpc-5668	175	12	not	not	PART
dpc-5668	175	13	isolated	isolate	VERB
dpc-5668	175	14	but	but	CCONJ
dpc-5668	175	15	are	be	AUX
dpc-5668	175	16	part	part	NOUN
dpc-5668	175	17	of	of	ADP
dpc-5668	175	18	a	a	DET
dpc-5668	175	19	widespread	widespread	ADJ
dpc-5668	175	20	challenge	challenge	NOUN
dpc-5668	175	21	.	.	PUNCT
dpc-5668	176	1	this	this	DET
dpc-5668	176	2	meta	meta	ADJ
dpc-5668	176	3	-	-	PUNCT
dpc-5668	176	4	research	research	NOUN
dpc-5668	176	5	study	study	NOUN
dpc-5668	176	6	has	have	VERB
dpc-5668	176	7	some	some	DET
dpc-5668	176	8	limitations	limitation	NOUN
dpc-5668	176	9	that	that	PRON
dpc-5668	176	10	should	should	AUX
dpc-5668	176	11	be	be	AUX
dpc-5668	176	12	acknowledged	acknowledge	VERB
dpc-5668	176	13	.	.	PUNCT
dpc-5668	177	1	first	first	ADV
dpc-5668	177	2	,	,	PUNCT
dpc-5668	177	3	although	although	SCONJ
dpc-5668	177	4	a	a	DET
dpc-5668	177	5	comprehensive	comprehensive	ADJ
dpc-5668	177	6	literature	literature	NOUN
dpc-5668	177	7	search	search	NOUN
dpc-5668	177	8	was	be	AUX
dpc-5668	177	9	conducted	conduct	VERB
dpc-5668	177	10	,	,	PUNCT
dpc-5668	177	11	the	the	DET
dpc-5668	177	12	possibility	possibility	NOUN
dpc-5668	177	13	of	of	ADP
dpc-5668	177	14	missing	miss	VERB
dpc-5668	177	15	relevant	relevant	ADJ
dpc-5668	177	16	studies	study	NOUN
dpc-5668	177	17	can	can	AUX
dpc-5668	177	18	not	not	PART
dpc-5668	177	19	be	be	AUX
dpc-5668	177	20	entirely	entirely	ADV
dpc-5668	177	21	excluded	exclude	VERB
dpc-5668	177	22	.	.	PUNCT
dpc-5668	178	1	second	second	ADJ
dpc-5668	178	2	,	,	PUNCT
dpc-5668	178	3	the	the	DET
dpc-5668	178	4	risk	risk	NOUN
dpc-5668	178	5	of	of	ADP
dpc-5668	178	6	bias	bias	NOUN
dpc-5668	178	7	assessment	assessment	NOUN
dpc-5668	178	8	depended	depend	VERB
dpc-5668	178	9	on	on	ADP
dpc-5668	178	10	the	the	DET
dpc-5668	178	11	quality	quality	NOUN
dpc-5668	178	12	and	and	CCONJ
dpc-5668	178	13	completeness	completeness	NOUN
dpc-5668	178	14	of	of	ADP
dpc-5668	178	15	the	the	DET
dpc-5668	178	16	reports	report	NOUN
dpc-5668	178	17	provided	provide	VERB
dpc-5668	178	18	by	by	ADP
dpc-5668	178	19	the	the	DET
dpc-5668	178	20	original	original	ADJ
dpc-5668	178	21	studies	study	NOUN
dpc-5668	178	22	.	.	PUNCT
dpc-5668	179	1	third	third	ADJ
dpc-5668	179	2	,	,	PUNCT
dpc-5668	179	3	the	the	DET
dpc-5668	179	4	wide	wide	ADJ
dpc-5668	179	5	confidence	confidence	NOUN
dpc-5668	179	6	intervals	interval	NOUN
dpc-5668	179	7	observed	observe	VERB
dpc-5668	179	8	in	in	ADP
dpc-5668	179	9	some	some	DET
dpc-5668	179	10	risk	risk	NOUN
dpc-5668	179	11	of	of	ADP
dpc-5668	179	12	bias	bias	NOUN
dpc-5668	179	13	domains	domain	NOUN
dpc-5668	179	14	reflect	reflect	VERB
dpc-5668	179	15	the	the	DET
dpc-5668	179	16	uncertainty	uncertainty	NOUN
dpc-5668	179	17	associated	associate	VERB
dpc-5668	179	18	with	with	ADP
dpc-5668	179	19	the	the	DET
dpc-5668	179	20	relatively	relatively	ADV
dpc-5668	179	21	small	small	ADJ
dpc-5668	179	22	number	number	NOUN
dpc-5668	179	23	of	of	ADP
dpc-5668	179	24	included	include	VERB
dpc-5668	179	25	trials	trial	NOUN
dpc-5668	179	26	.	.	PUNCT
dpc-5668	180	1	another	another	DET
dpc-5668	180	2	important	important	ADJ
dpc-5668	180	3	consideration	consideration	NOUN
dpc-5668	180	4	in	in	ADP
dpc-5668	180	5	our	our	PRON
dpc-5668	180	6	study	study	NOUN
dpc-5668	180	7	was	be	AUX
dpc-5668	180	8	the	the	DET
dpc-5668	180	9	choice	choice	NOUN
dpc-5668	180	10	of	of	ADP
dpc-5668	180	11	the	the	DET
dpc-5668	180	12	cochrane	cochrane	NOUN
dpc-5668	180	13	risk	risk	NOUN
dpc-5668	180	14	of	of	ADP
dpc-5668	180	15	bias	bias	NOUN
dpc-5668	180	16	tool	tool	NOUN
dpc-5668	180	17	version	version	PROPN
dpc-5668	180	18	1.0	1.0	NUM
dpc-5668	180	19	rather	rather	ADV
dpc-5668	180	20	than	than	ADP
dpc-5668	180	21	the	the	DET
dpc-5668	180	22	updated	update	VERB
dpc-5668	180	23	version	version	NOUN
dpc-5668	180	24	2.0	2.0	NUM
dpc-5668	180	25	.	.	PUNCT
dpc-5668	181	1	despite	despite	SCONJ
dpc-5668	181	2	the	the	DET
dpc-5668	181	3	methodological	methodological	ADJ
dpc-5668	181	4	improvements	improvement	NOUN
dpc-5668	181	5	introduced	introduce	VERB
dpc-5668	181	6	by	by	ADP
dpc-5668	181	7	rob	rob	PROPN
dpc-5668	181	8	2.0	2.0	NUM
dpc-5668	181	9	,	,	PUNCT
dpc-5668	181	10	particularly	particularly	ADV
dpc-5668	181	11	its	its	PRON
dpc-5668	181	12	outcome	outcome	NOUN
dpc-5668	181	13	-	-	PUNCT
dpc-5668	181	14	level	level	NOUN
dpc-5668	181	15	assessment	assessment	NOUN
dpc-5668	181	16	framework	framework	NOUN
dpc-5668	181	17	,	,	PUNCT
dpc-5668	181	18	the	the	DET
dpc-5668	181	19	choice	choice	NOUN
dpc-5668	181	20	to	to	PART
dpc-5668	181	21	use	use	VERB
dpc-5668	181	22	rob	rob	PROPN
dpc-5668	181	23	review	review	NOUN
dpc-5668	181	24	|	|	ADV
dpc-5668	181	25	dermatol	dermatol	ADJ
dpc-5668	181	26	pract	pract	NOUN
dpc-5668	181	27	concept	concept	NOUN
dpc-5668	181	28	.	.	PUNCT
dpc-5668	182	1	2025;15(4):5668	2025;15(4):5668	NUM
dpc-5668	182	2	9	9	NUM
dpc-5668	182	3	guideline	guideline	NOUN
dpc-5668	182	4	for	for	ADP
dpc-5668	182	5	reporting	report	VERB
dpc-5668	182	6	systematic	systematic	ADJ
dpc-5668	182	7	reviews	review	NOUN
dpc-5668	182	8	.	.	PUNCT
dpc-5668	183	1	bmj	bmj	PROPN
dpc-5668	184	1	[	[	X
dpc-5668	184	2	internet	internet	NOUN
dpc-5668	184	3	]	]	PUNCT
dpc-5668	184	4	.	.	PUNCT
dpc-5668	185	1	2021	2021	NUM
dpc-5668	185	2	march	march	PROPN
dpc-5668	185	3	29th;372	29th;372	NUM
dpc-5668	185	4	.	.	PUNCT
dpc-5668	185	5	available	available	ADJ
dpc-5668	185	6	from	from	ADP
dpc-5668	185	7	:	:	PUNCT
dpc-5668	185	8	https://www.bmj.com/content/372/bmj.n71	https://www.bmj.com/content/372/bmj.n71	X
dpc-5668	185	9	.	.	PUNCT
dpc-5668	186	1	doi	doi	NOUN
dpc-5668	186	2	:	:	PUNCT
dpc-5668	186	3	10.1136	10.1136	NUM
dpc-5668	186	4	/	/	SYM
dpc-5668	186	5	bmj.n71	bmj.n71	NOUN
dpc-5668	186	6	.	.	PUNCT
dpc-5668	187	1	pmid	pmid	NOUN
dpc-5668	187	2	:	:	PUNCT
dpc-5668	187	3	33782057	33782057	NUM
dpc-5668	187	4	11	11	NUM
dpc-5668	187	5	.	.	PUNCT
dpc-5668	188	1	ouzzani	ouzzani	PROPN
dpc-5668	188	2	m	m	PROPN
dpc-5668	188	3	,	,	PUNCT
dpc-5668	188	4	hammady	hammady	PROPN
dpc-5668	188	5	h	h	NOUN
dpc-5668	188	6	,	,	PUNCT
dpc-5668	188	7	fedorowicz	fedorowicz	PROPN
dpc-5668	188	8	z	z	NOUN
dpc-5668	188	9	,	,	PUNCT
dpc-5668	188	10	elmagarmid	elmagarmid	PROPN
dpc-5668	188	11	a.	a.	PROPN
dpc-5668	188	12	rayyan	rayyan	PROPN
dpc-5668	188	13	—	—	PUNCT
dpc-5668	188	14	a	a	DET
dpc-5668	188	15	web	web	NOUN
dpc-5668	188	16	and	and	CCONJ
dpc-5668	188	17	mobile	mobile	ADJ
dpc-5668	188	18	app	app	NOUN
dpc-5668	188	19	for	for	ADP
dpc-5668	188	20	systematic	systematic	ADJ
dpc-5668	188	21	reviews	review	NOUN
dpc-5668	188	22	.	.	PUNCT
dpc-5668	189	1	syst	syst	PROPN
dpc-5668	189	2	rev	rev	PROPN
dpc-5668	189	3	.	.	PROPN
dpc-5668	189	4	2016	2016	NUM
dpc-5668	189	5	dec;5(1):210	dec;5(1):210	PROPN
dpc-5668	189	6	.	.	PUNCT
dpc-5668	190	1	doi	doi	PROPN
dpc-5668	190	2	:	:	PUNCT
dpc-5668	190	3	10.1186	10.1186	NUM
dpc-5668	190	4	/	/	SYM
dpc-5668	190	5	s13643	s13643	PROPN
dpc-5668	190	6	-	-	PUNCT
dpc-5668	190	7	016	016	NUM
dpc-5668	190	8	-	-	PUNCT
dpc-5668	190	9	0384	0384	NUM
dpc-5668	190	10	-	-	SYM
dpc-5668	190	11	4	4	NUM
dpc-5668	190	12	.	.	PUNCT
dpc-5668	191	1	pmid	pmid	NOUN
dpc-5668	191	2	:	:	PUNCT
dpc-5668	191	3	27919275	27919275	NUM
dpc-5668	191	4	12	12	NUM
dpc-5668	191	5	.	.	PUNCT
dpc-5668	192	1	higgins	higgins	PROPN
dpc-5668	192	2	jpt	jpt	PROPN
dpc-5668	192	3	,	,	PUNCT
dpc-5668	192	4	green	green	PROPN
dpc-5668	192	5	s	s	PROPN
dpc-5668	192	6	,	,	PUNCT
dpc-5668	192	7	editors	editor	NOUN
dpc-5668	192	8	.	.	PUNCT
dpc-5668	193	1	cochrane	cochrane	NOUN
dpc-5668	193	2	handbook	handbook	NOUN
dpc-5668	193	3	for	for	ADP
dpc-5668	193	4	systematic	systematic	ADJ
dpc-5668	193	5	reviews	review	NOUN
dpc-5668	193	6	of	of	ADP
dpc-5668	193	7	interventions	intervention	NOUN
dpc-5668	193	8	version	version	NOUN
dpc-5668	194	1	5.1.0	5.1.0	PROPN
dpc-5668	195	1	[	[	X
dpc-5668	195	2	updated	update	VERB
dpc-5668	195	3	march	march	NOUN
dpc-5668	195	4	2011	2011	NUM
dpc-5668	195	5	]	]	PUNCT
dpc-5668	195	6	.	.	PUNCT
dpc-5668	196	1	the	the	DET
dpc-5668	196	2	cochrane	cochrane	PROPN
dpc-5668	196	3	collaboration	collaboration	NOUN
dpc-5668	196	4	;	;	PUNCT
dpc-5668	196	5	2011	2011	NUM
dpc-5668	196	6	[	[	X
dpc-5668	196	7	cited	cite	VERB
dpc-5668	196	8	2024	2024	NUM
dpc-5668	196	9	august	august	NOUN
dpc-5668	196	10	24th	24th	NOUN
dpc-5668	196	11	]	]	PUNCT
dpc-5668	196	12	.	.	PUNCT
dpc-5668	197	1	available	available	ADJ
dpc-5668	197	2	from	from	ADP
dpc-5668	197	3	:	:	PUNCT
dpc-5668	197	4	www.cochrane-handbook.org	www.cochrane-handbook.org	PROPN
dpc-5668	197	5	13	13	NUM
dpc-5668	197	6	.	.	PUNCT
dpc-5668	198	1	burnett	burnett	PROPN
dpc-5668	198	2	jw	jw	PROPN
dpc-5668	198	3	.	.	PUNCT
dpc-5668	199	1	the	the	DET
dpc-5668	199	2	route	route	NOUN
dpc-5668	199	3	of	of	ADP
dpc-5668	199	4	antibiotic	antibiotic	ADJ
dpc-5668	199	5	administration	administration	NOUN
dpc-5668	199	6	in	in	ADP
dpc-5668	199	7	superficial	superficial	ADJ
dpc-5668	199	8	impetigo	impetigo	NOUN
dpc-5668	199	9	.	.	PUNCT
dpc-5668	200	1	n	n	PROPN
dpc-5668	200	2	engl	engl	PROPN
dpc-5668	200	3	j	j	PROPN
dpc-5668	200	4	med	med	PROPN
dpc-5668	201	1	[	[	X
dpc-5668	201	2	internet	internet	NOUN
dpc-5668	201	3	]	]	PUNCT
dpc-5668	201	4	.	.	PUNCT
dpc-5668	202	1	1963	1963	NUM
dpc-5668	202	2	jan	jan	PROPN
dpc-5668	202	3	10;268(2):72–5	10;268(2):72–5	NUM
dpc-5668	202	4	.	.	PUNCT
dpc-5668	202	5	doi	doi	NOUN
dpc-5668	202	6	:	:	PUNCT
dpc-5668	202	7	10.1056	10.1056	NUM
dpc-5668	202	8	/	/	SYM
dpc-5668	202	9	nejm196301102680203	nejm196301102680203	PROPN
dpc-5668	202	10	.	.	PUNCT
dpc-5668	203	1	pmid	pmid	NOUN
dpc-5668	203	2	:	:	PUNCT
dpc-5668	203	3	14017141	14017141	NUM
dpc-5668	203	4	14	14	NUM
dpc-5668	203	5	.	.	PUNCT
dpc-5668	204	1	ferrieri	ferrieri	PROPN
dpc-5668	204	2	p	p	PROPN
dpc-5668	204	3	,	,	PUNCT
dpc-5668	204	4	dajani	dajani	NOUN
dpc-5668	204	5	as	as	ADP
dpc-5668	204	6	,	,	PUNCT
dpc-5668	204	7	wannamaker	wannamaker	PROPN
dpc-5668	204	8	lw	lw	PROPN
dpc-5668	204	9	.	.	PUNCT
dpc-5668	205	1	a	a	DET
dpc-5668	205	2	controlled	control	VERB
dpc-5668	205	3	study	study	NOUN
dpc-5668	205	4	of	of	ADP
dpc-5668	205	5	penicillin	penicillin	NOUN
dpc-5668	205	6	prophylaxis	prophylaxi	VERB
dpc-5668	205	7	against	against	ADP
dpc-5668	205	8	streptococcal	streptococcal	ADJ
dpc-5668	205	9	impetigo	impetigo	NOUN
dpc-5668	205	10	.	.	PUNCT
dpc-5668	206	1	j	j	PROPN
dpc-5668	206	2	infect	infect	VERB
dpc-5668	206	3	dis	dis	PROPN
dpc-5668	206	4	.	.	PUNCT
dpc-5668	207	1	1974	1974	NUM
dpc-5668	207	2	apr;129(4):429–38	apr;129(4):429–38	X
dpc-5668	207	3	.	.	PUNCT
dpc-5668	208	1	doi	doi	NOUN
dpc-5668	208	2	:	:	PUNCT
dpc-5668	208	3	10.1093	10.1093	NUM
dpc-5668	208	4	/	/	SYM
dpc-5668	208	5	infdis/129.4.429	infdis/129.4.429	PROPN
dpc-5668	208	6	.	.	PUNCT
dpc-5668	209	1	pmid	pmid	NOUN
dpc-5668	209	2	:	:	PUNCT
dpc-5668	209	3	4593872	4593872	NUM
dpc-5668	209	4	15	15	NUM
dpc-5668	209	5	.	.	PUNCT
dpc-5668	210	1	gropper	gropper	PROPN
dpc-5668	210	2	s	s	PROPN
dpc-5668	210	3	,	,	PUNCT
dpc-5668	210	4	cepero	cepero	PROPN
dpc-5668	210	5	al	al	PROPN
dpc-5668	210	6	,	,	PUNCT
dpc-5668	210	7	santos	santos	PROPN
dpc-5668	210	8	b	b	PROPN
dpc-5668	210	9	,	,	PUNCT
dpc-5668	210	10	kruger	kruger	PROPN
dpc-5668	210	11	d.	d.	PROPN
dpc-5668	210	12	systemic	systemic	ADJ
dpc-5668	210	13	bioavailability	bioavailability	NOUN
dpc-5668	210	14	and	and	CCONJ
dpc-5668	210	15	safety	safety	NOUN
dpc-5668	210	16	of	of	ADP
dpc-5668	210	17	twice	twice	ADV
dpc-5668	210	18	-	-	PUNCT
dpc-5668	210	19	daily	daily	ADJ
dpc-5668	210	20	topical	topical	NOUN
dpc-5668	210	21	ozenoxacin	ozenoxacin	VERB
dpc-5668	210	22	1	1	NUM
dpc-5668	210	23	%	%	NOUN
dpc-5668	210	24	cream	cream	NOUN
dpc-5668	210	25	in	in	ADP
dpc-5668	210	26	adults	adult	NOUN
dpc-5668	210	27	and	and	CCONJ
dpc-5668	210	28	children	child	NOUN
dpc-5668	210	29	with	with	ADP
dpc-5668	210	30	impetigo	impetigo	PROPN
dpc-5668	210	31	.	.	PUNCT
dpc-5668	211	1	future	future	ADJ
dpc-5668	211	2	microbiology	microbiology	NOUN
dpc-5668	211	3	.	.	PUNCT
dpc-5668	212	1	2014	2014	NUM
dpc-5668	212	2	aug;9(8s):s33–40	aug;9(8s):s33–40	NOUN
dpc-5668	212	3	.	.	PUNCT
dpc-5668	213	1	doi	doi	NOUN
dpc-5668	213	2	:	:	PUNCT
dpc-5668	213	3	10.2217	10.2217	NUM
dpc-5668	213	4	/	/	SYM
dpc-5668	213	5	fmb.14.85	fmb.14.85	NOUN
dpc-5668	213	6	.	.	PUNCT
dpc-5668	214	1	pmid	pmid	NOUN
dpc-5668	214	2	:	:	PUNCT
dpc-5668	214	3	25209523	25209523	NUM
dpc-5668	214	4	16	16	NUM
dpc-5668	214	5	.	.	PUNCT
dpc-5668	215	1	hebert	hebert	PROPN
dpc-5668	215	2	aa	aa	PROPN
dpc-5668	215	3	,	,	PUNCT
dpc-5668	215	4	rosen	rosen	PROPN
dpc-5668	215	5	t	t	PROPN
dpc-5668	215	6	,	,	PUNCT
dpc-5668	215	7	albareda	albareda	PROPN
dpc-5668	215	8	lópez	lópez	PROPN
dpc-5668	215	9	n	n	CCONJ
dpc-5668	215	10	,	,	PUNCT
dpc-5668	215	11	zsolt	zsolt	PROPN
dpc-5668	215	12	i	i	PROPN
dpc-5668	215	13	,	,	PUNCT
dpc-5668	215	14	masramon	masramon	PROPN
dpc-5668	215	15	x.	x.	NOUN
dpc-5668	215	16	safety	safety	PROPN
dpc-5668	215	17	and	and	CCONJ
dpc-5668	215	18	efficacy	efficacy	NOUN
dpc-5668	215	19	profile	profile	NOUN
dpc-5668	215	20	of	of	ADP
dpc-5668	215	21	ozenoxacin	ozenoxacin	ADJ
dpc-5668	215	22	1	1	NUM
dpc-5668	215	23	%	%	NOUN
dpc-5668	215	24	cream	cream	NOUN
dpc-5668	215	25	in	in	ADP
dpc-5668	215	26	pediatric	pediatric	ADJ
dpc-5668	215	27	patients	patient	NOUN
dpc-5668	215	28	with	with	ADP
dpc-5668	215	29	impetigo	impetigo	PROPN
dpc-5668	215	30	.	.	PUNCT
dpc-5668	216	1	int	int	PROPN
dpc-5668	216	2	j	j	PROPN
dpc-5668	216	3	womens	womens	PROPN
dpc-5668	216	4	dermatol	dermatol	NOUN
dpc-5668	216	5	.	.	PUNCT
dpc-5668	217	1	2020	2020	NUM
dpc-5668	217	2	mar;6(2):109–15	mar;6(2):109–15	PROPN
dpc-5668	217	3	.	.	PUNCT
dpc-5668	218	1	doi	doi	PROPN
dpc-5668	218	2	:	:	PUNCT
dpc-5668	218	3	10.1016	10.1016	NUM
dpc-5668	218	4	/	/	SYM
dpc-5668	218	5	j.ijwd.2019.10.008	j.ijwd.2019.10.008	PROPN
dpc-5668	218	6	.	.	PUNCT
dpc-5668	219	1	pmid	pmid	NOUN
dpc-5668	219	2	:	:	PUNCT
dpc-5668	219	3	32258344	32258344	NUM
dpc-5668	219	4	17	17	NUM
dpc-5668	219	5	.	.	PUNCT
dpc-5668	220	1	larcombe	larcombe	PROPN
dpc-5668	220	2	jh	jh	PROPN
dpc-5668	220	3	.	.	PUNCT
dpc-5668	221	1	review	review	NOUN
dpc-5668	221	2	:	:	PUNCT
dpc-5668	221	3	topical	topical	ADJ
dpc-5668	221	4	mupirocin	mupirocin	NOUN
dpc-5668	221	5	or	or	CCONJ
dpc-5668	221	6	fusidic	fusidic	ADJ
dpc-5668	221	7	acid	acid	NOUN
dpc-5668	221	8	may	may	AUX
dpc-5668	221	9	be	be	AUX
dpc-5668	221	10	more	more	ADV
dpc-5668	221	11	effective	effective	ADJ
dpc-5668	221	12	than	than	ADP
dpc-5668	221	13	oral	oral	ADJ
dpc-5668	221	14	antibiotics	antibiotic	NOUN
dpc-5668	221	15	for	for	ADP
dpc-5668	221	16	limited	limited	ADJ
dpc-5668	221	17	non	non	ADJ
dpc-5668	221	18	-	-	ADJ
dpc-5668	221	19	bullous	bullous	ADJ
dpc-5668	221	20	impetigo	impetigo	NOUN
dpc-5668	221	21	.	.	PUNCT
dpc-5668	222	1	evid	evid	PROPN
dpc-5668	222	2	based	base	VERB
dpc-5668	222	3	med	med	PROPN
dpc-5668	222	4	.	.	PUNCT
dpc-5668	222	5	2004	2004	NUM
dpc-5668	223	1	nov;9(6):176	nov;9(6):176	PROPN
dpc-5668	223	2	.	.	PUNCT
dpc-5668	224	1	doi	doi	NOUN
dpc-5668	224	2	:	:	PUNCT
dpc-5668	224	3	10.1136	10.1136	NUM
dpc-5668	224	4	/ebm.9.6.176	/ebm.9.6.176	NOUN
dpc-5668	224	5	.	.	PUNCT
dpc-5668	225	1	pmid	pmid	NOUN
dpc-5668	225	2	:	:	PUNCT
dpc-5668	225	3	15688485	15688485	NUM
dpc-5668	225	4	18	18	NUM
dpc-5668	225	5	.	.	PUNCT
dpc-5668	226	1	zubair	zubair	PROPN
dpc-5668	226	2	ahmed	ahmed	PROPN
dpc-5668	226	3	f	f	PROPN
dpc-5668	226	4	,	,	PUNCT
dpc-5668	226	5	m	m	VERB
dpc-5668	226	6	v	v	ADJ
dpc-5668	226	7	a.	a.	NOUN
dpc-5668	226	8	efficacy	efficacy	NOUN
dpc-5668	226	9	and	and	CCONJ
dpc-5668	226	10	cost	cost	NOUN
dpc-5668	226	11	-	-	PUNCT
dpc-5668	226	12	effectiveness	effectiveness	NOUN
dpc-5668	226	13	comparison	comparison	NOUN
dpc-5668	226	14	between	between	ADP
dpc-5668	226	15	fusidic	fusidic	ADJ
dpc-5668	226	16	acid	acid	NOUN
dpc-5668	226	17	and	and	CCONJ
dpc-5668	226	18	mupirocin	mupirocin	NOUN
dpc-5668	226	19	for	for	ADP
dpc-5668	226	20	impetigo	impetigo	PROPN
dpc-5668	226	21	.	.	PUNCT
dpc-5668	227	1	ip	ip	PROPN
dpc-5668	227	2	int	int	PROPN
dpc-5668	227	3	j	j	PROPN
dpc-5668	227	4	compr	compr	PROPN
dpc-5668	227	5	adv	adv	PROPN
dpc-5668	227	6	pharmacol	pharmacol	PROPN
dpc-5668	227	7	.	.	PROPN
dpc-5668	228	1	2019	2019	NUM
dpc-5668	228	2	october	october	PROPN
dpc-5668	228	3	15th;4(3):100–4	15th;4(3):100–4	NOUN
dpc-5668	228	4	.	.	PUNCT
dpc-5668	229	1	doi	doi	NOUN
dpc-5668	229	2	:	:	PUNCT
dpc-5668	229	3	10.18231	10.18231	NUM
dpc-5668	229	4	/	/	SYM
dpc-5668	229	5	j.ijcaap.2019.021	j.ijcaap.2019.021	PROPN
dpc-5668	229	6	19	19	NUM
dpc-5668	229	7	.	.	PUNCT
dpc-5668	230	1	barton	barton	PROPN
dpc-5668	230	2	ll	ll	PROPN
dpc-5668	230	3	,	,	PUNCT
dpc-5668	230	4	friedman	friedman	PROPN
dpc-5668	230	5	as	as	ADP
dpc-5668	230	6	,	,	PUNCT
dpc-5668	230	7	portilla	portilla	NOUN
dpc-5668	230	8	mg	mg	PROPN
dpc-5668	230	9	.	.	PUNCT
dpc-5668	231	1	impetigo	impetigo	PROPN
dpc-5668	231	2	contagiosa	contagiosa	PROPN
dpc-5668	231	3	:	:	PUNCT
dpc-5668	231	4	a	a	DET
dpc-5668	231	5	comparison	comparison	NOUN
dpc-5668	231	6	of	of	ADP
dpc-5668	231	7	erythromycin	erythromycin	NOUN
dpc-5668	231	8	and	and	CCONJ
dpc-5668	231	9	dicloxacillin	dicloxacillin	NOUN
dpc-5668	231	10	therapy	therapy	NOUN
dpc-5668	231	11	.	.	PUNCT
dpc-5668	232	1	pediatr	pediatr	ADJ
dpc-5668	232	2	dermatol	dermatol	NOUN
dpc-5668	232	3	.	.	PUNCT
dpc-5668	233	1	1988	1988	NUM
dpc-5668	233	2	may;5(2):88–91	may;5(2):88–91	NOUN
dpc-5668	233	3	.	.	PUNCT
dpc-5668	234	1	doi	doi	NOUN
dpc-5668	234	2	:	:	PUNCT
dpc-5668	234	3	10.1111	10.1111	NUM
dpc-5668	234	4	/	/	SYM
dpc-5668	234	5	j	j	PROPN
dpc-5668	234	6	.1525	.1525	PROPN
dpc-5668	234	7	-	-	PUNCT
dpc-5668	234	8	1470.1988.tb01144.x	1470.1988.tb01144.x	PROPN
dpc-5668	234	9	.	.	PUNCT
dpc-5668	235	1	pmid	pmid	NOUN
dpc-5668	235	2	:	:	PUNCT
dpc-5668	235	3	3045781	3045781	NUM
dpc-5668	235	4	20	20	NUM
dpc-5668	235	5	.	.	PUNCT
dpc-5668	236	1	ciftci	ciftci	PROPN
dpc-5668	236	2	e	e	PROPN
dpc-5668	236	3	,	,	PUNCT
dpc-5668	236	4	guriz	guriz	NOUN
dpc-5668	236	5	h	h	NOUN
dpc-5668	236	6	,	,	PUNCT
dpc-5668	236	7	aysev	aysev	VERB
dpc-5668	236	8	ad	ad	NOUN
dpc-5668	236	9	.	.	PUNCT
dpc-5668	237	1	mupirocin	mupirocin	NOUN
dpc-5668	237	2	vs	vs	ADP
dpc-5668	237	3	terbinafine	terbinafine	NOUN
dpc-5668	237	4	in	in	ADP
dpc-5668	237	5	impetigo	impetigo	PROPN
dpc-5668	237	6	.	.	PUNCT
dpc-5668	238	1	indian	indian	PROPN
dpc-5668	238	2	j	j	PROPN
dpc-5668	238	3	pediatr	pediatr	PROPN
dpc-5668	239	1	[	[	X
dpc-5668	239	2	internet	internet	NOUN
dpc-5668	239	3	]	]	PUNCT
dpc-5668	239	4	.	.	PUNCT
dpc-5668	240	1	2002	2002	NUM
dpc-5668	240	2	aug	aug	PROPN
dpc-5668	240	3	[	[	X
dpc-5668	240	4	cited	cite	VERB
dpc-5668	240	5	2024	2024	NUM
dpc-5668	240	6	apr	apr	NOUN
dpc-5668	240	7	5];69(8):679–82	5];69(8):679–82	NUM
dpc-5668	240	8	.	.	PUNCT
dpc-5668	241	1	doi	doi	NOUN
dpc-5668	241	2	:	:	PUNCT
dpc-5668	241	3	10.1007	10.1007	NUM
dpc-5668	241	4	/	/	SYM
dpc-5668	241	5	bf02722704	bf02722704	NOUN
dpc-5668	241	6	.	.	PUNCT
dpc-5668	242	1	pmid	pmid	NOUN
dpc-5668	242	2	:	:	PUNCT
dpc-5668	242	3	12356219	12356219	NUM
dpc-5668	242	4	21	21	NUM
dpc-5668	242	5	.	.	PUNCT
dpc-5668	243	1	dagan	dagan	PROPN
dpc-5668	243	2	r	r	NOUN
dpc-5668	243	3	,	,	PUNCT
dpc-5668	243	4	bar	bar	NOUN
dpc-5668	243	5	-	-	PUNCT
dpc-5668	243	6	david	david	PROPN
dpc-5668	243	7	y.	y.	PROPN
dpc-5668	243	8	double	double	ADJ
dpc-5668	243	9	-	-	PUNCT
dpc-5668	243	10	blind	blind	ADJ
dpc-5668	243	11	study	study	NOUN
dpc-5668	243	12	comparing	compare	VERB
dpc-5668	243	13	erythromycin	erythromycin	NOUN
dpc-5668	243	14	and	and	CCONJ
dpc-5668	243	15	mupirocin	mupirocin	NOUN
dpc-5668	243	16	for	for	ADP
dpc-5668	243	17	treatment	treatment	NOUN
dpc-5668	243	18	of	of	ADP
dpc-5668	243	19	impetigo	impetigo	NOUN
dpc-5668	243	20	in	in	ADP
dpc-5668	243	21	children	child	NOUN
dpc-5668	243	22	:	:	PUNCT
dpc-5668	243	23	implications	implication	NOUN
dpc-5668	243	24	of	of	ADP
dpc-5668	243	25	a	a	DET
dpc-5668	243	26	high	high	ADJ
dpc-5668	243	27	prevalence	prevalence	NOUN
dpc-5668	243	28	of	of	ADP
dpc-5668	243	29	erythromycin	erythromycin	NOUN
dpc-5668	243	30	-	-	PUNCT
dpc-5668	243	31	resistant	resistant	ADJ
dpc-5668	243	32	staphylococcus	staphylococcus	NOUN
dpc-5668	243	33	aureus	aureus	NOUN
dpc-5668	243	34	strains	strain	VERB
dpc-5668	243	35	.	.	PUNCT
dpc-5668	244	1	antimicrobial	antimicrobial	ADJ
dpc-5668	244	2	agents	agent	NOUN
dpc-5668	244	3	and	and	CCONJ
dpc-5668	244	4	chemotherapy	chemotherapy	NOUN
dpc-5668	244	5	.	.	PUNCT
dpc-5668	245	1	1992	1992	NUM
dpc-5668	245	2	feb;36(2):287–90	feb;36(2):287–90	PROPN
dpc-5668	245	3	.	.	PUNCT
dpc-5668	246	1	doi	doi	NOUN
dpc-5668	246	2	:	:	PUNCT
dpc-5668	246	3	10.1128	10.1128	NUM
dpc-5668	246	4	/	/	SYM
dpc-5668	246	5	aac.36.2.287	aac.36.2.287	NOUN
dpc-5668	246	6	.	.	PUNCT
dpc-5668	247	1	pmid	pmid	NOUN
dpc-5668	247	2	:	:	PUNCT
dpc-5668	247	3	1605593	1605593	NUM
dpc-5668	247	4	22	22	NUM
dpc-5668	247	5	.	.	PUNCT
dpc-5668	248	1	dash	dash	NOUN
dpc-5668	248	2	p	p	NOUN
dpc-5668	248	3	,	,	PUNCT
dpc-5668	248	4	khan	khan	PROPN
dpc-5668	248	5	f	f	PROPN
dpc-5668	248	6	,	,	PUNCT
dpc-5668	248	7	sarda	sarda	PROPN
dpc-5668	248	8	s	s	PROPN
dpc-5668	248	9	,	,	PUNCT
dpc-5668	248	10	tanwar	tanwar	PROPN
dpc-5668	248	11	r.	r.	PROPN
dpc-5668	248	12	a	a	DET
dpc-5668	248	13	comparative	comparative	ADJ
dpc-5668	248	14	study	study	NOUN
dpc-5668	248	15	of	of	ADP
dpc-5668	248	16	topical	topical	ADJ
dpc-5668	248	17	1	1	NUM
dpc-5668	248	18	%	%	NOUN
dpc-5668	248	19	ozenoxacin	ozenoxacin	VERB
dpc-5668	248	20	cream	cream	NOUN
dpc-5668	248	21	and	and	CCONJ
dpc-5668	248	22	2	2	NUM
dpc-5668	248	23	%	%	NOUN
dpc-5668	248	24	mupirocin	mupirocin	NOUN
dpc-5668	248	25	cream	cream	NOUN
dpc-5668	248	26	for	for	ADP
dpc-5668	248	27	the	the	DET
dpc-5668	248	28	treatment	treatment	NOUN
dpc-5668	248	29	of	of	ADP
dpc-5668	248	30	impetigo	impetigo	NOUN
dpc-5668	248	31	in	in	ADP
dpc-5668	248	32	children	child	NOUN
dpc-5668	248	33	.	.	PUNCT
dpc-5668	249	1	int	int	PROPN
dpc-5668	249	2	j	j	PROPN
dpc-5668	249	3	pharm	pharm	PROPN
dpc-5668	249	4	clin	clin	PROPN
dpc-5668	249	5	res	re	NOUN
dpc-5668	249	6	.	.	PUNCT
dpc-5668	250	1	2023	2023	NUM
dpc-5668	250	2	nov;15(11):116	nov;15(11):116	ADP
dpc-5668	250	3	23	23	NUM
dpc-5668	250	4	.	.	PUNCT
dpc-5668	251	1	demidovich	demidovich	PROPN
dpc-5668	251	2	cw	cw	NOUN
dpc-5668	251	3	,	,	PUNCT
dpc-5668	251	4	wittler	wittler	PROPN
dpc-5668	251	5	rr	rr	PROPN
dpc-5668	251	6	,	,	PUNCT
dpc-5668	251	7	ruff	ruff	VERB
dpc-5668	251	8	me	i	PRON
dpc-5668	251	9	,	,	PUNCT
dpc-5668	251	10	bass	bass	PROPN
dpc-5668	251	11	jw	jw	PROPN
dpc-5668	251	12	,	,	PUNCT
dpc-5668	251	13	browning	brown	VERB
dpc-5668	251	14	wc	wc	PROPN
dpc-5668	251	15	.	.	PROPN
dpc-5668	252	1	impetigo	impetigo	PROPN
dpc-5668	252	2	:	:	PUNCT
dpc-5668	252	3	current	current	ADJ
dpc-5668	252	4	etiology	etiology	NOUN
dpc-5668	252	5	and	and	CCONJ
dpc-5668	252	6	comparison	comparison	NOUN
dpc-5668	252	7	of	of	ADP
dpc-5668	252	8	penicillin	penicillin	NOUN
dpc-5668	252	9	,	,	PUNCT
dpc-5668	252	10	erythromycin	erythromycin	PROPN
dpc-5668	252	11	,	,	PUNCT
dpc-5668	252	12	and	and	CCONJ
dpc-5668	252	13	cephalexin	cephalexin	PROPN
dpc-5668	252	14	therapies	therapy	NOUN
dpc-5668	252	15	.	.	PUNCT
dpc-5668	253	1	am	be	AUX
dpc-5668	253	2	j	j	PROPN
dpc-5668	253	3	dis	dis	PROPN
dpc-5668	253	4	child	child	NOUN
dpc-5668	253	5	.	.	PUNCT
dpc-5668	254	1	1990	1990	NUM
dpc-5668	254	2	dec;144(12):1313–5.doi:10.1001	dec;144(12):1313–5.doi:10.1001	PROPN
dpc-5668	254	3	/	/	SYM
dpc-5668	254	4	archpedi.1990.02150360037015	archpedi.1990.02150360037015	NOUN
dpc-5668	254	5	.	.	PUNCT
dpc-5668	255	1	pmid	pmid	NOUN
dpc-5668	255	2	:	:	PUNCT
dpc-5668	255	3	2244610	2244610	NUM
dpc-5668	255	4	24	24	NUM
dpc-5668	255	5	.	.	PUNCT
dpc-5668	256	1	eells	eell	NOUN
dpc-5668	256	2	ld	ld	PROPN
dpc-5668	256	3	,	,	PUNCT
dpc-5668	256	4	mertz	mertz	PROPN
dpc-5668	256	5	pm	pm	PROPN
dpc-5668	256	6	,	,	PUNCT
dpc-5668	256	7	piovanetti	piovanetti	PROPN
dpc-5668	256	8	y	y	PROPN
dpc-5668	256	9	,	,	PUNCT
dpc-5668	256	10	pekoe	pekoe	PROPN
dpc-5668	256	11	gm	gm	PROPN
dpc-5668	256	12	,	,	PUNCT
dpc-5668	256	13	eaglstein	eaglstein	PROPN
dpc-5668	256	14	wh	wh	PROPN
dpc-5668	256	15	.	.	PUNCT
dpc-5668	256	16	topical	topical	ADJ
dpc-5668	256	17	antibiotic	antibiotic	ADJ
dpc-5668	256	18	treatment	treatment	NOUN
dpc-5668	256	19	of	of	ADP
dpc-5668	256	20	impetigo	impetigo	NOUN
dpc-5668	256	21	with	with	ADP
dpc-5668	256	22	mupirocin	mupirocin	PROPN
dpc-5668	256	23	.	.	PUNCT
dpc-5668	257	1	arch	arch	ADJ
dpc-5668	257	2	dermatol	dermatol	NOUN
dpc-5668	257	3	.	.	PUNCT
dpc-5668	258	1	1986	1986	NUM
dpc-5668	258	2	nov;122(11):1273	nov;122(11):1273	PROPN
dpc-5668	258	3	-	-	PUNCT
dpc-5668	258	4	6	6	NUM
dpc-5668	258	5	.	.	PUNCT
dpc-5668	259	1	pmid	pmid	NOUN
dpc-5668	259	2	:	:	PUNCT
dpc-5668	259	3	3096221.goldfarb	3096221.goldfarb	NUM
dpc-5668	259	4	j	j	PROPN
dpc-5668	259	5	,	,	PUNCT
dpc-5668	259	6	crenshaw	crenshaw	PROPN
dpc-5668	259	7	d	d	PROPN
dpc-5668	259	8	,	,	PUNCT
dpc-5668	259	9	o’horo	o’horo	PROPN
dpc-5668	259	10	j	j	PROPN
dpc-5668	259	11	,	,	PUNCT
dpc-5668	259	12	lemon	lemon	NOUN
dpc-5668	259	13	e	e	PROPN
dpc-5668	259	14	,	,	PUNCT
dpc-5668	259	15	blumer	blumer	PROPN
dpc-5668	259	16	jl	jl	PROPN
dpc-5668	259	17	.	.	PUNCT
dpc-5668	259	18	randomized	randomize	VERB
dpc-5668	259	19	of	of	ADP
dpc-5668	259	20	attrition	attrition	NOUN
dpc-5668	259	21	bias	bias	NOUN
dpc-5668	259	22	due	due	ADP
dpc-5668	259	23	to	to	ADP
dpc-5668	259	24	significant	significant	ADJ
dpc-5668	259	25	participant	participant	ADJ
dpc-5668	259	26	losses	loss	NOUN
dpc-5668	259	27	without	without	ADP
dpc-5668	259	28	justification	justification	NOUN
dpc-5668	259	29	;	;	PUNCT
dpc-5668	259	30	iv	iv	X
dpc-5668	259	31	)	)	PUNCT
dpc-5668	259	32	81	81	NUM
dpc-5668	259	33	%	%	NOUN
dpc-5668	259	34	had	have	VERB
dpc-5668	259	35	an	an	DET
dpc-5668	259	36	unclear	unclear	ADJ
dpc-5668	259	37	risk	risk	NOUN
dpc-5668	259	38	of	of	ADP
dpc-5668	259	39	bias	bias	NOUN
dpc-5668	259	40	due	due	ADP
dpc-5668	259	41	to	to	ADP
dpc-5668	259	42	the	the	DET
dpc-5668	259	43	lack	lack	NOUN
dpc-5668	259	44	of	of	ADP
dpc-5668	259	45	registered	register	VERB
dpc-5668	259	46	protocols	protocol	NOUN
dpc-5668	259	47	.	.	PUNCT
dpc-5668	260	1	these	these	DET
dpc-5668	260	2	methodological	methodological	ADJ
dpc-5668	260	3	weaknesses	weakness	NOUN
dpc-5668	260	4	highlight	highlight	VERB
dpc-5668	260	5	the	the	DET
dpc-5668	260	6	need	need	NOUN
dpc-5668	260	7	for	for	ADP
dpc-5668	260	8	more	more	ADV
dpc-5668	260	9	rigorous	rigorous	ADJ
dpc-5668	260	10	design	design	NOUN
dpc-5668	260	11	and	and	CCONJ
dpc-5668	260	12	reporting	reporting	NOUN
dpc-5668	260	13	standards	standard	NOUN
dpc-5668	260	14	in	in	ADP
dpc-5668	260	15	future	future	ADJ
dpc-5668	260	16	rcts	rct	NOUN
dpc-5668	260	17	on	on	ADP
dpc-5668	260	18	impetigo	impetigo	NOUN
dpc-5668	260	19	treatments	treatment	NOUN
dpc-5668	260	20	,	,	PUNCT
dpc-5668	260	21	adopting	adopt	VERB
dpc-5668	260	22	the	the	DET
dpc-5668	260	23	spirit	spirit	PROPN
dpc-5668	260	24	checklist	checklist	NOUN
dpc-5668	260	25	for	for	ADP
dpc-5668	260	26	protocol	protocol	NOUN
dpc-5668	260	27	development	development	NOUN
dpc-5668	260	28	,	,	PUNCT
dpc-5668	260	29	the	the	DET
dpc-5668	260	30	consort	consort	NOUN
dpc-5668	260	31	statement	statement	NOUN
dpc-5668	260	32	for	for	ADP
dpc-5668	260	33	reporting	reporting	NOUN
dpc-5668	260	34	,	,	PUNCT
dpc-5668	260	35	and	and	CCONJ
dpc-5668	260	36	the	the	DET
dpc-5668	260	37	cochrane	cochrane	PROPN
dpc-5668	260	38	rob	rob	PROPN
dpc-5668	260	39	2.0	2.0	NUM
dpc-5668	260	40	tool	tool	NOUN
dpc-5668	260	41	for	for	ADP
dpc-5668	260	42	bias	bias	NOUN
dpc-5668	260	43	assessment	assessment	NOUN
dpc-5668	260	44	,	,	PUNCT
dpc-5668	260	45	to	to	PART
dpc-5668	260	46	enhance	enhance	VERB
dpc-5668	260	47	the	the	DET
dpc-5668	260	48	transparency	transparency	NOUN
dpc-5668	260	49	,	,	PUNCT
dpc-5668	260	50	validity	validity	NOUN
dpc-5668	260	51	,	,	PUNCT
dpc-5668	260	52	and	and	CCONJ
dpc-5668	260	53	consistency	consistency	NOUN
dpc-5668	260	54	of	of	ADP
dpc-5668	260	55	evidence	evidence	NOUN
dpc-5668	260	56	to	to	PART
dpc-5668	260	57	better	well	ADV
dpc-5668	260	58	support	support	VERB
dpc-5668	260	59	clinical	clinical	ADJ
dpc-5668	260	60	decision	decision	NOUN
dpc-5668	260	61	-	-	PUNCT
dpc-5668	260	62	making	making	NOUN
dpc-5668	260	63	.	.	PUNCT
dpc-5668	261	1	references	reference	NOUN
dpc-5668	261	2	1	1	NUM
dpc-5668	261	3	.	.	PUNCT
dpc-5668	261	4	page	page	NOUN
dpc-5668	261	5	mj	mj	PROPN
dpc-5668	261	6	,	,	PUNCT
dpc-5668	261	7	higgins	higgins	PROPN
dpc-5668	261	8	jp	jp	PROPN
dpc-5668	261	9	,	,	PUNCT
dpc-5668	261	10	clayton	clayton	PROPN
dpc-5668	261	11	g	g	PROPN
dpc-5668	261	12	,	,	PUNCT
dpc-5668	261	13	sterne	sterne	PROPN
dpc-5668	261	14	ja	ja	PROPN
dpc-5668	261	15	,	,	PUNCT
dpc-5668	261	16	hróbjartsson	hróbjartsson	NOUN
dpc-5668	261	17	a	a	NOUN
dpc-5668	261	18	,	,	PUNCT
dpc-5668	261	19	savović	savović	NOUN
dpc-5668	261	20	j.	j.	PROPN
dpc-5668	261	21	empirical	empirical	ADJ
dpc-5668	261	22	evidence	evidence	NOUN
dpc-5668	261	23	of	of	ADP
dpc-5668	261	24	study	study	NOUN
dpc-5668	261	25	design	design	NOUN
dpc-5668	261	26	biases	bias	NOUN
dpc-5668	261	27	in	in	ADP
dpc-5668	261	28	randomized	randomized	ADJ
dpc-5668	261	29	trials	trial	NOUN
dpc-5668	261	30	:	:	PUNCT
dpc-5668	261	31	systematic	systematic	ADJ
dpc-5668	261	32	review	review	NOUN
dpc-5668	261	33	of	of	ADP
dpc-5668	261	34	meta	meta	ADJ
dpc-5668	261	35	-	-	PUNCT
dpc-5668	261	36	epidemiological	epidemiological	ADJ
dpc-5668	261	37	studies	study	NOUN
dpc-5668	261	38	.	.	PUNCT
dpc-5668	262	1	plos	plos	PROPN
dpc-5668	262	2	one	one	NUM
dpc-5668	262	3	.	.	PUNCT
dpc-5668	263	1	2016	2016	NUM
dpc-5668	263	2	jul	jul	PROPN
dpc-5668	263	3	11;11(7):e0159267	11;11(7):e0159267	NUM
dpc-5668	263	4	.	.	PUNCT
dpc-5668	263	5	 	 	SPACE
dpc-5668	264	1	doi	doi	NOUN
dpc-5668	264	2	:	:	PUNCT
dpc-5668	264	3	10.1371	10.1371	NUM
dpc-5668	264	4	/	/	SYM
dpc-5668	264	5	journal	journal	NOUN
dpc-5668	264	6	.pone.0159267	.pone.0159267	PROPN
dpc-5668	264	7	.	.	PUNCT
dpc-5668	265	1	pmid	pmid	NOUN
dpc-5668	265	2	:	:	PUNCT
dpc-5668	265	3	27398997	27398997	NUM
dpc-5668	265	4	2	2	NUM
dpc-5668	265	5	.	.	X
dpc-5668	265	6	guyatt	guyatt	PROPN
dpc-5668	265	7	g	g	PROPN
dpc-5668	265	8	,	,	PUNCT
dpc-5668	265	9	cairns	cairns	PROPN
dpc-5668	265	10	j	j	PROPN
dpc-5668	265	11	,	,	PUNCT
dpc-5668	265	12	churchill	churchill	PROPN
dpc-5668	265	13	d	d	PROPN
dpc-5668	265	14	,	,	PUNCT
dpc-5668	265	15	cook	cook	VERB
dpc-5668	265	16	d	d	PROPN
dpc-5668	265	17	,	,	PUNCT
dpc-5668	265	18	haynes	haynes	PROPN
dpc-5668	265	19	b	b	PROPN
dpc-5668	265	20	,	,	PUNCT
dpc-5668	265	21	hirsh	hirsh	PROPN
dpc-5668	265	22	j	j	PROPN
dpc-5668	265	23	,	,	PUNCT
dpc-5668	265	24	et	et	PROPN
dpc-5668	265	25	al	al	PROPN
dpc-5668	265	26	.	.	PROPN
dpc-5668	265	27	evidence	evidence	NOUN
dpc-5668	265	28	-	-	PUNCT
dpc-5668	265	29	based	base	VERB
dpc-5668	265	30	medicine	medicine	NOUN
dpc-5668	265	31	:	:	PUNCT
dpc-5668	265	32	a	a	DET
dpc-5668	265	33	new	new	ADJ
dpc-5668	265	34	approach	approach	NOUN
dpc-5668	265	35	to	to	ADP
dpc-5668	265	36	teaching	teach	VERB
dpc-5668	265	37	the	the	DET
dpc-5668	265	38	practice	practice	NOUN
dpc-5668	265	39	of	of	ADP
dpc-5668	265	40	medicine	medicine	NOUN
dpc-5668	265	41	.	.	PUNCT
dpc-5668	266	1	jama	jama	PROPN
dpc-5668	266	2	.	.	PUNCT
dpc-5668	267	1	1992;268(17):2420–5	1992;268(17):2420–5	NUM
dpc-5668	267	2	.	.	X
dpc-5668	267	3	doi	doi	NOUN
dpc-5668	267	4	:	:	PUNCT
dpc-5668	267	5	10.1001	10.1001	NUM
dpc-5668	267	6	/jama.1992.03490170092032	/jama.1992.03490170092032	NOUN
dpc-5668	267	7	.	.	PUNCT
dpc-5668	268	1	pmid	pmid	NOUN
dpc-5668	268	2	:	:	PUNCT
dpc-5668	268	3	1404801	1404801	NUM
dpc-5668	268	4	3	3	NUM
dpc-5668	268	5	.	.	PUNCT
dpc-5668	268	6	sackett	sackett	PROPN
dpc-5668	268	7	dl	dl	PROPN
dpc-5668	268	8	,	,	PUNCT
dpc-5668	268	9	rosenberg	rosenberg	PROPN
dpc-5668	268	10	wmc	wmc	PROPN
dpc-5668	268	11	,	,	PUNCT
dpc-5668	268	12	gray	gray	ADJ
dpc-5668	268	13	jam	jam	NOUN
dpc-5668	268	14	,	,	PUNCT
dpc-5668	268	15	haynes	haynes	PROPN
dpc-5668	268	16	rb	rb	PROPN
dpc-5668	268	17	,	,	PUNCT
dpc-5668	268	18	richardson	richardson	PROPN
dpc-5668	268	19	ws	ws	PROPN
dpc-5668	268	20	.	.	PUNCT
dpc-5668	268	21	evidence	evidence	NOUN
dpc-5668	268	22	-	-	PUNCT
dpc-5668	268	23	based	base	VERB
dpc-5668	268	24	medicine	medicine	NOUN
dpc-5668	268	25	:	:	PUNCT
dpc-5668	268	26	what	what	PRON
dpc-5668	268	27	it	it	PRON
dpc-5668	268	28	is	be	AUX
dpc-5668	268	29	and	and	CCONJ
dpc-5668	268	30	what	what	PRON
dpc-5668	268	31	it	it	PRON
dpc-5668	268	32	is	be	AUX
dpc-5668	268	33	n’t	n’t	ADJ
dpc-5668	268	34	.	.	PUNCT
dpc-5668	269	1	bmj	bmj	PROPN
dpc-5668	270	1	[	[	X
dpc-5668	270	2	internet	internet	NOUN
dpc-5668	270	3	]	]	PUNCT
dpc-5668	270	4	.	.	PUNCT
dpc-5668	271	1	1996	1996	NUM
dpc-5668	271	2	jan	jan	PROPN
dpc-5668	271	3	13;312(7023):71–2	13;312(7023):71–2	NUM
dpc-5668	271	4	.	.	PUNCT
dpc-5668	272	1	doi	doi	NOUN
dpc-5668	272	2	:	:	PUNCT
dpc-5668	272	3	10.1136	10.1136	NUM
dpc-5668	272	4	/bmj.312.7023.71	/bmj.312.7023.71	NOUN
dpc-5668	272	5	.	.	PUNCT
dpc-5668	273	1	pmid	pmid	NOUN
dpc-5668	273	2	:	:	PUNCT
dpc-5668	273	3	8555924	8555924	NUM
dpc-5668	273	4	4	4	NUM
dpc-5668	273	5	.	.	PUNCT
dpc-5668	273	6	mansournia	mansournia	PROPN
dpc-5668	273	7	ma	ma	PROPN
dpc-5668	273	8	,	,	PUNCT
dpc-5668	273	9	higgins	higgins	PROPN
dpc-5668	273	10	jp	jp	PROPN
dpc-5668	273	11	,	,	PUNCT
dpc-5668	273	12	sterne	sterne	PROPN
dpc-5668	273	13	ja	ja	PROPN
dpc-5668	273	14	,	,	PUNCT
dpc-5668	273	15	hernán	hernán	PROPN
dpc-5668	273	16	ma	ma	PROPN
dpc-5668	273	17	.	.	PROPN
dpc-5668	273	18	biases	bias	NOUN
dpc-5668	273	19	in	in	ADP
dpc-5668	273	20	randomized	randomized	ADJ
dpc-5668	273	21	trials	trial	NOUN
dpc-5668	273	22	:	:	PUNCT
dpc-5668	273	23	a	a	DET
dpc-5668	273	24	conversation	conversation	NOUN
dpc-5668	273	25	between	between	ADP
dpc-5668	273	26	trialists	trialist	NOUN
dpc-5668	273	27	and	and	CCONJ
dpc-5668	273	28	epidemiologists	epidemiologist	NOUN
dpc-5668	273	29	.	.	PUNCT
dpc-5668	274	1	epidemiology	epidemiology	NOUN
dpc-5668	274	2	.	.	PUNCT
dpc-5668	275	1	2017	2017	NUM
dpc-5668	275	2	jan;28(1):54	jan;28(1):54	PROPN
dpc-5668	275	3	-	-	PUNCT
dpc-5668	275	4	59	59	NUM
dpc-5668	275	5	.	.	PUNCT
dpc-5668	276	1	doi	doi	NOUN
dpc-5668	276	2	:	:	PUNCT
dpc-5668	276	3	10.1097	10.1097	NUM
dpc-5668	276	4	/ede.0000000000000564	/ede.0000000000000564	NUM
dpc-5668	276	5	.	.	PUNCT
dpc-5668	277	1	pmid	pmid	NOUN
dpc-5668	277	2	:	:	PUNCT
dpc-5668	277	3	27748683	27748683	NUM
dpc-5668	277	4	5	5	NUM
dpc-5668	277	5	.	.	PUNCT
dpc-5668	278	1	savović	savović	PROPN
dpc-5668	278	2	j	j	PROPN
dpc-5668	278	3	,	,	PUNCT
dpc-5668	278	4	jones	jones	PROPN
dpc-5668	278	5	h	h	PROPN
dpc-5668	278	6	,	,	PUNCT
dpc-5668	278	7	altman	altman	PROPN
dpc-5668	278	8	d	d	PROPN
dpc-5668	278	9	,	,	PUNCT
dpc-5668	278	10	harris	harris	PROPN
dpc-5668	278	11	r	r	PROPN
dpc-5668	278	12	,	,	PUNCT
dpc-5668	278	13	jűni	jűni	NOUN
dpc-5668	278	14	p	p	NOUN
dpc-5668	278	15	,	,	PUNCT
dpc-5668	278	16	pildal	pildal	PROPN
dpc-5668	278	17	j	j	PROPN
dpc-5668	278	18	,	,	PUNCT
dpc-5668	278	19	et	et	PROPN
dpc-5668	278	20	al	al	PROPN
dpc-5668	278	21	.	.	PROPN
dpc-5668	278	22	influence	influence	NOUN
dpc-5668	278	23	of	of	ADP
dpc-5668	278	24	reported	report	VERB
dpc-5668	278	25	study	study	NOUN
dpc-5668	278	26	design	design	NOUN
dpc-5668	278	27	characteristics	characteristic	NOUN
dpc-5668	278	28	on	on	ADP
dpc-5668	278	29	intervention	intervention	ADJ
dpc-5668	278	30	effect	effect	NOUN
dpc-5668	278	31	estimates	estimate	NOUN
dpc-5668	278	32	from	from	ADP
dpc-5668	278	33	randomised	randomised	ADJ
dpc-5668	278	34	controlled	control	VERB
dpc-5668	278	35	trials	trial	NOUN
dpc-5668	278	36	:	:	PUNCT
dpc-5668	278	37	combined	combine	VERB
dpc-5668	278	38	analysis	analysis	NOUN
dpc-5668	278	39	of	of	ADP
dpc-5668	278	40	meta	meta	ADJ
dpc-5668	278	41	-	-	PUNCT
dpc-5668	278	42	epidemiological	epidemiological	ADJ
dpc-5668	278	43	studies	study	NOUN
dpc-5668	278	44	.	.	PUNCT
dpc-5668	279	1	health	health	PROPN
dpc-5668	279	2	technol	technol	PROPN
dpc-5668	279	3	assess	assess	NOUN
dpc-5668	279	4	.	.	PUNCT
dpc-5668	280	1	2012	2012	NUM
dpc-5668	280	2	sep;16(35):1	sep;16(35):1	PROPN
dpc-5668	280	3	-	-	SYM
dpc-5668	280	4	82	82	NUM
dpc-5668	280	5	.	.	PUNCT
dpc-5668	280	6	 	 	SPACE
dpc-5668	280	7	doi	doi	NOUN
dpc-5668	280	8	:	:	PUNCT
dpc-5668	280	9	10.3310	10.3310	NUM
dpc-5668	280	10	/	/	SYM
dpc-5668	280	11	hta16350	hta16350	NOUN
dpc-5668	280	12	.	.	PUNCT
dpc-5668	281	1	pmid	pmid	NOUN
dpc-5668	281	2	:	:	PUNCT
dpc-5668	281	3	22989478	22989478	NUM
dpc-5668	281	4	6	6	NUM
dpc-5668	281	5	.	.	PUNCT
dpc-5668	282	1	moustgaard	moustgaard	PROPN
dpc-5668	282	2	h	h	PROPN
dpc-5668	282	3	,	,	PUNCT
dpc-5668	282	4	clayton	clayton	PROPN
dpc-5668	282	5	gl	gl	PROPN
dpc-5668	282	6	,	,	PUNCT
dpc-5668	282	7	jones	jones	PROPN
dpc-5668	282	8	he	he	PRON
dpc-5668	282	9	,	,	PUNCT
dpc-5668	282	10	boutron	boutron	PROPN
dpc-5668	282	11	i	i	PRON
dpc-5668	282	12	,	,	PUNCT
dpc-5668	282	13	jørgensen	jørgensen	PROPN
dpc-5668	282	14	l	l	PROPN
dpc-5668	282	15	,	,	PUNCT
dpc-5668	282	16	laursen	laursen	PROPN
dpc-5668	282	17	drt	drt	PROPN
dpc-5668	282	18	,	,	PUNCT
dpc-5668	282	19	et	et	PROPN
dpc-5668	282	20	al	al	PROPN
dpc-5668	282	21	.	.	PROPN
dpc-5668	282	22	impact	impact	NOUN
dpc-5668	282	23	of	of	ADP
dpc-5668	282	24	blinding	blind	VERB
dpc-5668	282	25	on	on	ADP
dpc-5668	282	26	estimated	estimate	VERB
dpc-5668	282	27	treatment	treatment	NOUN
dpc-5668	282	28	effects	effect	NOUN
dpc-5668	282	29	in	in	ADP
dpc-5668	282	30	randomised	randomised	ADJ
dpc-5668	282	31	clinical	clinical	ADJ
dpc-5668	282	32	trials	trial	NOUN
dpc-5668	282	33	:	:	PUNCT
dpc-5668	282	34	meta	meta	ADJ
dpc-5668	282	35	-	-	PUNCT
dpc-5668	282	36	epidemiological	epidemiological	ADJ
dpc-5668	282	37	study	study	NOUN
dpc-5668	282	38	.	.	PUNCT
dpc-5668	283	1	bmj	bmj	PROPN
dpc-5668	283	2	.	.	PUNCT
dpc-5668	283	3	2020	2020	NUM
dpc-5668	283	4	jan	jan	PROPN
dpc-5668	283	5	21;368	21;368	NUM
dpc-5668	283	6	:	:	PUNCT
dpc-5668	283	7	l6802	l6802	PROPN
dpc-5668	283	8	.	.	PUNCT
dpc-5668	283	9	doi	doi	NOUN
dpc-5668	283	10	:	:	PUNCT
dpc-5668	283	11	10.1136	10.1136	NUM
dpc-5668	283	12	/	/	SYM
dpc-5668	283	13	bmj.l6802	bmj.l6802	NOUN
dpc-5668	283	14	.	.	PUNCT
dpc-5668	284	1	pmid	pmid	NOUN
dpc-5668	284	2	:	:	PUNCT
dpc-5668	284	3	31964641	31964641	NUM
dpc-5668	284	4	7	7	NUM
dpc-5668	284	5	.	.	PUNCT
dpc-5668	285	1	gahlawat	gahlawat	PROPN
dpc-5668	285	2	g	g	PROPN
dpc-5668	285	3	,	,	PUNCT
dpc-5668	285	4	tesfaye	tesfaye	VERB
dpc-5668	285	5	w	w	PROPN
dpc-5668	285	6	,	,	PUNCT
dpc-5668	285	7	bushell	bushell	PROPN
dpc-5668	285	8	m	m	PROPN
dpc-5668	285	9	,	,	PUNCT
dpc-5668	285	10	abrha	abrha	PROPN
dpc-5668	285	11	s	s	PROPN
dpc-5668	285	12	,	,	PUNCT
dpc-5668	285	13	peterson	peterson	PROPN
dpc-5668	285	14	gm	gm	PROPN
dpc-5668	285	15	,	,	PUNCT
dpc-5668	285	16	mathew	mathew	PROPN
dpc-5668	285	17	c	c	PROPN
dpc-5668	285	18	,	,	PUNCT
dpc-5668	285	19	et	et	PROPN
dpc-5668	285	20	al	al	PROPN
dpc-5668	285	21	.	.	PUNCT
dpc-5668	286	1	emerging	emerge	VERB
dpc-5668	286	2	treatment	treatment	NOUN
dpc-5668	286	3	strategies	strategy	NOUN
dpc-5668	286	4	for	for	ADP
dpc-5668	286	5	impetigo	impetigo	NOUN
dpc-5668	286	6	in	in	ADP
dpc-5668	286	7	endemic	endemic	ADJ
dpc-5668	286	8	and	and	CCONJ
dpc-5668	286	9	nonendemic	nonendemic	ADJ
dpc-5668	286	10	settings	setting	NOUN
dpc-5668	286	11	:	:	PUNCT
dpc-5668	286	12	a	a	DET
dpc-5668	286	13	systematic	systematic	ADJ
dpc-5668	286	14	review	review	NOUN
dpc-5668	286	15	.	.	PUNCT
dpc-5668	287	1	clin	clin	PROPN
dpc-5668	287	2	ther	ther	PROPN
dpc-5668	287	3	.	.	PUNCT
dpc-5668	288	1	2021	2021	NUM
dpc-5668	288	2	jun;43(6):986–1006	jun;43(6):986–1006	PROPN
dpc-5668	288	3	.	.	PUNCT
dpc-5668	289	1	doi	doi	NOUN
dpc-5668	289	2	:	:	PUNCT
dpc-5668	289	3	10.1016	10.1016	NUM
dpc-5668	289	4	/	/	SYM
dpc-5668	289	5	j	j	PROPN
dpc-5668	289	6	.clinthera.2021.04.013	.clinthera.2021.04.013	PUNCT
dpc-5668	289	7	.	.	PUNCT
dpc-5668	290	1	pmid	pmid	NOUN
dpc-5668	290	2	:	:	PUNCT
dpc-5668	290	3	34053699	34053699	NUM
dpc-5668	290	4	8	8	NUM
dpc-5668	290	5	.	.	PUNCT
dpc-5668	291	1	primhak	primhak	PROPN
dpc-5668	291	2	s	s	PROPN
dpc-5668	291	3	,	,	PUNCT
dpc-5668	291	4	gataua	gataua	PROPN
dpc-5668	291	5	a	a	PRON
dpc-5668	291	6	,	,	PUNCT
dpc-5668	291	7	purvis	purvis	PROPN
dpc-5668	291	8	d	d	PROPN
dpc-5668	291	9	,	,	PUNCT
dpc-5668	291	10	thompson	thompson	PROPN
dpc-5668	291	11	jmd	jmd	PROPN
dpc-5668	291	12	,	,	PUNCT
dpc-5668	291	13	walker	walker	PROPN
dpc-5668	291	14	c	c	PROPN
dpc-5668	291	15	,	,	PUNCT
dpc-5668	291	16	best	good	ADJ
dpc-5668	291	17	e	e	NOUN
dpc-5668	291	18	,	,	PUNCT
dpc-5668	291	19	et	et	PROPN
dpc-5668	291	20	al	al	PROPN
dpc-5668	291	21	.	.	PROPN
dpc-5668	291	22	treatment	treatment	NOUN
dpc-5668	291	23	of	of	ADP
dpc-5668	291	24	impetigo	impetigo	NOUN
dpc-5668	291	25	with	with	ADP
dpc-5668	291	26	antiseptics	antiseptic	NOUN
dpc-5668	291	27	replacing	replace	VERB
dpc-5668	291	28	antibiotics	antibiotic	NOUN
dpc-5668	291	29	(	(	PUNCT
dpc-5668	291	30	tiara	tiara	NOUN
dpc-5668	291	31	)	)	PUNCT
dpc-5668	291	32	trial	trial	NOUN
dpc-5668	291	33	:	:	PUNCT
dpc-5668	291	34	a	a	DET
dpc-5668	291	35	single	single	ADJ
dpc-5668	291	36	-	-	PUNCT
dpc-5668	291	37	blind	blind	ADJ
dpc-5668	291	38	randomized	randomize	VERB
dpc-5668	291	39	controlled	control	VERB
dpc-5668	291	40	trial	trial	NOUN
dpc-5668	291	41	in	in	ADP
dpc-5668	291	42	school	school	NOUN
dpc-5668	291	43	health	health	NOUN
dpc-5668	291	44	clinics	clinic	NOUN
dpc-5668	291	45	within	within	ADP
dpc-5668	291	46	socioeconomically	socioeconomically	ADV
dpc-5668	291	47	disadvantaged	disadvantaged	ADJ
dpc-5668	291	48	communities	community	NOUN
dpc-5668	291	49	in	in	ADP
dpc-5668	291	50	new	new	PROPN
dpc-5668	291	51	zealand	zealand	PROPN
dpc-5668	291	52	.	.	PUNCT
dpc-5668	292	1	trials	trial	NOUN
dpc-5668	292	2	.	.	PUNCT
dpc-5668	293	1	2022	2022	NUM
dpc-5668	293	2	feb	feb	NOUN
dpc-5668	293	3	2;23(1	2;23(1	NUM
dpc-5668	293	4	)	)	PUNCT
dpc-5668	293	5	.	.	PUNCT
dpc-5668	294	1	doi	doi	NOUN
dpc-5668	294	2	:	:	PUNCT
dpc-5668	294	3	10.1186	10.1186	NUM
dpc-5668	294	4	/	/	SYM
dpc-5668	294	5	s13063	s13063	PROPN
dpc-5668	294	6	-	-	PUNCT
dpc-5668	294	7	022	022	NUM
dpc-5668	294	8	-	-	PUNCT
dpc-5668	294	9	06042	06042	NUM
dpc-5668	294	10	-	-	PUNCT
dpc-5668	294	11	0	0	NUM
dpc-5668	294	12	.	.	PUNCT
dpc-5668	295	1	pmid	pmid	NOUN
dpc-5668	295	2	:	:	PUNCT
dpc-5668	295	3	35109906	35109906	NUM
dpc-5668	295	4	9	9	NUM
dpc-5668	295	5	.	.	PUNCT
dpc-5668	295	6	murad	murad	PROPN
dpc-5668	295	7	mh	mh	PROPN
dpc-5668	295	8	,	,	PUNCT
dpc-5668	295	9	wang	wang	PROPN
dpc-5668	295	10	z.	z.	PROPN
dpc-5668	295	11	guidelines	guideline	NOUN
dpc-5668	295	12	for	for	ADP
dpc-5668	295	13	reporting	report	VERB
dpc-5668	295	14	meta	meta	PRON
dpc-5668	295	15	epidemiological	epidemiological	ADJ
dpc-5668	295	16	methodology	methodology	NOUN
dpc-5668	295	17	research	research	NOUN
dpc-5668	295	18	.	.	PUNCT
dpc-5668	296	1	evid	evid	PROPN
dpc-5668	296	2	based	base	VERB
dpc-5668	296	3	med	med	PROPN
dpc-5668	296	4	.	.	PROPN
dpc-5668	296	5	2017	2017	NUM
dpc-5668	296	6	jul;22(4):139–42	jul;22(4):139–42	PROPN
dpc-5668	296	7	.	.	PUNCT
dpc-5668	296	8	doi	doi	PROPN
dpc-5668	296	9	:	:	PUNCT
dpc-5668	296	10	10.1136	10.1136	NUM
dpc-5668	296	11	/	/	SYM
dpc-5668	296	12	ebmed-2017	ebmed-2017	NOUN
dpc-5668	296	13	-	-	PUNCT
dpc-5668	296	14	110713	110713	NUM
dpc-5668	296	15	.	.	PUNCT
dpc-5668	297	1	pmid	pmid	NOUN
dpc-5668	297	2	:	:	PUNCT
dpc-5668	297	3	28701372	28701372	NUM
dpc-5668	297	4	10	10	NUM
dpc-5668	297	5	.	.	PUNCT
dpc-5668	297	6	page	page	NOUN
dpc-5668	297	7	mj	mj	PROPN
dpc-5668	297	8	,	,	PUNCT
dpc-5668	297	9	mckenzie	mckenzie	PROPN
dpc-5668	297	10	je	je	PROPN
dpc-5668	297	11	,	,	PUNCT
dpc-5668	297	12	bossuyt	bossuyt	NOUN
dpc-5668	297	13	pm	pm	NOUN
dpc-5668	297	14	,	,	PUNCT
dpc-5668	297	15	boutron	boutron	PROPN
dpc-5668	297	16	i	i	PRON
dpc-5668	297	17	,	,	PUNCT
dpc-5668	297	18	hoffmann	hoffmann	PROPN
dpc-5668	297	19	tc	tc	PROPN
dpc-5668	297	20	,	,	PUNCT
dpc-5668	297	21	mulrow	mulrow	PROPN
dpc-5668	297	22	cd	cd	PROPN
dpc-5668	297	23	,	,	PUNCT
dpc-5668	297	24	et	et	PROPN
dpc-5668	297	25	al	al	PROPN
dpc-5668	297	26	.	.	PUNCT
dpc-5668	298	1	the	the	DET
dpc-5668	298	2	prisma	prisma	PROPN
dpc-5668	298	3	2020	2020	NUM
dpc-5668	298	4	statement	statement	NOUN
dpc-5668	298	5	:	:	PUNCT
dpc-5668	298	6	an	an	DET
dpc-5668	298	7	updated	update	VERB
dpc-5668	298	8	10	10	NUM
dpc-5668	298	9	review	review	NOUN
dpc-5668	298	10	|	|	ADV
dpc-5668	298	11	dermatol	dermatol	ADJ
dpc-5668	298	12	pract	pract	NOUN
dpc-5668	298	13	concept	concept	NOUN
dpc-5668	298	14	.	.	PUNCT
dpc-5668	299	1	2025;15(4):5668	2025;15(4):5668	NUM
dpc-5668	299	2	children	child	NOUN
dpc-5668	299	3	.	.	PUNCT
dpc-5668	300	1	int	int	PROPN
dpc-5668	301	1	j	j	PROPN
dpc-5668	301	2	curr	curr	PROPN
dpc-5668	301	3	pharm	pharm	PROPN
dpc-5668	301	4	sci	sci	PROPN
dpc-5668	301	5	.	.	PROPN
dpc-5668	301	6	2017	2017	NUM
dpc-5668	301	7	november	november	PROPN
dpc-5668	301	8	14th;9(6):52–2	14th;9(6):52–2	NUM
dpc-5668	301	9	.	.	PUNCT
dpc-5668	302	1	doi	doi	NOUN
dpc-5668	302	2	:	:	PUNCT
dpc-5668	302	3	10.22159	10.22159	NUM
dpc-5668	302	4	/	/	SYM
dpc-5668	302	5	ijcpr.2017v9i6.23429	ijcpr.2017v9i6.23429	NOUN
dpc-5668	302	6	.	.	PUNCT
dpc-5668	303	1	pmid	pmid	NOUN
dpc-5668	303	2	:	:	PUNCT
dpc-5668	303	3	pmc7259577	pmc7259577	NOUN
dpc-5668	303	4	37	37	NUM
dpc-5668	303	5	.	.	PUNCT
dpc-5668	304	1	tong	tong	PROPN
dpc-5668	304	2	sy	sy	PROPN
dpc-5668	304	3	,	,	PUNCT
dpc-5668	304	4	andrews	andrews	PROPN
dpc-5668	304	5	rm	rm	PROPN
dpc-5668	304	6	,	,	PUNCT
dpc-5668	304	7	kearns	kearns	PROPN
dpc-5668	304	8	t	t	PROPN
dpc-5668	304	9	,	,	PUNCT
dpc-5668	304	10	gundjirryirr	gundjirryirr	PROPN
dpc-5668	304	11	r	r	PROPN
dpc-5668	304	12	,	,	PUNCT
dpc-5668	304	13	mcdonald	mcdonald	PROPN
dpc-5668	304	14	mi	mi	PROPN
dpc-5668	304	15	,	,	PUNCT
dpc-5668	304	16	currie	currie	PROPN
dpc-5668	304	17	bj	bj	PROPN
dpc-5668	304	18	,	,	PUNCT
dpc-5668	304	19	et	et	PROPN
dpc-5668	304	20	al	al	PROPN
dpc-5668	304	21	.	.	PUNCT
dpc-5668	305	1	trimethoprim	trimethoprim	NOUN
dpc-5668	305	2	-	-	PUNCT
dpc-5668	305	3	sulfamethoxazole	sulfamethoxazole	NOUN
dpc-5668	305	4	compared	compare	VERB
dpc-5668	305	5	with	with	ADP
dpc-5668	305	6	benzathine	benzathine	ADJ
dpc-5668	305	7	penicillin	penicillin	NOUN
dpc-5668	305	8	for	for	ADP
dpc-5668	305	9	treatment	treatment	NOUN
dpc-5668	305	10	of	of	ADP
dpc-5668	305	11	impetigo	impetigo	NOUN
dpc-5668	305	12	in	in	ADP
dpc-5668	305	13	aboriginal	aboriginal	ADJ
dpc-5668	305	14	children	child	NOUN
dpc-5668	305	15	:	:	PUNCT
dpc-5668	305	16	a	a	DET
dpc-5668	305	17	pilot	pilot	NOUN
dpc-5668	305	18	randomised	randomise	VERB
dpc-5668	305	19	controlled	control	VERB
dpc-5668	305	20	trial	trial	NOUN
dpc-5668	305	21	.	.	PUNCT
dpc-5668	306	1	paediatr	paediatr	NOUN
dpc-5668	306	2	child	child	NOUN
dpc-5668	306	3	health	health	NOUN
dpc-5668	306	4	.	.	PUNCT
dpc-5668	307	1	2010	2010	NUM
dpc-5668	307	2	mar	mar	PROPN
dpc-5668	307	3	17;46(3):131–3	17;46(3):131–3	PROPN
dpc-5668	307	4	.	.	PUNCT
dpc-5668	308	1	doi	doi	NOUN
dpc-5668	308	2	:	:	PUNCT
dpc-5668	308	3	10.1111	10.1111	NUM
dpc-5668	308	4	/	/	SYM
dpc-5668	308	5	j.1440	j.1440	PROPN
dpc-5668	308	6	-1754.2010.01697.x	-1754.2010.01697.x	NOUN
dpc-5668	308	7	.	.	PUNCT
dpc-5668	309	1	pmid	pmid	NOUN
dpc-5668	309	2	:	:	PUNCT
dpc-5668	309	3	20415992	20415992	NUM
dpc-5668	309	4	38	38	NUM
dpc-5668	309	5	.	.	PUNCT
dpc-5668	310	1	catalogue	catalogue	NOUN
dpc-5668	310	2	of	of	ADP
dpc-5668	310	3	bias	bias	NOUN
dpc-5668	310	4	collaboration	collaboration	NOUN
dpc-5668	310	5	.	.	PUNCT
dpc-5668	311	1	spencer	spencer	PROPN
dpc-5668	311	2	ea	ea	PROPN
dpc-5668	311	3	,	,	PUNCT
dpc-5668	311	4	aronson	aronson	PROPN
dpc-5668	311	5	jk	jk	PROPN
dpc-5668	311	6	,	,	PUNCT
dpc-5668	311	7	nunan	nunan	PROPN
dpc-5668	311	8	d	d	PROPN
dpc-5668	311	9	,	,	PUNCT
dpc-5668	311	10	heneghan	heneghan	PROPN
dpc-5668	311	11	c.	c.	PROPN
dpc-5668	311	12	berkson	berkson	PROPN
dpc-5668	311	13	’s	’s	PART
dpc-5668	311	14	bias	bias	NOUN
dpc-5668	311	15	.	.	PUNCT
dpc-5668	312	1	in	in	ADP
dpc-5668	312	2	:	:	PUNCT
dpc-5668	312	3	catalogue	catalogue	NOUN
dpc-5668	312	4	of	of	ADP
dpc-5668	312	5	bias	bias	NOUN
dpc-5668	312	6	2018	2018	NUM
dpc-5668	312	7	:	:	PUNCT
dpc-5668	312	8	https://catalogofbias.org/	https://catalogofbias.org/	PROPN
dpc-5668	312	9	39	39	NUM
dpc-5668	312	10	.	.	PUNCT
dpc-5668	313	1	wang	wang	PROPN
dpc-5668	313	2	a	a	PROPN
dpc-5668	313	3	,	,	PUNCT
dpc-5668	313	4	menon	menon	PROPN
dpc-5668	313	5	r	r	PROPN
dpc-5668	313	6	,	,	PUNCT
dpc-5668	313	7	li	li	PROPN
dpc-5668	313	8	t	t	PROPN
dpc-5668	313	9	,	,	PUNCT
dpc-5668	313	10	harris	harris	PROPN
dpc-5668	313	11	l	l	PROPN
dpc-5668	313	12	,	,	PUNCT
dpc-5668	313	13	harris	harris	PROPN
dpc-5668	313	14	ia	ia	PROPN
dpc-5668	313	15	,	,	PUNCT
dpc-5668	313	16	naylor	naylor	PROPN
dpc-5668	313	17	j	j	PROPN
dpc-5668	313	18	,	,	PUNCT
dpc-5668	313	19	et	et	PROPN
dpc-5668	313	20	al	al	PROPN
dpc-5668	313	21	.	.	PROPN
dpc-5668	313	22	has	have	VERB
dpc-5668	313	23	the	the	DET
dpc-5668	313	24	degree	degree	NOUN
dpc-5668	313	25	of	of	ADP
dpc-5668	313	26	outcome	outcome	NOUN
dpc-5668	313	27	reporting	reporting	NOUN
dpc-5668	313	28	bias	bias	NOUN
dpc-5668	313	29	in	in	ADP
dpc-5668	313	30	surgical	surgical	ADJ
dpc-5668	313	31	randomized	randomized	ADJ
dpc-5668	313	32	trials	trial	NOUN
dpc-5668	313	33	changed	change	VERB
dpc-5668	313	34	?	?	PUNCT
dpc-5668	314	1	a	a	DET
dpc-5668	314	2	meta	meta	ADJ
dpc-5668	314	3	-	-	PUNCT
dpc-5668	314	4	regression	regression	NOUN
dpc-5668	314	5	analysis	analysis	NOUN
dpc-5668	314	6	.	.	PUNCT
dpc-5668	315	1	anz	anz	PROPN
dpc-5668	315	2	j	j	PROPN
dpc-5668	315	3	surg	surg	PROPN
dpc-5668	315	4	.	.	PUNCT
dpc-5668	316	1	2023	2023	NUM
dpc-5668	316	2	jan;93(1	jan;93(1	ADV
dpc-5668	316	3	-	-	PUNCT
dpc-5668	316	4	2):76	2):76	NUM
dpc-5668	316	5	-	-	SYM
dpc-5668	316	6	82	82	NUM
dpc-5668	316	7	.	.	PUNCT
dpc-5668	316	8	 	 	SPACE
dpc-5668	316	9	doi	doi	NOUN
dpc-5668	316	10	:	:	PUNCT
dpc-5668	316	11	10.1111	10.1111	NUM
dpc-5668	316	12	/	/	SYM
dpc-5668	316	13	ans.18273	ans.18273	PROPN
dpc-5668	316	14	.	.	PUNCT
dpc-5668	317	1	pmid	pmid	NOUN
dpc-5668	317	2	:	:	PUNCT
dpc-5668	317	3	36655339	36655339	NUM
dpc-5668	317	4	.	.	PUNCT
dpc-5668	318	1	40	40	NUM
dpc-5668	318	2	.	.	PUNCT
dpc-5668	319	1	van	van	PROPN
dpc-5668	319	2	der	der	PROPN
dpc-5668	319	3	steen	steen	PROPN
dpc-5668	319	4	jt	jt	PROPN
dpc-5668	319	5	,	,	PUNCT
dpc-5668	319	6	van	van	PROPN
dpc-5668	319	7	den	den	PROPN
dpc-5668	319	8	bogert	bogert	PROPN
dpc-5668	319	9	ca	ca	PROPN
dpc-5668	319	10	,	,	PUNCT
dpc-5668	319	11	van	van	PROPN
dpc-5668	319	12	soest	soest	NOUN
dpc-5668	319	13	-	-	PUNCT
dpc-5668	319	14	poortvliet	poortvliet	PROPN
dpc-5668	319	15	mc	mc	PROPN
dpc-5668	319	16	,	,	PUNCT
dpc-5668	319	17	fazeli	fazeli	PROPN
dpc-5668	319	18	farsani	farsani	PROPN
dpc-5668	319	19	s	s	PROPN
dpc-5668	319	20	,	,	PUNCT
dpc-5668	319	21	otten	otten	PROPN
dpc-5668	319	22	rhj	rhj	PROPN
dpc-5668	319	23	,	,	PUNCT
dpc-5668	319	24	et	et	PROPN
dpc-5668	319	25	al	al	PROPN
dpc-5668	319	26	.	.	PUNCT
dpc-5668	319	27	determinants	determinant	NOUN
dpc-5668	319	28	of	of	ADP
dpc-5668	319	29	selective	selective	ADJ
dpc-5668	319	30	reporting	reporting	NOUN
dpc-5668	319	31	:	:	PUNCT
dpc-5668	319	32	a	a	DET
dpc-5668	319	33	taxonomy	taxonomy	NOUN
dpc-5668	319	34	based	base	VERB
dpc-5668	319	35	on	on	ADP
dpc-5668	319	36	content	content	ADJ
dpc-5668	319	37	analysis	analysis	NOUN
dpc-5668	319	38	of	of	ADP
dpc-5668	319	39	a	a	DET
dpc-5668	319	40	random	random	ADJ
dpc-5668	319	41	selection	selection	NOUN
dpc-5668	319	42	of	of	ADP
dpc-5668	319	43	the	the	DET
dpc-5668	319	44	literature	literature	NOUN
dpc-5668	319	45	.	.	PUNCT
dpc-5668	320	1	plos	plos	PROPN
dpc-5668	320	2	one	one	NUM
dpc-5668	320	3	.	.	PUNCT
dpc-5668	320	4	2018	2018	NUM
dpc-5668	320	5	feb	feb	X
dpc-5668	320	6	5;13(2):e0188247	5;13(2):e0188247	NUM
dpc-5668	320	7	.	.	PUNCT
dpc-5668	320	8	  	  	SPACE
dpc-5668	320	9	doi	doi	NOUN
dpc-5668	320	10	:	:	PUNCT
dpc-5668	320	11	10.1371	10.1371	NUM
dpc-5668	320	12	/	/	SYM
dpc-5668	320	13	journal.pone.0188247	journal.pone.0188247	PROPN
dpc-5668	320	14	.	.	PUNCT
dpc-5668	321	1	pmid	pmid	NOUN
dpc-5668	321	2	:	:	PUNCT
dpc-5668	321	3	29401497	29401497	NUM
dpc-5668	321	4	41	41	NUM
dpc-5668	321	5	.	.	PUNCT
dpc-5668	322	1	dal	dal	NOUN
dpc-5668	322	2	-	-	PUNCT
dpc-5668	322	3	ré	ré	ADJ
dpc-5668	322	4	r	r	NOUN
dpc-5668	322	5	,	,	PUNCT
dpc-5668	322	6	marušić	marušić	ADJ
dpc-5668	322	7	a.	a.	NOUN
dpc-5668	322	8	prevention	prevention	NOUN
dpc-5668	322	9	of	of	ADP
dpc-5668	322	10	selective	selective	ADJ
dpc-5668	322	11	outcome	outcome	NOUN
dpc-5668	322	12	reporting	reporting	NOUN
dpc-5668	322	13	:	:	PUNCT
dpc-5668	322	14	let	let	VERB
dpc-5668	322	15	us	we	PRON
dpc-5668	322	16	start	start	VERB
dpc-5668	322	17	from	from	ADP
dpc-5668	322	18	the	the	DET
dpc-5668	322	19	beginning	beginning	NOUN
dpc-5668	322	20	.	.	PUNCT
dpc-5668	323	1	eur	eur	PROPN
dpc-5668	323	2	j	j	PROPN
dpc-5668	323	3	clin	clin	PROPN
dpc-5668	323	4	pharmacol	pharmacol	PROPN
dpc-5668	323	5	.	.	PUNCT
dpc-5668	324	1	2016	2016	NUM
dpc-5668	324	2	oct;72(10):1283	oct;72(10):1283	NOUN
dpc-5668	324	3	-	-	PUNCT
dpc-5668	324	4	1288	1288	NUM
dpc-5668	324	5	.	.	PUNCT
dpc-5668	324	6	  	  	SPACE
dpc-5668	325	1	doi	doi	NOUN
dpc-5668	325	2	:	:	PUNCT
dpc-5668	325	3	10.1007	10.1007	NUM
dpc-5668	325	4	/	/	SYM
dpc-5668	325	5	s00228	s00228	VERB
dpc-5668	325	6	-	-	PUNCT
dpc-5668	325	7	016	016	NUM
dpc-5668	325	8	-	-	PUNCT
dpc-5668	325	9	2107	2107	NUM
dpc-5668	325	10	-	-	PUNCT
dpc-5668	325	11	6	6	NUM
dpc-5668	325	12	.	.	PUNCT
dpc-5668	326	1	pmid	pmid	NOUN
dpc-5668	326	2	:	:	PUNCT
dpc-5668	326	3	27473455	27473455	NUM
dpc-5668	326	4	42	42	NUM
dpc-5668	326	5	.	.	PUNCT
dpc-5668	327	1	ratib	ratib	PROPN
dpc-5668	327	2	s	s	PROPN
dpc-5668	327	3	,	,	PUNCT
dpc-5668	327	4	wilkes	wilkes	PROPN
dpc-5668	327	5	sr	sr	PROPN
dpc-5668	327	6	,	,	PUNCT
dpc-5668	327	7	grainge	grainge	PROPN
dpc-5668	327	8	mj	mj	PROPN
dpc-5668	327	9	,	,	PUNCT
dpc-5668	327	10	thomas	thomas	PROPN
dpc-5668	327	11	ks	ks	PROPN
dpc-5668	327	12	,	,	PUNCT
dpc-5668	327	13	tobinska	tobinska	PROPN
dpc-5668	327	14	c	c	PROPN
dpc-5668	327	15	,	,	PUNCT
dpc-5668	327	16	williams	williams	PROPN
dpc-5668	327	17	hc	hc	PROPN
dpc-5668	327	18	.	.	PROPN
dpc-5668	327	19	is	be	AUX
dpc-5668	327	20	there	there	PRON
dpc-5668	327	21	an	an	DET
dpc-5668	327	22	association	association	NOUN
dpc-5668	327	23	between	between	ADP
dpc-5668	327	24	study	study	NOUN
dpc-5668	327	25	size	size	NOUN
dpc-5668	327	26	and	and	CCONJ
dpc-5668	327	27	reporting	reporting	NOUN
dpc-5668	327	28	of	of	ADP
dpc-5668	327	29	study	study	NOUN
dpc-5668	327	30	quality	quality	NOUN
dpc-5668	327	31	in	in	ADP
dpc-5668	327	32	dermatological	dermatological	ADJ
dpc-5668	327	33	clinical	clinical	ADJ
dpc-5668	327	34	trials	trial	NOUN
dpc-5668	327	35	?	?	PUNCT
dpc-5668	328	1	a	a	DET
dpc-5668	328	2	meta	meta	ADJ
dpc-5668	328	3	epidemiological	epidemiological	ADJ
dpc-5668	328	4	review	review	NOUN
dpc-5668	328	5	.	.	PUNCT
dpc-5668	329	1	br	br	PROPN
dpc-5668	329	2	j	j	PROPN
dpc-5668	329	3	dermatol	dermatol	NOUN
dpc-5668	329	4	.	.	PUNCT
dpc-5668	330	1	2017	2017	NUM
dpc-5668	330	2	jun;176(6):16571658	jun;176(6):16571658	PROPN
dpc-5668	330	3	.	.	PUNCT
dpc-5668	331	1	doi	doi	NOUN
dpc-5668	331	2	:	:	PUNCT
dpc-5668	331	3	10.1111	10.1111	NUM
dpc-5668	331	4	/	/	SYM
dpc-5668	331	5	bjd.15372	bjd.15372	PROPN
dpc-5668	331	6	.	.	PUNCT
dpc-5668	332	1	pmid	pmid	NOUN
dpc-5668	332	2	:	:	PUNCT
dpc-5668	332	3	28369781	28369781	NUM
dpc-5668	332	4	43	43	NUM
dpc-5668	332	5	.	.	PUNCT
dpc-5668	333	1	sá	sá	PROPN
dpc-5668	333	2	kmm	kmm	PROPN
dpc-5668	333	3	,	,	PUNCT
dpc-5668	333	4	rodrigues	rodrigues	PROPN
dpc-5668	333	5	jc	jc	PROPN
dpc-5668	333	6	,	,	PUNCT
dpc-5668	333	7	da	da	PROPN
dpc-5668	333	8	silva	silva	PROPN
dpc-5668	333	9	lb	lb	PROPN
dpc-5668	333	10	,	,	PUNCT
dpc-5668	333	11	santos	santos	PROPN
dpc-5668	333	12	gm	gm	PROPN
dpc-5668	333	13	,	,	PUNCT
dpc-5668	333	14	colovati	colovati	PROPN
dpc-5668	333	15	mes	mes	PROPN
dpc-5668	333	16	,	,	PUNCT
dpc-5668	333	17	martimbianco	martimbianco	PROPN
dpc-5668	333	18	alc	alc	PROPN
dpc-5668	333	19	.	.	PUNCT
dpc-5668	333	20	quality	quality	NOUN
dpc-5668	333	21	of	of	ADP
dpc-5668	333	22	systematic	systematic	ADJ
dpc-5668	333	23	reviews	review	NOUN
dpc-5668	333	24	on	on	ADP
dpc-5668	333	25	the	the	DET
dpc-5668	333	26	treatment	treatment	NOUN
dpc-5668	333	27	of	of	ADP
dpc-5668	333	28	vesiculobullous	vesiculobullous	ADJ
dpc-5668	333	29	skin	skin	NOUN
dpc-5668	333	30	diseases	disease	NOUN
dpc-5668	333	31	.	.	PUNCT
dpc-5668	334	1	a	a	DET
dpc-5668	334	2	metaepidemiological	metaepidemiological	ADJ
dpc-5668	334	3	study	study	NOUN
dpc-5668	334	4	.	.	PUNCT
dpc-5668	335	1	an	an	DET
dpc-5668	335	2	bras	bras	NOUN
dpc-5668	335	3	dermatol	dermatol	NOUN
dpc-5668	335	4	.	.	PUNCT
dpc-5668	336	1	2024	2024	NUM
dpc-5668	336	2	mar	mar	PROPN
dpc-5668	336	3	-	-	PUNCT
dpc-5668	336	4	apr;99(2):223	apr;99(2):223	PROPN
dpc-5668	336	5	-	-	PUNCT
dpc-5668	336	6	232	232	NUM
dpc-5668	336	7	.	.	PUNCT
dpc-5668	336	8	doi	doi	NOUN
dpc-5668	336	9	:	:	PUNCT
dpc-5668	336	10	10.1016	10.1016	NUM
dpc-5668	336	11	/	/	SYM
dpc-5668	336	12	j.abd.2023.06.003	j.abd.2023.06.003	PROPN
dpc-5668	336	13	.	.	PUNCT
dpc-5668	337	1	pmid	pmid	PROPN
dpc-5668	337	2	:	:	PUNCT
dpc-5668	337	3	37985301	37985301	NUM
dpc-5668	337	4	44	44	NUM
dpc-5668	337	5	.	.	PUNCT
dpc-5668	338	1	martimbianco	martimbianco	PROPN
dpc-5668	338	2	alc	alc	PROPN
dpc-5668	338	3	,	,	PUNCT
dpc-5668	338	4	sá	sá	PROPN
dpc-5668	338	5	kmm	kmm	PROPN
dpc-5668	338	6	,	,	PUNCT
dpc-5668	338	7	santos	santos	PROPN
dpc-5668	338	8	gm	gm	PROPN
dpc-5668	338	9	,	,	PUNCT
dpc-5668	338	10	santos	santo	VERB
dpc-5668	338	11	em	em	PRON
dpc-5668	338	12	,	,	PUNCT
dpc-5668	338	13	pacheco	pacheco	PROPN
dpc-5668	338	14	rl	rl	PROPN
dpc-5668	338	15	,	,	PUNCT
dpc-5668	338	16	riera	riera	PROPN
dpc-5668	338	17	r.	r.	PROPN
dpc-5668	338	18	most	most	ADJ
dpc-5668	338	19	cochrane	cochrane	PROPN
dpc-5668	338	20	systematic	systematic	ADJ
dpc-5668	338	21	reviews	review	NOUN
dpc-5668	338	22	and	and	CCONJ
dpc-5668	338	23	protocols	protocol	NOUN
dpc-5668	338	24	did	do	AUX
dpc-5668	338	25	not	not	PART
dpc-5668	338	26	adhere	adhere	VERB
dpc-5668	338	27	to	to	ADP
dpc-5668	338	28	the	the	DET
dpc-5668	338	29	cochrane	cochrane	NOUN
dpc-5668	338	30	’s	’s	PART
dpc-5668	338	31	risk	risk	NOUN
dpc-5668	338	32	of	of	ADP
dpc-5668	338	33	bias	bias	NOUN
dpc-5668	338	34	2.0	2.0	NUM
dpc-5668	338	35	tool	tool	NOUN
dpc-5668	338	36	.	.	PUNCT
dpc-5668	339	1	rev	rev	PROPN
dpc-5668	339	2	assoc	assoc	PROPN
dpc-5668	339	3	med	med	PROPN
dpc-5668	339	4	bras	bras	NOUN
dpc-5668	339	5	.	.	PUNCT
dpc-5668	340	1	2023	2023	NUM
dpc-5668	340	2	feb	feb	NOUN
dpc-5668	340	3	20;69(3):469	20;69(3):469	PROPN
dpc-5668	340	4	-	-	PROPN
dpc-5668	340	5	472	472	NUM
dpc-5668	340	6	.	.	PUNCT
dpc-5668	341	1	doi	doi	NOUN
dpc-5668	341	2	:	:	PUNCT
dpc-5668	341	3	10.1590/1806	10.1590/1806	NUM
dpc-5668	341	4	-9282.20221593	-9282.20221593	NOUN
dpc-5668	341	5	.	.	PUNCT
dpc-5668	342	1	pmid	pmid	NOUN
dpc-5668	342	2	:	:	PUNCT
dpc-5668	342	3	36820779	36820779	NUM
dpc-5668	342	4	45	45	NUM
dpc-5668	342	5	.	.	PUNCT
dpc-5668	342	6	minozzi	minozzi	PROPN
dpc-5668	342	7	s	s	PART
dpc-5668	342	8	,	,	PUNCT
dpc-5668	342	9	cinquini	cinquini	PROPN
dpc-5668	342	10	m	m	PROPN
dpc-5668	342	11	,	,	PUNCT
dpc-5668	342	12	gianola	gianola	PROPN
dpc-5668	342	13	s	s	PROPN
dpc-5668	342	14	,	,	PUNCT
dpc-5668	342	15	gonzalez	gonzalez	PROPN
dpc-5668	342	16	-	-	PUNCT
dpc-5668	342	17	lorenzo	lorenzo	PROPN
dpc-5668	342	18	m	m	PROPN
dpc-5668	342	19	,	,	PUNCT
dpc-5668	342	20	banzi	banzi	PROPN
dpc-5668	342	21	r.	r.	PROPN
dpc-5668	342	22	the	the	DET
dpc-5668	342	23	revised	revise	VERB
dpc-5668	342	24	cochrane	cochrane	NOUN
dpc-5668	342	25	risk	risk	NOUN
dpc-5668	342	26	of	of	ADP
dpc-5668	342	27	bias	bias	NOUN
dpc-5668	342	28	tool	tool	NOUN
dpc-5668	342	29	for	for	ADP
dpc-5668	342	30	randomized	randomized	ADJ
dpc-5668	342	31	trials	trial	NOUN
dpc-5668	342	32	(	(	PUNCT
dpc-5668	342	33	rob	rob	PROPN
dpc-5668	342	34	2	2	NUM
dpc-5668	342	35	)	)	PUNCT
dpc-5668	342	36	showed	show	VERB
dpc-5668	342	37	low	low	ADJ
dpc-5668	342	38	interrater	interrater	NOUN
dpc-5668	342	39	reliability	reliability	NOUN
dpc-5668	342	40	and	and	CCONJ
dpc-5668	342	41	challenges	challenge	NOUN
dpc-5668	342	42	in	in	ADP
dpc-5668	342	43	its	its	PRON
dpc-5668	342	44	application	application	NOUN
dpc-5668	342	45	.	.	PUNCT
dpc-5668	343	1	j	j	PROPN
dpc-5668	343	2	clin	clin	PROPN
dpc-5668	343	3	epidemiol	epidemiol	PROPN
dpc-5668	343	4	.	.	PROPN
dpc-5668	344	1	2020	2020	NUM
dpc-5668	344	2	oct;126:37	oct;126:37	PROPN
dpc-5668	344	3	-	-	PUNCT
dpc-5668	344	4	44	44	NUM
dpc-5668	344	5	.	.	PUNCT
dpc-5668	345	1	doi	doi	NOUN
dpc-5668	345	2	:	:	PUNCT
dpc-5668	345	3	10.1016	10.1016	NUM
dpc-5668	345	4	/	/	SYM
dpc-5668	345	5	j.jclinepi.2020.06.015	j.jclinepi.2020.06.015	PROPN
dpc-5668	345	6	.	.	PUNCT
dpc-5668	346	1	pmid	pmid	NOUN
dpc-5668	346	2	:	:	PUNCT
dpc-5668	346	3	32562833	32562833	NUM
dpc-5668	346	4	46	46	NUM
dpc-5668	346	5	.	.	PUNCT
dpc-5668	347	1	wang	wang	PROPN
dpc-5668	347	2	y	y	PROPN
dpc-5668	347	3	,	,	PUNCT
dpc-5668	347	4	keitz	keitz	PROPN
dpc-5668	347	5	s	s	PROPN
dpc-5668	347	6	,	,	PUNCT
dpc-5668	347	7	briel	briel	PROPN
dpc-5668	347	8	m	m	PROPN
dpc-5668	347	9	,	,	PUNCT
dpc-5668	347	10	glasziou	glasziou	VERB
dpc-5668	347	11	p	p	PRON
dpc-5668	347	12	,	,	PUNCT
dpc-5668	347	13	brignardello	brignardello	PROPN
dpc-5668	347	14	-	-	PUNCT
dpc-5668	347	15	petersen	petersen	PROPN
dpc-5668	347	16	r	r	PROPN
dpc-5668	347	17	,	,	PUNCT
dpc-5668	347	18	siemieniuk	siemieniuk	PROPN
dpc-5668	347	19	rac	rac	PROPN
dpc-5668	347	20	,	,	PUNCT
dpc-5668	347	21	et	et	PROPN
dpc-5668	347	22	al	al	PROPN
dpc-5668	347	23	.	.	PUNCT
dpc-5668	348	1	development	development	NOUN
dpc-5668	348	2	of	of	ADP
dpc-5668	348	3	robust	robust	ADJ
dpc-5668	348	4	-	-	PUNCT
dpc-5668	348	5	rct	rct	NOUN
dpc-5668	348	6	:	:	PUNCT
dpc-5668	348	7	risk	risk	NOUN
dpc-5668	348	8	of	of	ADP
dpc-5668	348	9	bias	bias	NOUN
dpc-5668	348	10	instrument	instrument	NOUN
dpc-5668	348	11	for	for	ADP
dpc-5668	348	12	use	use	NOUN
dpc-5668	348	13	in	in	ADP
dpc-5668	348	14	systematic	systematic	ADJ
dpc-5668	348	15	reviews	review	NOUN
dpc-5668	348	16	-	-	PUNCT
dpc-5668	348	17	for	for	ADP
dpc-5668	348	18	randomised	randomised	ADJ
dpc-5668	348	19	controlled	control	VERB
dpc-5668	348	20	trials	trial	NOUN
dpc-5668	348	21	.	.	PUNCT
dpc-5668	349	1	bmj	bmj	PROPN
dpc-5668	349	2	.	.	PUNCT
dpc-5668	350	1	2025	2025	NUM
dpc-5668	350	2	mar	mar	PROPN
dpc-5668	350	3	25;388	25;388	NUM
dpc-5668	350	4	:	:	PUNCT
dpc-5668	350	5	e081199	e081199	NOUN
dpc-5668	350	6	.	.	PUNCT
dpc-5668	350	7	doi	doi	NOUN
dpc-5668	350	8	:	:	PUNCT
dpc-5668	350	9	10.1136	10.1136	NUM
dpc-5668	350	10	/	/	SYM
dpc-5668	350	11	bmj-2024	bmj-2024	NOUN
dpc-5668	350	12	-	-	PUNCT
dpc-5668	350	13	081199	081199	NUM
dpc-5668	350	14	.	.	PUNCT
dpc-5668	351	1	pmid	pmid	NOUN
dpc-5668	351	2	:	:	PUNCT
dpc-5668	351	3	40132800	40132800	NUM
dpc-5668	351	4	47	47	NUM
dpc-5668	351	5	.	.	PUNCT
dpc-5668	352	1	chan	chan	PROPN
dpc-5668	352	2	aw	aw	INTJ
dpc-5668	352	3	,	,	PUNCT
dpc-5668	352	4	tetzlaff	tetzlaff	PROPN
dpc-5668	352	5	jm	jm	PROPN
dpc-5668	352	6	,	,	PUNCT
dpc-5668	352	7	altman	altman	PROPN
dpc-5668	352	8	dg	dg	PROPN
dpc-5668	352	9	,	,	PUNCT
dpc-5668	352	10	laupacis	laupacis	PROPN
dpc-5668	352	11	a	a	NOUN
dpc-5668	352	12	,	,	PUNCT
dpc-5668	352	13	gøtzsche	gøtzsche	PROPN
dpc-5668	352	14	pc	pc	PROPN
dpc-5668	352	15	,	,	PUNCT
dpc-5668	352	16	krleža	krleža	NOUN
dpc-5668	352	17	-	-	PUNCT
dpc-5668	352	18	jerić	jerić	PROPN
dpc-5668	352	19	k	k	PROPN
dpc-5668	352	20	,	,	PUNCT
dpc-5668	352	21	et	et	PROPN
dpc-5668	352	22	al	al	PROPN
dpc-5668	352	23	.	.	PROPN
dpc-5668	352	24	spirit	spirit	PROPN
dpc-5668	352	25	2013	2013	NUM
dpc-5668	352	26	statement	statement	NOUN
dpc-5668	352	27	:	:	PUNCT
dpc-5668	352	28	defining	define	VERB
dpc-5668	352	29	standard	standard	ADJ
dpc-5668	352	30	protocol	protocol	NOUN
dpc-5668	352	31	items	item	NOUN
dpc-5668	352	32	for	for	ADP
dpc-5668	352	33	clinical	clinical	ADJ
dpc-5668	352	34	trials	trial	NOUN
dpc-5668	352	35	.	.	PUNCT
dpc-5668	353	1	ann	ann	PROPN
dpc-5668	353	2	intern	intern	PROPN
dpc-5668	353	3	med	med	PROPN
dpc-5668	353	4	.	.	PUNCT
dpc-5668	354	1	2013	2013	NUM
dpc-5668	354	2	feb5	feb5	NOUN
dpc-5668	354	3	;	;	PUNCT
dpc-5668	354	4	158(3	158(3	NUM
dpc-5668	354	5	)	)	PUNCT
dpc-5668	354	6	:	:	PUNCT
dpc-5668	354	7	200	200	NUM
dpc-5668	354	8	-	-	SYM
dpc-5668	354	9	7	7	NUM
dpc-5668	354	10	.doi	.doi	PUNCT
dpc-5668	354	11	:	:	PUNCT
dpc-5668	354	12	10	10	NUM
dpc-5668	354	13	.7326	.7326	NOUN
dpc-5668	354	14	/0003	/0003	PUNCT
dpc-5668	354	15	-	-	PUNCT
dpc-5668	354	16	4819	4819	NUM
dpc-5668	354	17	-	-	PUNCT
dpc-5668	354	18	158	158	NUM
dpc-5668	354	19	-	-	SYM
dpc-5668	354	20	3	3	NUM
dpc-5668	354	21	-201302050	-201302050	NOUN
dpc-5668	354	22	-	-	PUNCT
dpc-5668	354	23	00583	00583	NUM
dpc-5668	354	24	.	.	PUNCT
dpc-5668	355	1	pmid	pmid	NOUN
dpc-5668	355	2	:	:	PUNCT
dpc-5668	355	3	23295957	23295957	NUM
dpc-5668	355	4	48	48	NUM
dpc-5668	355	5	.	.	PUNCT
dpc-5668	356	1	schulz	schulz	PROPN
dpc-5668	356	2	kf	kf	PROPN
dpc-5668	356	3	,	,	PUNCT
dpc-5668	356	4	altman	altman	PROPN
dpc-5668	356	5	dg	dg	PROPN
dpc-5668	356	6	,	,	PUNCT
dpc-5668	356	7	moher	moher	PROPN
dpc-5668	356	8	d	d	PROPN
dpc-5668	356	9	;	;	PUNCT
dpc-5668	356	10	for	for	ADP
dpc-5668	356	11	the	the	DET
dpc-5668	356	12	consort	consort	PROPN
dpc-5668	356	13	group	group	PROPN
dpc-5668	356	14	.	.	PUNCT
dpc-5668	357	1	consort	consort	PROPN
dpc-5668	357	2	2010	2010	NUM
dpc-5668	357	3	statement	statement	NOUN
dpc-5668	357	4	:	:	PUNCT
dpc-5668	357	5	updated	update	VERB
dpc-5668	357	6	guidelines	guideline	NOUN
dpc-5668	357	7	for	for	ADP
dpc-5668	357	8	reporting	report	VERB
dpc-5668	357	9	parallel	parallel	ADJ
dpc-5668	357	10	group	group	NOUN
dpc-5668	357	11	randomised	randomise	VERB
dpc-5668	357	12	trials	trial	NOUN
dpc-5668	357	13	.	.	PUNCT
dpc-5668	358	1	bmj	bmj	PROPN
dpc-5668	358	2	.	.	PUNCT
dpc-5668	359	1	2010;340	2010;340	NUM
dpc-5668	359	2	:	:	PUNCT
dpc-5668	359	3	c332	c332	PROPN
dpc-5668	359	4	.	.	PUNCT
dpc-5668	359	5	doi	doi	PROPN
dpc-5668	359	6	:	:	PUNCT
dpc-5668	359	7	10.1136	10.1136	NUM
dpc-5668	359	8	/	/	SYM
dpc-5668	359	9	bmj.c332	bmj.c332	NUM
dpc-5668	359	10	.	.	PUNCT
dpc-5668	360	1	pmid	pmid	NOUN
dpc-5668	360	2	:	:	PUNCT
dpc-5668	360	3	20332509	20332509	NUM
dpc-5668	360	4	clinical	clinical	ADJ
dpc-5668	360	5	trial	trial	NOUN
dpc-5668	360	6	of	of	ADP
dpc-5668	360	7	topical	topical	ADJ
dpc-5668	360	8	mupirocin	mupirocin	NOUN
dpc-5668	360	9	versus	versus	ADP
dpc-5668	360	10	oral	oral	ADJ
dpc-5668	360	11	erythromycin	erythromycin	NOUN
dpc-5668	360	12	for	for	ADP
dpc-5668	360	13	impetigo	impetigo	PROPN
dpc-5668	360	14	.	.	PUNCT
dpc-5668	361	1	antimicrobial	antimicrobial	ADJ
dpc-5668	361	2	agents	agent	NOUN
dpc-5668	361	3	and	and	CCONJ
dpc-5668	361	4	chemotherapy	chemotherapy	NOUN
dpc-5668	361	5	.	.	PUNCT
dpc-5668	362	1	1988	1988	NUM
dpc-5668	362	2	dec	dec	PROPN
dpc-5668	362	3	1;32(12):1780–3	1;32(12):1780–3	NUM
dpc-5668	362	4	.	.	PUNCT
dpc-5668	363	1	doi	doi	NOUN
dpc-5668	363	2	:	:	PUNCT
dpc-5668	363	3	10.1128	10.1128	NUM
dpc-5668	363	4	/	/	SYM
dpc-5668	363	5	aac.32.12.1780	aac.32.12.1780	PROPN
dpc-5668	363	6	.	.	PUNCT
dpc-5668	364	1	pmid	pmid	NOUN
dpc-5668	364	2	:	:	PUNCT
dpc-5668	364	3	3149884	3149884	NUM
dpc-5668	364	4	25	25	NUM
dpc-5668	364	5	.	.	PUNCT
dpc-5668	365	1	gropper	gropper	PROPN
dpc-5668	365	2	s	s	PROPN
dpc-5668	365	3	,	,	PUNCT
dpc-5668	365	4	albareda	albareda	NOUN
dpc-5668	365	5	n	n	CCONJ
dpc-5668	365	6	,	,	PUNCT
dpc-5668	365	7	chelius	chelius	PROPN
dpc-5668	365	8	k	k	PROPN
dpc-5668	365	9	,	,	PUNCT
dpc-5668	365	10	kruger	kruger	PROPN
dpc-5668	365	11	d	d	PROPN
dpc-5668	365	12	,	,	PUNCT
dpc-5668	365	13	mitha	mitha	PROPN
dpc-5668	365	14	i	i	PRON
dpc-5668	365	15	,	,	PUNCT
dpc-5668	365	16	vahed	vahe	VERB
dpc-5668	365	17	y	y	PROPN
dpc-5668	365	18	,	,	PUNCT
dpc-5668	365	19	et	et	PROPN
dpc-5668	365	20	al	al	PROPN
dpc-5668	365	21	.	.	PROPN
dpc-5668	365	22	ozenoxacin	ozenoxacin	VERB
dpc-5668	365	23	1	1	NUM
dpc-5668	365	24	%	%	NOUN
dpc-5668	365	25	cream	cream	NOUN
dpc-5668	365	26	in	in	ADP
dpc-5668	365	27	the	the	DET
dpc-5668	365	28	treatment	treatment	NOUN
dpc-5668	365	29	of	of	ADP
dpc-5668	365	30	impetigo	impetigo	NOUN
dpc-5668	365	31	:	:	PUNCT
dpc-5668	365	32	a	a	DET
dpc-5668	365	33	multicenter	multicenter	NOUN
dpc-5668	365	34	,	,	PUNCT
dpc-5668	365	35	randomized	randomize	VERB
dpc-5668	365	36	,	,	PUNCT
dpc-5668	365	37	placeboand	placeboand	NOUN
dpc-5668	365	38	retapamulin	retapamulin	NOUN
dpc-5668	365	39	-	-	PUNCT
dpc-5668	365	40	controlled	control	VERB
dpc-5668	365	41	clinical	clinical	ADJ
dpc-5668	365	42	trial	trial	NOUN
dpc-5668	365	43	.	.	PUNCT
dpc-5668	366	1	future	future	ADJ
dpc-5668	366	2	microbiology	microbiology	NOUN
dpc-5668	366	3	.	.	PUNCT
dpc-5668	366	4	2014	2014	NUM
dpc-5668	367	1	sep;9(9):1013–23	sep;9(9):1013–23	PROPN
dpc-5668	367	2	.	.	PUNCT
dpc-5668	367	3	doi	doi	PROPN
dpc-5668	367	4	:	:	PUNCT
dpc-5668	367	5	10.2217	10.2217	NUM
dpc-5668	367	6	/	/	SYM
dpc-5668	367	7	fmb.14.78	fmb.14.78	ADJ
dpc-5668	367	8	.	.	PUNCT
dpc-5668	368	1	pmid	pmid	NOUN
dpc-5668	368	2	:	:	PUNCT
dpc-5668	368	3	25340832	25340832	NUM
dpc-5668	368	4	26	26	NUM
dpc-5668	368	5	.	.	PUNCT
dpc-5668	369	1	iovino	iovino	PROPN
dpc-5668	369	2	sm	sm	PROPN
dpc-5668	369	3	,	,	PUNCT
dpc-5668	369	4	krantz	krantz	PROPN
dpc-5668	369	5	kd	kd	PROPN
dpc-5668	369	6	,	,	PUNCT
dpc-5668	369	7	blanco	blanco	PROPN
dpc-5668	369	8	dm	dm	PROPN
dpc-5668	369	9	,	,	PUNCT
dpc-5668	369	10	fernández	fernández	PROPN
dpc-5668	369	11	ja	ja	PROPN
dpc-5668	369	12	,	,	PUNCT
dpc-5668	369	13	ocampo	ocampo	PROPN
dpc-5668	369	14	n	n	CCONJ
dpc-5668	369	15	,	,	PUNCT
dpc-5668	369	16	najafi	najafi	VERB
dpc-5668	369	17	a	a	PRON
dpc-5668	369	18	,	,	PUNCT
dpc-5668	369	19	et	et	PROPN
dpc-5668	369	20	al	al	PROPN
dpc-5668	369	21	.	.	PROPN
dpc-5668	369	22	nvc-422	nvc-422	ADJ
dpc-5668	369	23	topical	topical	ADJ
dpc-5668	369	24	gel	gel	NOUN
dpc-5668	369	25	for	for	ADP
dpc-5668	369	26	the	the	DET
dpc-5668	369	27	treatment	treatment	NOUN
dpc-5668	369	28	of	of	ADP
dpc-5668	369	29	impetigo	impetigo	PROPN
dpc-5668	369	30	.	.	PUNCT
dpc-5668	370	1	international	international	ADJ
dpc-5668	370	2	journal	journal	PROPN
dpc-5668	370	3	of	of	ADP
dpc-5668	370	4	clinical	clinical	ADJ
dpc-5668	370	5	and	and	CCONJ
dpc-5668	370	6	experimental	experimental	ADJ
dpc-5668	370	7	pathology	pathology	NOUN
dpc-5668	371	1	[	[	X
dpc-5668	371	2	internet	internet	NOUN
dpc-5668	371	3	]	]	PUNCT
dpc-5668	371	4	.	.	PUNCT
dpc-5668	371	5	2011	2011	NUM
dpc-5668	372	1	[	[	X
dpc-5668	372	2	cited	cite	VERB
dpc-5668	372	3	2024	2024	NUM
dpc-5668	372	4	aug	aug	PROPN
dpc-5668	372	5	24];4(6):587–95	24];4(6):587–95	NUM
dpc-5668	372	6	.	.	PUNCT
dpc-5668	373	1	pmid	pmid	NOUN
dpc-5668	373	2	:	:	PUNCT
dpc-5668	373	3	21904634	21904634	NUM
dpc-5668	373	4	27	27	NUM
dpc-5668	373	5	.	.	PUNCT
dpc-5668	374	1	jeffrey	jeffrey	PROPN
dpc-5668	374	2	lt	lt	PROPN
dpc-5668	374	3	,	,	PUNCT
dpc-5668	374	4	britton	britton	PROPN
dpc-5668	374	5	w	w	PROPN
dpc-5668	374	6	,	,	PUNCT
dpc-5668	374	7	j.	j.	PROPN
dpc-5668	374	8	eduardo	eduardo	PROPN
dpc-5668	374	9	fajardo	fajardo	PROPN
dpc-5668	374	10	,	,	PUNCT
dpc-5668	374	11	krafte	krafte	PROPN
dpc-5668	374	12	-	-	PUNCT
dpc-5668	374	13	jacobs	jacobs	PROPN
dpc-5668	374	14	b.	b.	PROPN
dpc-5668	374	15	comparison	comparison	NOUN
dpc-5668	374	16	of	of	ADP
dpc-5668	374	17	mupirocin	mupirocin	NOUN
dpc-5668	374	18	and	and	CCONJ
dpc-5668	374	19	erythromycin	erythromycin	NOUN
dpc-5668	374	20	in	in	ADP
dpc-5668	374	21	the	the	DET
dpc-5668	374	22	treatment	treatment	NOUN
dpc-5668	374	23	of	of	ADP
dpc-5668	374	24	impetigo	impetigo	PROPN
dpc-5668	374	25	.	.	PUNCT
dpc-5668	375	1	the	the	DET
dpc-5668	375	2	journal	journal	NOUN
dpc-5668	375	3	of	of	ADP
dpc-5668	375	4	pediatrics	pediatric	NOUN
dpc-5668	375	5	[	[	X
dpc-5668	375	6	internet	internet	NOUN
dpc-5668	375	7	]	]	PUNCT
dpc-5668	375	8	.	.	PUNCT
dpc-5668	376	1	1990	1990	NUM
dpc-5668	376	2	nov	nov	NOUN
dpc-5668	376	3	1	1	NUM
dpc-5668	376	4	[	[	X
dpc-5668	376	5	cited	cite	VERB
dpc-5668	376	6	2024	2024	NUM
dpc-5668	376	7	aug	aug	PROPN
dpc-5668	376	8	24];117(5):827–9	24];117(5):827–9	NUM
dpc-5668	376	9	.	.	PUNCT
dpc-5668	377	1	doi	doi	NOUN
dpc-5668	377	2	:	:	PUNCT
dpc-5668	377	3	10.1016	10.1016	NUM
dpc-5668	377	4	/	/	SYM
dpc-5668	377	5	s0022	s0022	NOUN
dpc-5668	377	6	-	-	PUNCT
dpc-5668	377	7	3476(05)83352	3476(05)83352	NUM
dpc-5668	377	8	-	-	PUNCT
dpc-5668	377	9	9	9	NUM
dpc-5668	377	10	.	.	PUNCT
dpc-5668	378	1	pmid	pmid	NOUN
dpc-5668	378	2	:	:	PUNCT
dpc-5668	378	3	2121951	2121951	NUM
dpc-5668	378	4	28	28	NUM
dpc-5668	378	5	.	.	PUNCT
dpc-5668	379	1	koning	koning	PROPN
dpc-5668	379	2	s.	s.	PROPN
dpc-5668	379	3	fusidic	fusidic	PROPN
dpc-5668	379	4	acid	acid	PROPN
dpc-5668	379	5	cream	cream	NOUN
dpc-5668	379	6	in	in	ADP
dpc-5668	379	7	the	the	DET
dpc-5668	379	8	treatment	treatment	NOUN
dpc-5668	379	9	of	of	ADP
dpc-5668	379	10	impetigo	impetigo	NOUN
dpc-5668	379	11	in	in	ADP
dpc-5668	379	12	general	general	ADJ
dpc-5668	379	13	practice	practice	NOUN
dpc-5668	379	14	:	:	PUNCT
dpc-5668	379	15	double	double	ADJ
dpc-5668	379	16	blind	blind	ADJ
dpc-5668	379	17	randomised	randomised	ADJ
dpc-5668	379	18	placebo	placebo	NOUN
dpc-5668	379	19	controlled	control	VERB
dpc-5668	379	20	trial	trial	NOUN
dpc-5668	379	21	.	.	PUNCT
dpc-5668	380	1	bmj	bmj	PROPN
dpc-5668	380	2	.	.	PROPN
dpc-5668	380	3	2002	2002	NUM
dpc-5668	380	4	jan	jan	PROPN
dpc-5668	380	5	26;324(7331):203–3	26;324(7331):203–3	NUM
dpc-5668	380	6	.	.	PUNCT
dpc-5668	381	1	doi	doi	NOUN
dpc-5668	381	2	:	:	PUNCT
dpc-5668	381	3	10.1136	10.1136	NUM
dpc-5668	381	4	/bmj.324.7331.203	/bmj.324.7331.203	NOUN
dpc-5668	381	5	.	.	PUNCT
dpc-5668	382	1	pmid	pmid	NOUN
dpc-5668	382	2	:	:	PUNCT
dpc-5668	382	3	11809642	11809642	NUM
dpc-5668	382	4	29	29	NUM
dpc-5668	382	5	.	.	PUNCT
dpc-5668	383	1	koning	koning	PROPN
dpc-5668	383	2	s	s	PROPN
dpc-5668	383	3	,	,	PUNCT
dpc-5668	383	4	van	van	PROPN
dpc-5668	383	5	der	der	PROPN
dpc-5668	383	6	wouden	wouden	PROPN
dpc-5668	383	7	jc	jc	PROPN
dpc-5668	383	8	,	,	PUNCT
dpc-5668	383	9	chosidow	chosidow	NOUN
dpc-5668	383	10	o	o	NOUN
dpc-5668	383	11	,	,	PUNCT
dpc-5668	383	12	twynholm	twynholm	PROPN
dpc-5668	383	13	m	m	PROPN
dpc-5668	383	14	,	,	PUNCT
dpc-5668	383	15	singh	singh	PROPN
dpc-5668	383	16	kp	kp	PROPN
dpc-5668	383	17	,	,	PUNCT
dpc-5668	383	18	scangarella	scangarella	NOUN
dpc-5668	383	19	n	n	CCONJ
dpc-5668	383	20	,	,	PUNCT
dpc-5668	383	21	et	et	PROPN
dpc-5668	383	22	al	al	PROPN
dpc-5668	383	23	.	.	PROPN
dpc-5668	383	24	efficacy	efficacy	NOUN
dpc-5668	383	25	and	and	CCONJ
dpc-5668	383	26	safety	safety	NOUN
dpc-5668	383	27	of	of	ADP
dpc-5668	383	28	retapamulin	retapamulin	PROPN
dpc-5668	383	29	ointment	ointment	NOUN
dpc-5668	383	30	as	as	ADP
dpc-5668	383	31	treatment	treatment	NOUN
dpc-5668	383	32	of	of	ADP
dpc-5668	383	33	impetigo	impetigo	NOUN
dpc-5668	383	34	:	:	PUNCT
dpc-5668	383	35	randomized	randomize	VERB
dpc-5668	383	36	double	double	ADJ
dpc-5668	383	37	-	-	PUNCT
dpc-5668	383	38	blind	blind	ADJ
dpc-5668	383	39	multicentre	multicentre	NOUN
dpc-5668	383	40	placebo	placebo	NOUN
dpc-5668	383	41	-	-	PUNCT
dpc-5668	383	42	controlled	control	VERB
dpc-5668	383	43	trial	trial	NOUN
dpc-5668	383	44	.	.	PUNCT
dpc-5668	384	1	br	br	PROPN
dpc-5668	384	2	j	j	PROPN
dpc-5668	384	3	dermatol	dermatol	NOUN
dpc-5668	384	4	.	.	PUNCT
dpc-5668	385	1	2008	2008	NUM
dpc-5668	385	2	may;158(5):1077–82	may;158(5):1077–82	NUM
dpc-5668	385	3	.	.	PUNCT
dpc-5668	385	4	doi	doi	PROPN
dpc-5668	385	5	:	:	PUNCT
dpc-5668	385	6	10.1111	10.1111	NUM
dpc-5668	385	7	/	/	SYM
dpc-5668	385	8	j.1365	j.1365	NOUN
dpc-5668	385	9	-2133.2008.08485.x	-2133.2008.08485.x	ADJ
dpc-5668	385	10	.	.	PUNCT
dpc-5668	386	1	pmid	pmid	NOUN
dpc-5668	386	2	:	:	PUNCT
dpc-5668	386	3	18341664	18341664	NUM
dpc-5668	386	4	30	30	NUM
dpc-5668	386	5	.	.	PUNCT
dpc-5668	387	1	kuniyuki	kuniyuki	PROPN
dpc-5668	387	2	s	s	PROPN
dpc-5668	387	3	,	,	PUNCT
dpc-5668	387	4	nakano	nakano	PROPN
dpc-5668	387	5	k	k	PROPN
dpc-5668	387	6	,	,	PUNCT
dpc-5668	387	7	maekawa	maekawa	PROPN
dpc-5668	387	8	n	n	CCONJ
dpc-5668	387	9	,	,	PUNCT
dpc-5668	387	10	suzuki	suzuki	PROPN
dpc-5668	387	11	s.	s.	PROPN
dpc-5668	387	12	topical	topical	ADJ
dpc-5668	387	13	antibiotic	antibiotic	ADJ
dpc-5668	387	14	treatment	treatment	NOUN
dpc-5668	387	15	of	of	ADP
dpc-5668	387	16	impetigo	impetigo	NOUN
dpc-5668	387	17	with	with	ADP
dpc-5668	387	18	tetracycline	tetracycline	NOUN
dpc-5668	387	19	.	.	PUNCT
dpc-5668	388	1	j	j	PROPN
dpc-5668	388	2	dermatol	dermatol	NOUN
dpc-5668	388	3	.	.	PUNCT
dpc-5668	389	1	2005	2005	NUM
dpc-5668	389	2	oct;32(10):788–92	oct;32(10):788–92	NOUN
dpc-5668	389	3	.	.	PUNCT
dpc-5668	390	1	doi	doi	NOUN
dpc-5668	390	2	:	:	PUNCT
dpc-5668	390	3	10.1111	10.1111	NUM
dpc-5668	390	4	/	/	SYM
dpc-5668	390	5	j.1346	j.1346	VERB
dpc-5668	390	6	-	-	PUNCT
dpc-5668	390	7	8138.2005	8138.2005	NUM
dpc-5668	390	8	.tb00846.x	.tb00846.x	ADJ
dpc-5668	390	9	.	.	PUNCT
dpc-5668	391	1	pmid	pmid	NOUN
dpc-5668	391	2	:	:	PUNCT
dpc-5668	391	3	16361729	16361729	NUM
dpc-5668	391	4	31	31	NUM
dpc-5668	391	5	.	.	PUNCT
dpc-5668	392	1	mclinn	mclinn	PROPN
dpc-5668	392	2	s.	s.	PROPN
dpc-5668	392	3	a	a	DET
dpc-5668	392	4	bacteriologically	bacteriologically	ADV
dpc-5668	392	5	controlled	control	VERB
dpc-5668	392	6	,	,	PUNCT
dpc-5668	392	7	randomized	randomized	ADJ
dpc-5668	392	8	study	study	NOUN
dpc-5668	392	9	comparing	compare	VERB
dpc-5668	392	10	the	the	DET
dpc-5668	392	11	efficacy	efficacy	NOUN
dpc-5668	392	12	of	of	ADP
dpc-5668	392	13	2	2	NUM
dpc-5668	392	14	%	%	NOUN
dpc-5668	392	15	mupirocin	mupirocin	NOUN
dpc-5668	392	16	ointment	ointment	NOUN
dpc-5668	392	17	(	(	PUNCT
dpc-5668	392	18	bactroban	bactroban	PROPN
dpc-5668	392	19	)	)	PUNCT
dpc-5668	392	20	with	with	ADP
dpc-5668	392	21	oral	oral	ADJ
dpc-5668	392	22	erythromycin	erythromycin	NOUN
dpc-5668	392	23	in	in	ADP
dpc-5668	392	24	the	the	DET
dpc-5668	392	25	treatment	treatment	NOUN
dpc-5668	392	26	of	of	ADP
dpc-5668	392	27	patients	patient	NOUN
dpc-5668	392	28	with	with	ADP
dpc-5668	392	29	impetigo	impetigo	PROPN
dpc-5668	392	30	.	.	PUNCT
dpc-5668	393	1	j	j	PROPN
dpc-5668	393	2	am	be	AUX
dpc-5668	393	3	acad	acad	ADJ
dpc-5668	393	4	dermatol	dermatol	NOUN
dpc-5668	393	5	.	.	PUNCT
dpc-5668	394	1	1990	1990	NUM
dpc-5668	394	2	may;22(5):883–5	may;22(5):883–5	PROPN
dpc-5668	394	3	.	.	PUNCT
dpc-5668	394	4	doi	doi	PROPN
dpc-5668	394	5	:	:	PUNCT
dpc-5668	394	6	10.1016/0190	10.1016/0190	NUM
dpc-5668	394	7	-	-	SYM
dpc-5668	394	8	9622(90)70118	9622(90)70118	NUM
dpc-5668	394	9	-	-	PUNCT
dpc-5668	394	10	2	2	NUM
dpc-5668	394	11	.	.	PUNCT
dpc-5668	395	1	pmid	pmid	NOUN
dpc-5668	395	2	:	:	PUNCT
dpc-5668	395	3	2112166	2112166	NUM
dpc-5668	395	4	32	32	NUM
dpc-5668	395	5	.	.	PUNCT
dpc-5668	396	1	mertz	mertz	PROPN
dpc-5668	396	2	.	.	PUNCT
dpc-5668	397	1	topical	topical	ADJ
dpc-5668	397	2	mupirocin	mupirocin	NOUN
dpc-5668	397	3	treatment	treatment	NOUN
dpc-5668	397	4	of	of	ADP
dpc-5668	397	5	impetigo	impetigo	NOUN
dpc-5668	397	6	is	be	AUX
dpc-5668	397	7	equal	equal	ADJ
dpc-5668	397	8	to	to	ADP
dpc-5668	397	9	oral	oral	ADJ
dpc-5668	397	10	erythromycin	erythromycin	NOUN
dpc-5668	397	11	therapy	therapy	NOUN
dpc-5668	397	12	.	.	PUNCT
dpc-5668	398	1	arch	arch	ADJ
dpc-5668	398	2	dermatol	dermatol	NOUN
dpc-5668	399	1	[	[	X
dpc-5668	399	2	internet	internet	NOUN
dpc-5668	399	3	]	]	PUNCT
dpc-5668	399	4	.	.	PUNCT
dpc-5668	399	5	2020	2020	NUM
dpc-5668	400	1	[	[	X
dpc-5668	400	2	cited	cite	VERB
dpc-5668	400	3	2024	2024	NUM
dpc-5668	400	4	august	august	PROPN
dpc-5668	400	5	24th];125(8	24th];125(8	NUM
dpc-5668	400	6	)	)	PUNCT
dpc-5668	400	7	.	.	PUNCT
dpc-5668	401	1	pmid	pmid	NOUN
dpc-5668	401	2	:	:	PUNCT
dpc-5668	401	3	2502950	2502950	NUM
dpc-5668	401	4	33	33	NUM
dpc-5668	401	5	.	.	PUNCT
dpc-5668	402	1	molting	molt	VERB
dpc-5668	402	2	s	s	PROPN
dpc-5668	402	3	,	,	PUNCT
dpc-5668	402	4	strauss	strauss	PROPN
dpc-5668	402	5	wb	wb	PROPN
dpc-5668	402	6	.	.	PROPN
dpc-5668	402	7	treatment	treatment	NOUN
dpc-5668	402	8	of	of	ADP
dpc-5668	402	9	impetigo	impetigo	NOUN
dpc-5668	402	10	and	and	CCONJ
dpc-5668	402	11	ecthyma	ecthyma	NOUN
dpc-5668	402	12	.	.	PUNCT
dpc-5668	403	1	int	int	NOUN
dpc-5668	403	2	j	j	PROPN
dpc-5668	403	3	dermatol	dermatol	NOUN
dpc-5668	403	4	.	.	PUNCT
dpc-5668	404	1	1988	1988	NUM
dpc-5668	404	2	dec;27(10):716–9	dec;27(10):716–9	PROPN
dpc-5668	404	3	.	.	PUNCT
dpc-5668	405	1	doi	doi	NOUN
dpc-5668	405	2	:	:	PUNCT
dpc-5668	405	3	10.1111	10.1111	NUM
dpc-5668	405	4	/	/	SYM
dpc-5668	405	5	j.13654362.1988.tb01273.x	j.13654362.1988.tb01273.x	PROPN
dpc-5668	405	6	.	.	PUNCT
dpc-5668	406	1	pmid	pmid	PROPN
dpc-5668	406	2	:	:	PUNCT
dpc-5668	406	3	3069760	3069760	NUM
dpc-5668	406	4	34	34	NUM
dpc-5668	406	5	.	.	PUNCT
dpc-5668	406	6	oranje	oranje	PROPN
dpc-5668	406	7	ap	ap	PROPN
dpc-5668	406	8	,	,	PUNCT
dpc-5668	406	9	chosidow	chosidow	NOUN
dpc-5668	406	10	o	o	NOUN
dpc-5668	406	11	,	,	PUNCT
dpc-5668	406	12	sacchidanand	sacchidanand	PROPN
dpc-5668	406	13	s	s	PROPN
dpc-5668	406	14	,	,	PUNCT
dpc-5668	406	15	todd	todd	PROPN
dpc-5668	406	16	g	g	PROPN
dpc-5668	406	17	,	,	PUNCT
dpc-5668	406	18	singh	singh	PROPN
dpc-5668	406	19	k	k	PROPN
dpc-5668	406	20	,	,	PUNCT
dpc-5668	406	21	scangarella	scangarella	NOUN
dpc-5668	406	22	n	n	CCONJ
dpc-5668	406	23	,	,	PUNCT
dpc-5668	406	24	et	et	PROPN
dpc-5668	406	25	al	al	PROPN
dpc-5668	406	26	.	.	PUNCT
dpc-5668	406	27	topical	topical	ADJ
dpc-5668	406	28	retapamulin	retapamulin	NOUN
dpc-5668	406	29	ointment	ointment	NOUN
dpc-5668	406	30	,	,	PUNCT
dpc-5668	406	31	1	1	NUM
dpc-5668	406	32	%	%	NOUN
dpc-5668	406	33	,	,	PUNCT
dpc-5668	406	34	versus	versus	ADP
dpc-5668	406	35	sodium	sodium	NOUN
dpc-5668	406	36	fusidate	fusidate	ADJ
dpc-5668	406	37	ointment	ointment	NOUN
dpc-5668	406	38	,	,	PUNCT
dpc-5668	406	39	2	2	NUM
dpc-5668	406	40	%	%	NOUN
dpc-5668	406	41	,	,	PUNCT
dpc-5668	406	42	for	for	ADP
dpc-5668	406	43	impetigo	impetigo	PROPN
dpc-5668	406	44	:	:	PUNCT
dpc-5668	406	45	a	a	DET
dpc-5668	406	46	randomized	randomized	ADJ
dpc-5668	406	47	,	,	PUNCT
dpc-5668	406	48	observer	observer	NOUN
dpc-5668	406	49	-	-	PUNCT
dpc-5668	406	50	blinded	blinded	ADJ
dpc-5668	406	51	,	,	PUNCT
dpc-5668	406	52	noninferiority	noninferiority	NOUN
dpc-5668	406	53	study	study	NOUN
dpc-5668	406	54	.	.	PUNCT
dpc-5668	407	1	dermatology	dermatology	NOUN
dpc-5668	407	2	.	.	PUNCT
dpc-5668	408	1	2007;215(4):331–40	2007;215(4):331–40	NUM
dpc-5668	408	2	.	.	PUNCT
dpc-5668	409	1	doi	doi	NOUN
dpc-5668	409	2	:	:	PUNCT
dpc-5668	409	3	10.1159/000107776	10.1159/000107776	NUM
dpc-5668	409	4	.	.	PUNCT
dpc-5668	410	1	pmid	pmid	NOUN
dpc-5668	410	2	:	:	PUNCT
dpc-5668	410	3	17911992	17911992	NUM
dpc-5668	410	4	35	35	NUM
dpc-5668	410	5	.	.	PUNCT
dpc-5668	411	1	rosen	rosen	PROPN
dpc-5668	411	2	t	t	PROPN
dpc-5668	411	3	,	,	PUNCT
dpc-5668	411	4	albareda	albareda	NOUN
dpc-5668	411	5	n	n	CCONJ
dpc-5668	411	6	,	,	PUNCT
dpc-5668	411	7	rosenberg	rosenberg	PROPN
dpc-5668	411	8	n	n	CCONJ
dpc-5668	411	9	,	,	PUNCT
dpc-5668	411	10	alonso	alonso	PROPN
dpc-5668	411	11	fg	fg	PROPN
dpc-5668	411	12	,	,	PUNCT
dpc-5668	411	13	roth	roth	PROPN
dpc-5668	411	14	s	s	PROPN
dpc-5668	411	15	,	,	PUNCT
dpc-5668	411	16	zsolt	zsolt	PROPN
dpc-5668	411	17	i	i	PROPN
dpc-5668	411	18	,	,	PUNCT
dpc-5668	411	19	et	et	PROPN
dpc-5668	411	20	al	al	PROPN
dpc-5668	411	21	.	.	PROPN
dpc-5668	411	22	efficacy	efficacy	NOUN
dpc-5668	411	23	and	and	CCONJ
dpc-5668	411	24	safety	safety	NOUN
dpc-5668	411	25	of	of	ADP
dpc-5668	411	26	ozenoxacin	ozenoxacin	VERB
dpc-5668	411	27	cream	cream	NOUN
dpc-5668	411	28	for	for	ADP
dpc-5668	411	29	treatment	treatment	NOUN
dpc-5668	411	30	of	of	ADP
dpc-5668	411	31	adult	adult	NOUN
dpc-5668	411	32	and	and	CCONJ
dpc-5668	411	33	pediatric	pediatric	ADJ
dpc-5668	411	34	patients	patient	NOUN
dpc-5668	411	35	with	with	ADP
dpc-5668	411	36	impetigo	impetigo	PROPN
dpc-5668	411	37	.	.	PUNCT
dpc-5668	412	1	jama	jama	PROPN
dpc-5668	412	2	dermatol	dermatol	NOUN
dpc-5668	412	3	.	.	PUNCT
dpc-5668	413	1	2018	2018	NUM
dpc-5668	413	2	jul	jul	PROPN
dpc-5668	413	3	1;154(7):806	1;154(7):806	NUM
dpc-5668	413	4	.	.	PUNCT
dpc-5668	414	1	doi	doi	NOUN
dpc-5668	414	2	:	:	PUNCT
dpc-5668	414	3	10.1001	10.1001	NUM
dpc-5668	414	4	/	/	SYM
dpc-5668	414	5	jamadermatol.2018.1103	jamadermatol.2018.1103	NOUN
dpc-5668	414	6	.	.	PUNCT
dpc-5668	415	1	pmid	pmid	NOUN
dpc-5668	415	2	:	:	PUNCT
dpc-5668	415	3	29898217	29898217	NUM
dpc-5668	415	4	.	.	PUNCT
dpc-5668	416	1	36	36	NUM
dpc-5668	416	2	.	.	PUNCT
dpc-5668	417	1	dharani	dharani	PROPN
dpc-5668	417	2	sudha	sudha	PROPN
dpc-5668	417	3	g	g	PROPN
dpc-5668	417	4	,	,	PUNCT
dpc-5668	417	5	nirmala	nirmala	PROPN
dpc-5668	417	6	p	p	PROPN
dpc-5668	417	7	,	,	PUNCT
dpc-5668	417	8	ramanathan	ramanathan	PROPN
dpc-5668	417	9	r	r	PROPN
dpc-5668	417	10	,	,	PUNCT
dpc-5668	417	11	samuel	samuel	PROPN
dpc-5668	417	12	v.	v.	ADP
dpc-5668	417	13	comparative	comparative	ADJ
dpc-5668	417	14	study	study	NOUN
dpc-5668	417	15	of	of	ADP
dpc-5668	417	16	efficacy	efficacy	NOUN
dpc-5668	417	17	and	and	CCONJ
dpc-5668	417	18	safety	safety	NOUN
dpc-5668	417	19	of	of	ADP
dpc-5668	417	20	azithromycin	azithromycin	NOUN
dpc-5668	417	21	alone	alone	ADJ
dpc-5668	417	22	and	and	CCONJ
dpc-5668	417	23	in	in	ADP
dpc-5668	417	24	combination	combination	NOUN
dpc-5668	417	25	with	with	ADP
dpc-5668	417	26	probiotic	probiotic	ADJ
dpc-5668	417	27	in	in	ADP
dpc-5668	417	28	the	the	DET
dpc-5668	417	29	treatment	treatment	NOUN
dpc-5668	417	30	of	of	ADP
dpc-5668	417	31	impetigo	impetigo	NOUN
dpc-5668	417	32	in	in	ADP